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Abstract 
 
This PhD thesis is divided into three chapters: Introduction, Results and Discussion and 
Experimental Part. 
First part of chapter one is a review of compounds incorporating diamine moieties. 
Nowadays, it is one of the most investigated area of studies in several fields. Their uses 
in medicine and in chemistry will be discussed. However, attention will be refunded 
mainly on the use of diamines in organic synthesis as chiral auxiliaries, as chiral ligands 
in asymmetric synthesis or as organocatalysts. Additionally, the selected methods for 
their preparation will be given. 
In the second part of chapter one, the research area of the phosphorus-heteroatom 
heterocyclic compounds will be the main focus. This part of chapter one will present the 
cyclisation process of chiral diamines around the phosphorus atom. The cyclisation step 
affords heterocycles containing a trivalent or pentavalent stereogenic phosphorus atom. 
Finally, the application of these compounds in catalyzed transition metal 
transformations will be discussed. 
The investigation, presented in terms of the current thesis in chapter two, covers the 
preparation of various diamine ligands based on camphoric acid. The chiral diamine 
ligands with nitrogen atoms containing the same or different substituents will be 
described and their application in to the nitroaldol reaction presented which provides an 
easy access to chiral β-nitroalcohols in high enantioselectivity up to 84% and excellent 
yield in up to 93%. The further transformations of the secondary chiral diamines into 
heterocycles containing phosphorus atom in quantitative yields in up to 97% without 
any purification and their application as ligands or as versatile chiral shift reagents will 
be also discussed in the second chapter.  
Lastly, the third chapter is the collection of experimental procedures and data of the 
presented work. 
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Kurzzusammenfassung 
 
Die vorgelegte Doktorarbeit ist in drei Hauptkapitel gegliedert: Einleitung, Ergebnisse 
und Diskussion und Experimenteller Teil. 
Der erste Teil der Einleitung gibt einen Überblick über Verbindungen mit einer Diamin-
Komponente, die in den unterschiedlichsten Bereichen intensiv untersucht werden. 
Dabei wird deren Verwendung in der Medizin und Chemie diskutiert. Hauptsächlich 
werden sie jedoch als chirale Auxiliare in der organischen Synthese, als chirale 
Liganden in der asymmetrischen Synthese und als Organokatalysatoren eingesetzt. 
Zusätzlich werden ausgewählte Synthesemöglichkeiten der Diamin-Verbindungen 
aufgeführt. 
In dem zweiten Teil der Einleitung liegt der Fokus auf dem Forschungsfeld der 
Phosphor-basierten heterozyklischen Verbindungen. Dieser Teil beschreibt die 
Zyklisierung von chiralen Diamin-Verbindungen zu Phosphor-basierten Heterozyklen 
mit einem drei- oder fünfbindigen stereogenen Phosphoratom. Abschließend wird die 
Anwendung dieser Verbindungen in übergangsmetall-katalytischen Reaktionen 
diskutiert. 
Die Synthese und darauffolgende Untersuchung unterschiedlicher Diamin-
Verbindungen basierend auf Camphersäure werden im zweiten Kapitel dargestellt. 
Dabei werden die chiralen Diamin-Liganden, deren Stickstoffatome entweder gleiche 
oder unterschiedliche Substituenten tragen, beschrieben und deren Anwendung in der 
Nitroaldol-Reaktion vorgestellt. Über diese Reaktion können, chirale-ß-Nitroalkohole 
mit hoher Enantioselektivität von bis zu 84% und hervorragenden Ausbeuten von bis zu 
93% unter Verwendung der neuen Liganden erhalten werden. Anschließend wird die 
Umsetzung der hierbei dargestellten chiralen sekundären Diamin-Verbindungen zu 
Phosphor-basierten Heterozyklen beschrieben, die mit einer Ausbeute von bis zu 97% 
ohne weitere Aufreinigung erhalten werden Zudem werden sie als Liganden und als 
vielseitig einsetzbare chirale Shift-Reagenzien diskutiert und untersucht. 
Abschließend sind im letzten Kapitel die Synthesen und experimentellen Daten der im 
Rahmen dieser Arbeit dargestellten Verbindungen aufgeführt. 
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Abbreviations 
 
δ     Chemical shift 
°C     Temperature in degree centigrade 
Ac     Acetyl 
AD-H Amylose tris(3,5-dimethylphenylcarbamate) high         
performance 
AS-H Amylose tris[(S)-α-methylbenzylcarbamate] high 
performance 
aq.     Aqueous 
Ar     Aryl 
BINAP   2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl 
Bn     Benzyl 
bp    Boiling point 
br    Broad  
br s    Broad singlet 
BSA    Bis(trimethylsilyl)acetamide 
Bu    Butyl 
c     Concentration 
CDCl3    Deuterated chloroform 
CHCl3    Chloroform 
cm     Centimeter 
d     doublet 
DABCO    1,4-Diazabicyclo[2.2.2]octane 
 v 
 
DCM     Dichloromethane 
dd     doublet doublet 
ddd     doublet doublet doublet 
DIAPHOX   Diaminophosphine oxide    
dr     diastereomeric ratio 
EDTA    Ethylenediaminetetraacetic acid 
ee     enantiomeric excess 
eq     Equivalent 
ESI     Electron spray ionisation 
et al.     et alii (‘and others’) 
Et     Ethyl 
Et2O     Diethyl ether 
EtOAc    Ethyl acetate 
EtOH     Ethanol 
FCC     Flash column chromatography 
g     Gram 
h     Hour 
HASPO   Heteroatom-substituted secondary phosphine oxide 
HPLC    High pressure liquid chromatograpy 
HRMS    High resolution mass spectroscopy 
Hz     Hertz 
i     iso 
iPrOH    Isopropanol 
 vi 
 
IR     Infrared 
J     Coupling constant 
m     Multiplet 
M    Molar (mol/L) 
m/z     Mass to charge ratio 
Me     Methyl 
MeCN    Acetonitrile 
MeOH    Methanol 
MHz     Megahertz 
min     Minute(s) 
mmol     Millimole 
mol     Mole 
mp.     Melting point 
MS     Mass spectroscopy 
Naphth    Naphthyl 
NMR     Nuclear magnetic reasonance 
o     ortho 
p     para 
Ph     Phenyl 
ppm     Parts per million 
q     Quartet 
R     Alkyl 
rt     Room temperature (25°C) 
 vii 
 
SPO    Secondary phosphine oxide 
t     triplet 
TEA     Triethylamine 
THF     Tetrahydrofuran 
TMEDA   Tetramethylethylenediamine 
Ts     para-Toluene sulfonate 
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1. Introduction 
The phenomenon of chirality, common in nature, is an inseparable feature of various 
levels of matter. Chirality plays a huge role in many areas such as biology and material 
science.
1
 Chiral recognition and differentiation of the enatiomers are indeed a 
fundamental goal in chemistry. This point affects the climax of many branches of 
chemistry and industry, in particular pharmacy.
2
 Chiral separation of isomers in 
medicine and pharmacy plays a key role. One of the enantiomers may not have 
therapeutic properties, while the second enantiomer may be inactive, and in the worst 
case, one may be toxic.
3
 One of the example of the importance of separation of two 
isomers and the relation between molecular chirality and pharmacological activity is the 
tragedies of the thalidomide babies in the 1960s, when the drug was used for a treatment 
of nausea in pregnant women.
4
 In the case of thalidomide, (S)-enantiomer 1 demonstrate 
teratogenic and induces fetal malformations, while (R)-enantiomer 2 posse’s desirable 
sedative properties.
5 Unfortunately, later tests showed that (R)-(+)-thalidomide 2 can 
racemize in the liver. Thus, another example of the significance of separation of two 
isomers is ethambutol. The (S,S)-enantiomer 3 is a frontline antituberculous drug, while 
(R,R)-enantiomer 4 can cause blindness
6 
(Figure 1). 
 
 
 
Figure 1. The Absolute Configuration of Thalidomide and Ethambutol. 
 
Despite many accidences associated with racemates until 1992, the Food and Drug 
Administration in the U.S. introduced clear rules called “racemic switches” in order to 
syntheses single enantiomers.
1
 Since that time, progress in the separation of enantiomers 
is impressive. Nowadays it has been an essential challenge for chemists in academia and 
industry. Racemates have large importance not only in medicine but also in such areas 
like cosmetics and food industry. One essential example is limonene of which the     
(R)-enantiomer 5 smells like orange and the (S)-enantiomer 6 smells like lemon.
7,8
 The 
same situation is with the (S)-enantiomer 7 of the amino acid asparagines which is 
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responsible for a sweet taste while the (R)-enantiomer 8 is responsible for a bitter taste 
(Figure 2).
9
  
 
 
 
Figure 2. Examples of Enantiomers. 
 
1.1. Chiral Diamines 
Chiral diamines contain in their structure two amino groups, which can be attached to 
different atoms in a chain of carbon atoms. Since many years chiral diamine derivatives 
are investigated by many research groups. Some examples of them which are the most 
widely used and reported are presented in Figure 3.
10
 
 
 
 
Figure 3. Examples of Chiral Diamines.  
 
Since enantiopure diamines are constituents of many natural products
11
 they play an 
important role in various areas of science such as pharmaceutical or medicinal 
chemistry.
12
 Also chiral diamines found huge interest in stereoselective organic 
synthesis
13
 where they can be successful used as chiral catalysts, chiral reagents and 
chiral ligands. Taking into account the wide use of these compounds it is not a surprise 
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that development of novel synthetic methodologies to obtain enantiopure diamines has 
been a subject of intense research.
14
 
 
1.1.1. Diamines in Natural Products
13
 
Nowadays many natural products are known where we can find diamino moieties in 
their structures. One of the best examples are peptides which contain n, n+1 diamino 
carboxylic acid 15,
15
 like diaminopropanoic acid which is part of the composition of 
antibiotics such as edeines and tuberactomycin derivatives. 2,3-Diamino carboxylic acid 
is a part of well known antibiotics, like penicillin 16
16
 discovered by Alexander Fleming 
in 1929
17
 and cephalosporin 17
18
 found by Giuseppe Brotzu in 1948. The vitamin H 
also called biotin or coenzyme R 18
19
 contains a 1,2-diamino unit (Figure 4).
13
 
 
 
 
Figure 4. Natural Products Containing Diamino Moieties. 
 
1.1.2.  Diamines in Medicinal Chemistry 
Diamines are an essential part of biologically active compounds. Chiral diamines such 
as 1,4-diamines have found application as intermediates in the synthesis of potent HIV 
protease inhibitors. However, 1,2-diamines play a key role in applications in medicinal 
chemistry. These compounds have been reported for instance against, antiarrhythmics, 
antidepressant agents antipsychotics, analgesics, antianxiety agents, antiparasitic agents 
and anticancer drugs.
13
 Cisplatin 19 is one of the most well-known cancer drugs. In the 
mid 1960s Rosenberg discovered antitumoral properties of cisplatin, which started a 
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new beginning of the synthesis of novel diamine-platinum complexes like DWA 2114R 
20, NK 121 21, oxaliplatin 22 and NDDP 23 (Figure 5). 1,2-Diaminoplatinum 
complexes are used in antitumor chemotherapy because they have high antitumoral 
activity and less toxicity.
13 
 
 
 
Figure 5. Diamine – Platinum Complexes. 
 
EDTA 24 is another example of a compound which posses in its structure a 1,2-diamine 
moiety (Figure 6).
20
 From a medical point view, EDTA has the ability to chelate metal 
ions to generate stable complexes which can be used in the field of nuclear medicine.
21
 
 
 
 
Figure 6. Structure of EDTA. 
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1.1.3. Diamines in Organic Chemistry 
Organic chemistry is an area where chiral diamines are widely used as auxiliaries or 
ligands in stereoselective synthesis. Diamines also have found applications as novel 
reagents for enantioselective synthesis. 
One of the types of important diamines which are often used in organic transformations 
is TMEDA 25. It plays a key role as a ligand which is able to generate stable complexes 
with many metal halides.
22
 Next interesting example is DABCO 26. This compound can 
be a Lewis base catalyst for polyurethane for the Baylis-Hillman reaction, or it can be 
used as a Brønsted base (Figure 7).
23
 
 
 
 
Figure 7. TMEDA and DABCO as Examples of Diamines in Organic Chemistry. 
 
1.1.3.1. Resolution of Racemates and Determination of Enantiomeric 
Excess
13
 
Resolution is one of the oldest methods used for the separation of racemic compounds 
into their enantiomerically pure forms.
24,25
 The most common example of a resolution 
of trans-1,2-cyclohexadiamine 9 by crystallization was described by Larrow and 
Jacobsen which is illustrated in Scheme 1.
26
 
 
 
 
Scheme 1. Resolution of rac-27. 
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The (R,R)-1,2-cyclohexadiamine 9 and (R,R)-1,2-diphenylethylenediamine 10 were 
used to resolve binaphthol atropisomers 30 (Figure 8).
13
 
 
 
 
Figure 8. 1,2-Diamines Used to Resolve Atropisomeric Binaphthols.
13
 
 
Diamines have found also application as resolving agents for chiral aldehydes. 
Mangeney, Alexacis and co-workers proved that the enantiopure aldehydes can be 
determined by NMR or isolated by chromatographic methods after converting them into 
diastereomeric imidazolidines (aminals) by condensation with N,N’-dimethyl-1,2-
diphenylethylene diamine (DMPEDA)
27
 which was the most efficient diamine in this 
case (Scheme 2).
28
 
 
 
 
Scheme 2. 1,2-Diamines as Resolving Agents for Aldehydes. 
 
1.1.3.2. Diamines as Chiral Auxiliaries  
Chiral auxiliaries are enantiomerically pure compounds that are connected to a substrate 
in order to control the stereochemical course of a reaction.
29
 Especially for asymmetric 
transformations the use of chiral auxiliaries is a flexible and well-established method.
30
 
Several examples of chiral auxiliaries based on diamines have found their way in highly 
stereoselective synthesis.
13
 
Introduction 
8 
 
Chiral bicyclic phosphonamides 31 were reported from diaminocyclohexane as chiral 
auxiliaries by Hanessian’s group,31,32 and also inspired by the work of Blazis et al.33 
The process is shown in Scheme 3. The anion derived from 31, which was prepared 
from (R,R)-1,2-bis-N-methylamino-cyclohexane 32 with a base such as n-BuLi or LDA, 
was treated by an alkyl halide and after hydrolysis of the resulting product 33 the 
corresponding α-substituted phosphonic acids 34 were obtained in excellent yields.32 
 
 
 
Scheme 3. Chiral Bicyclic Phosphonamides Prepared from a C2 Symmetrical 
Diamine. 
 
Corey described the boron-containing chiral auxiliaries, derived from 1,2-
diphenylethylenediamine
13
 35 which was applied in an enantioselective aldol reactions 
as presented in Scheme 4 for the synthesis of syn aldol product 36 and the anti aldol 
product 37 with excellent diastereoselectivity and enantioselectivity.
34
 The investigation 
shows that the difference in stereochemistry of enolate construction from 1,2-
diphenylethylenediamine 35 as a function of ester formation can be due to a 
fundamental mechanistic dichotomy. The initial complex of 35 with S-phenyl 
thiopropionate 40 may undergo sulfur-promoted dissociation of bromide ion in CH2Cl2 
to generate ion pair 41 more rapidly than direct deprotonation by the hindered base 
diisopropylethylamine (DPEA). Deprotonation of 41 in the conformation shown would 
then favor the "cisoid" enolate 39. The less polar solvent should slow the dissociation of 
40 to ion pair 41 while the sterically smaller TEA (triethylamine) is supposed to 
accelerate the direct deprotonation of 40 to generate the transoid enolate. In contrast, the 
bulky tert-butyl group prefers an out-of-plane orientation which disfavors ionization to 
45 that’s why the complex of 35 and tert-butyl propionate 42 should lose bromide ion 
slowly compared to deprotonation by TEA, to generate the transoid enolate.
35 
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Scheme 4. Enantioselective Syn or Anti Aldol Reactions of Boron Enolates Derived 
from a C2-Symmetric Diazaborolidine.   
 
1.1.3.3. Diamines as Ligands in Asymmetric Synthesis 
Asymmetric synthesis is one of the most developing areas in organic chemistry. 
Therefore, it is very important nowadays to design external chiral ligands.
36
 One of 
them are diamines which play a huge role as ligands for organometallic catalysis.  
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The group of Knochel reported a successful example of the addition of dialkylzinc 46 to 
aldehydes 47 in the presence of the diamine 48 linked chiral Ti(IV) complex as the 
catalyst
37
 which affords functionalized secondary alcohols 49 with high 
enantioselectivity (Scheme 5).
38-40  
 
 
Scheme 5. Enantioselective Addition of Dialkyzinc to Aldehydes in the Presence of 
1,2-Diamine. 
 
Evans et al. described the influence of C2-symmetric bis(oxazoline)copper complexes 
from diamine as catalysts for the Diels-Alder reactions. Cycloadducts synthesized from 
a diene and an oxazolidinone were achieved in excellent yields and enantioselectivities 
(Scheme 6).
41
 In addition, Corey has proved that the same ligands linked with Mg(II)
42
 
and Fe(III)
43
 complexes as chiral Lewis acid catalysts showed the successful application 
in the Diels-Alder reaction of unsubstituted acrylimides.
41
  
 
Scheme 6. Enantioselective Diels-Alder Reaction. 
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Chiral diamines found also applications in the catalytic transfer hydrogenation using 
formic acid as hydrogen source which is a well known, inexpensive reducing agent.
44
 
Noyori were successful in the asymmetric reduction of racemic threo-β-hydroxy-α-
amino acids 56 applying this hydride donor to furnish threo-57 isomer in 94% ee using 
a chiral rhodium catalysts and vicinal diamine 58 as ligand (Scheme 7).
45
 More recently, 
followed by Nyori’s work, Miostkowski and co-workers proved that introducing a 
better electron-withdrawing perfluorobutylsulfonate group on the TsDPEN (N-tosyl-
1,2-diphenylethylenediamine) ligand increases the catalyst activity and stereoselectivity 
up to > 99% ee in transfer hydrogenations via dynamic resolution.
46
  
 
 
 
Scheme 7. Asymmetric Transfer Hydrogenation Using Chiral Ru-Diamine 
Complex as a Catalyst. 
 
1.1.3.4. Diamines as Organocatalysts 
The phrase organocatalyst is a connection between two words: “organic” and “catalyst”. 
In connection with the use of L-proline as organocatalysts for the intramolecular aldol 
reaction by two independent pharmaceutical companies Hoffman-La Roche
47
 and 
Schering AG
48
 in the early 1970s
49
, proline started to be a good asymmetric catalyst. 
There are many reasons why it has become a significant, chiral molecule in asymmetric 
catalysis. First of all, proline is available in both enantiomeric forms. From the 
chemistry side, proline is bifunctional, which means in proline’s structure is a 
carboxylic acid and amine portion, which can both act as an acid or base and also can 
facilitate chemical transformations in concert, similar to enzymatic catalysis.
49
 
Surprisingly, this idea was not exploited until lately.
50
 In 2000 a breakthrough for 
organocatalytic reactions was achevied. MacMillan proposed the concept of 
organocatalysis which defines itself as the acceleration of chemical reactions with a 
substoichiometric amount of an organic molecule which does not include a metal atom 
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in the catalytic active center.
51
 The field of asymmetric organocatalysis is a rapidly 
progressing area and catalysts have been used in many different reactions such as the 
Michael reaction,
52
 aldol condensation,
53
 and others. 
Nowadays, many groups are focused on proline-derived diamines. Alexakis et al. 
described the 2,2’-bipyrrolidine derivatives 59 a-h which can be compared to L-proline 
due to its pyrrolidine backbone
50
 as an organocatalysts for the asymmetric addition of 
ketones to nitroolefins 60 (Scheme 8).
54
 Change of the additive from p-TSA
.
H2O to HCl 
in MeOH and from acetone to cyclohexane afforded much higher enantioselectivities in 
up to 81% ee.
54
  
 
 
 
Scheme 8. Asymmetric Michael Addition of Ketones to Nitroolefins. 
 
The group of Deok-Chan Ha reported a successful example of a bisammonium salt of 
mono-N-alkylated chiral 1,2-diamino-1,1-diphenylethane (DPEN) in the Diels-Alder 
reaction between cyclopentadiene 51 and crotonaldehyde 62 (Scheme 9). It is the first 
case where a chiral 1,2-diamine formed an imine intermediate 3 which is activated for 
the cycloaddition by an internal ammonium Brønsted acid in wet solvent. Interesting is 
that solvents having more than 10% (by volume) of water indicated a decreased 
endo/exo selectivity and endo-enantioselectivity.
55 
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Scheme 9. Diels-Alder Reaction. 
 
DMEDA was examined by Lei and co-workers as catalyst to promote the direct C-H 
arylation of unactivated benzene 65 with aryl iodides 66 in the presence of potassium 
tert-butoxide (Scheme 10). The novel method is believed to involve an aryl radical 
anion as an intermediate. This discovery suggests an option toward establishing a new 
horizon for the direct C-H/cross-coupling reactions.
56
 
 
 
 
Scheme 10. DMEDA-Catalyzed C-H Arylation.  
 
1.1.4. Methods of Diamine Syntheses 
Due to the huge interests in the use of diamines in many areas of chemistry, many 
researchers have been developed novel and effective methods for their preparation. 
Recently, several ways have been described using different compounds as a starting 
material, such as double substitution of diols, reduction and addition of organometallic 
reagents to diimines, reductive coupling of imines and N-sulfinylimines, and diaza-
Cope rearrangement
57
 (Scheme 11).
13
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Scheme 11. Routes for the Synthesis of Diamines. 
 
1.1.4.1. Synthesis of DPEN  
DPEN (1,2-diphenylethylenediamine) is one of the most recognized and common used 
substance as a diamine moiety. Racemic DPEN 10 can be synthesized in two ways. It 
can be obtained through the hydrolysis of isoamirine synthesized from ammonia and 
benzaldehyde 68 (Scheme 12a)
58
 or from the reduction of the intermediate imidazole 
generated by the reductive ammination of cyclohexanone 69 and benzyl             
(Scheme 12b).
59
 The enantiomerically pure form of (S,S)-10 and (R,R)-10 can be 
obtained by the resolution of the racemic product with L- or D-tartaric acid.
60
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Scheme 12. Synthesis of DPEN. 
 
1.1.4.2. The Development of Diamination of Alkenes 
Sharpless et al. have reported the diamination of monosubstituted and disubstituted E-
olefins through a stereospecific cis addition in the presence of the triimidoosmium 
complex 77 (Scheme 13).
61
 Although the desire products were obtained in good yields, 
the reaction is only possible with E-alkenes. In addition, complex 75 has to be 
synthesized from OsO4, which is expensive and has to be used in stoichiometric 
amounts.
13 
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Scheme 13. Asymmetric Diamination of Alkenes in the Presence of the 
Triimidoosmium Complex. 
 
Nowadays, the diamination is an established method. Shi and co-workers proposed the 
regioselective diamination of dienes. They suggested in their report that conjugated 
dienes 79 can be regioselectively diaminated by Cu(I) as a catalyst and di-tert-
butyldiazaridone 80 as a nitrogen source. The desired chiral diamines (R,R)-81 and 
(S,S)-81 were obtained via the diamination at the internal double bond and the 
resolution of the racemic diamine with L- and D-tartaric acid in the last step, with high 
regio- and diastereoselectivity in good yield (Scheme 14).
62
 The CuBr as the catalyst 
provided a higher regioselectivity than CuCl.
63,64
  
 
 
 
Scheme 14. CuBr-Catalyzed Regioselective Diamination. 
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1.1.4.3.  Diamines from Imines 
The reductive coupling of imines is a straightforward method for generating vicinal 
diamines.
65
 In principle, the reductive coupling leads to variable proportions of anti- 
and syn-diamines.
13
  
Pederson and Roskamp researched a convenient method for the preparation of 
unsubstituted vicinal diamines from N-(trimethylsilyl) imines with d
1
 niobium reagent 
(NbCl4(THF)2) 84 (Scheme 15). The presented process is able to give the desired 
diamines with good yields and diastereoselectivities. The dialkyl products show 
however lower results
66
 and the resolution of racemic diamines can require the use of 
complicated methods.
67
 
 
 
 
Scheme 15. Vicinal Diamines by Pederson. 
 
More recently, Xu et al.
65
 have investigated a practical way for the preparation of 
diamines by the reductive homocoupling of aromatic N-tert-butanesulfinyl imines in the 
presence of SmI2 and HMPA (Scheme 16). The authors were able to prepare 
enantimerically enriched C2-symmetrical diamines in excellent yields and 
diastereoselectivities. However, the electron-donating substituted imines were relatively 
less reactive and gave a lower yield of homocoupling products.
65 
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Scheme 16. Preparation of Diamine by Reductive Homocupling. 
 
1.1.4.4. Diamines from β-Amino Alcohols 
Taking into account the development of effective methods for the preparation of 
diamines, amines substituted at the β-position by a hydroxyl group are widely used as 
starting material. Many optically active β-amino alcohols can be synthesized from 
natural compounds from the chiral pool such as alkylated amino acids through 
reduction.
13,68
 
Kokotos and co-workers have developed the method to reach diamine 89 with 62% 
yield using L-glutamic acid 90 by reduction of the amino acid, replacement of the 
hydroxyl group by an azido group and selective reduction (Scheme 17). The presented 
procedure reported for the conversion of glutamic acid into diamine is free of 
racemization.
69
 
 
  
 
Scheme 17. Diamines from Amino Acids. 
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Syntheses of chiral diamines have been reported by O’Brien et al.70-72 They proposed a 
one-pot method to obtain homochiral diamines 94 from commercially available         
(R)-styrene oxide 95 in high yields. Unfortunately, the reaction was only possible when 
reactive amines such as pyrrolidine and piperidine were used in the first step. Hence, in 
further work they investigated new strategies where they used phenylglycinol 96 which 
is available in two enantiomeric forms as a precursor to diamines 97 (Scheme 18).
13,70
   
 
 
 
 
Scheme 18. Preparation of Diamines from (R)-Styrene Oxide or (R)-Phenylglycinol 
 
1.1.5.  Summary 
Compounds incorporating diamino moiety in their structures play significant roles in 
synthesis. The diamines can be derived from natural products or from synthesis. This 
fact let to use diamines in many scientific fields. Taking into account their biological 
properties some of them found applications as medicinal agents. Moreover, chiral 
diamine derivatives are useful compounds in organic synthesis. They are ideally suited 
as chiral auxiliaries or as ligands especially in catalytic asymmetric reactions. 
Additionally, there are many different routes for the synthesis of diamines. However, 
few examples are of broad scope. Most of them are able to form specific classes of 
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primary, secondary, and tertiary diamines or syn, anti products. Others are suited for the 
preparation of C2-symmetrical desired diamines. These days the challenge is to develop 
new ways to prepare chiral diamines selectively either from the chiral pool and via 
asymmetric catalysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
21 
 
1.2. Organophosphorus Compounds 
Arabian alchemists have discovered phosphorus in the 12
th 
century nonetheless the 
whole success of the discovery of the element belongs to a German physician and 
alchemist who first isolated it in 1669 by distillation from urine. Nowadays phosphorus 
has found huge interest in many areas of research. Especially the development of 
organophosphorus compounds has found huge attention this days.
73
  
Since the early 1970s, chiral ligands and their application to several transition metal-
catalyzed asymmetric transformations has been the subject of attention for several 
research groups.
74
 Desirable ligands, from a practical view, should be air-stable, easily 
accessible and inexpensive. On the other hand, from a functional view a new ligand 
should give the desired product in a highly regio- and enantioselective manner. There 
are many examples of organophosphorus compounds which have found huge 
applications, for example in agriculture, medicine or organic synthesis like the 
Mitsunobu, Wittig and Staudinger reaction and as ligands in catalysis or as 
organocatalysts.
75
 They play an important role in the growth, reproduction and 
sustenance of life. For example, esters and thioesters of phosphoric acid are used as 
pesticides. Phosphate esters are known as precursors in the bio-synthesis of many macro 
molecules. Diazophospholes, diazophosphirinanes and certain phosphinyl carbamates 
have applications in the field of medicine and chemistry. Some of them have 
demonstrated to possess antitumor, antiviral, bactericidal and anti-carcinogenic 
activity.
76
 Organophosphorus combinations are very important chiral auxiliaries in  
synthesizing many organic compounds.
77
 Those compounds are also applied as chiral or 
achiral ligands to the nowadays rapidly growing field of transition metal-catalyzed 
transformations.
78
 
 
1.2.1. Phosphines 
Since phosphines and derivatives are known to be excellent ligand precursors, they have 
found huge applications as stable ligands in numerous transition-metal-catalyzed 
asymmetric reactions.
79
 Significantly, ligands play an important role in activating the 
transition metal as an efficient catalyst. Despite the variety of ligands available, the 
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large number of phosphine ligands with different functions and structural forms 
nowadays are the most essential type of ligands in transition-metal catalyzed 
transformations.
80
 The most common and useful phosphines are presented in Figure 9.
78,81-87
  
 
 
 
 
Figure 9. Examples of the Most Used Phosphines. 
 
The development of novel chiral ligands containing heterodonor atoms with nitrogen 
and phosphorus functional moieties (P,N-ligands) are widely investigated in metal-
catalyzed asymmetric reactions.
88
 The P,N-ligands are extremely attractive compounds 
because they can stabilize metal ions in a variety of oxidation states and geometries.
89
 
These hemilabile ligands in their structure have the well balanced combination of hard 
and soft donor atoms which is resulting unsymmetrical coordination to transition 
metals.
87 Another advantage of this class of ligands is that they can display different 
coordination modes compared with P,P- and N,N- ligands.
89
 The π-acceptor character of 
the phosphorous ligand can stabilize a metal center in a low oxidation state, while the 
metals more susceptible to oxidative addition reactions.
90
 Furthemore, their chelating 
effect confers stability to the catalyst in the absence of substrates.
89
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1.2.2. Phosphorus-Heteroatom Heterocyclic Compounds 
In the late years of the 19
th
 century phosphorus-containing heterocycles were 
synthesized for the first time. Although phosphorus heterocyclic compounds have been 
studied for many years, it is only since the middle of the 20
th
 century that researchers 
have realized the importance of these compounds especially in biological areas. This 
fact started the development of new varies of functionalized phosphorus-containing 
heterocycles, especially structures containing phosphorus-heteroatom bonds,
91
 which 
can be  abbreviated as SPO (secondary phosphine oxides) or according to the  
suggestion of Ackermann HASPO (heteroatom-substituted phosphine oxides).
92
 First 
heterocyclic compounds having both phosphorus and nitrogen atoms were prepared by 
Liebig and Wöhler.
93
  
Enantiopure or enantioenriched heterocycles containing a trivalent or pentavalent        
P-stereogenic phosphorus atom can be easily generate by cyclisation of diamines, amino 
alcohols or diols around phosphorus moieties. Another advantage of this class of 
compounds is that they can be prepared in an inexpensive easy way in high yields and 
optical purities. Phosphorus-heteroatom heterocycles are extremely attractive 
compounds because in contrast to the classic phosphines they presented marked stability 
towards moisture and air. In addition, they can be used as organocatalysts or as ligands 
in transition metal transformations (Figure 10).
94
  
 
 
 
Figure 10. Phosphorus-Heteroatom Heterocycles. 
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1.2.2.1. Diazophospholidines 
 
1.2.2.1.1. Phosphorus Tertiary Diazophospholidines 
Five-membered ring diazophospholidines called also diaminophosphines which contain 
in their structure N,P,N atoms are nowadays very desired compounds in chemistry. 
These stable P-compounds can be easily synthesized in two possible pathways which 
are depending on the phosphorus precursors. The procedures are based on the 
displacement of two leaving groups (chlorine or dimethylamino groups) via a chiral 
secondary diamine (Scheme 19).  
 
 
 
Scheme 19. Possible Pathways to Obtain P-Diazophospholidines. 
 
The first route described in Scheme 19 shows the preparation of P(III) 
diazophospholidines with phosphorus trichloride or a dichlorophosphine in benzene or 
toluene at low temperature in the presence of a triethylamine as a base
95
 followed by the 
filtration of the resulting Et3N
.
HCl.
96
  
Many examples of diazophospholidines were achieved through the first route. Bondarev 
et al. proposed the preparation of chlorodiaminophospane 118 which marked the 
beginning of a series of desired derivatives of phosphoprus triamides. The compound 
118 contains a chiral P atom and was achieved as an anti isomer through the 
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diastereoselective phosphorylation of (S)-2-(anilinomethyl)pyrrolidine 119. The latter 
was easily prepared from L-glutamic acid 120 (Scheme 20).
97,98
  
 
 
 
Scheme 20. Preparaton of Chlorodiaminophospane. 
 
Further research has been performed by Leitner, Franciò and co-workers. They obtained 
compound 118 as a mixture of the two diastereoisomers in which the syn diastereomer 
predominates.
94,99
 Additionally, they noted that the presence of a base accelerates the 
epimerization process. In further studies they obtained novel ligands in good to 
excellent yields and with high diastereomeric purities by treating the diastereomeric 
mixture 118 with various secondary amines (Figure 11).
99
 
 
 
 
Figure 11. 
 
Gavrilov’s group following the first procedure afforded many various ligands. One 
group of novel P,N-ligands were synthesized through a one step phosphorylation of 
amino alcohols
100
 or terpene alcohols
101
 with chlorodiaminophospane 118 (Figure 12). 
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The synthesis of stable compounds was highly stereoselective, yielding only epimers 
with exocyclic substituents at the phosphorus atom in a pseudo-equatorial location.
100
 
 
 
 
Figure 12. 
 
Inspired from previously synthesized BINAP 105, they also discovered very promissing 
phosphite-type ligands with P*-stereogenic phosphoramidites derived from ortho-
substituted BINOL (Figure 13).
102,103
  
 
 
 
Figure 13. 
 
Tsarev et al. proposed the synthesis of novel P,N-bidentate diamidophosphites 
possesing a P*-stereocentre and a distant ferrocenylimino group (Figure 14).
104
  Chiral 
ligands containing in their structure ferrocene and its derivatives have been the subject 
of increasing attention in organometallic chemistry.
105
 This sandwich structure has 
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perfect properties such as: thermal stability or high tolerance to moisture and many 
kinds of reagents.
106,107,108  
 
 
 
Figure 14. 
 
A second route has been performed through the reaction between the diamine and 
bis(dimethylamino)phosphines or tris(dimethylamino)phosphine (HMPT) in toluene at 
reflux to obtain usually the pure anti diastereoisomer (Scheme 19, Second Route).
109
 In 
contrast to the first pathway, no base is required in the second case. Although the 
second pathway is limited to thermally stable compounds,
94
 excellent results were 
obtained.  
An example for the preparation of ligand (SEMI-EPHOS) 137 by the second route was 
presented by Buono and co-workers
110
 following the initial work of Wills.
111
 They 
obtained SEMI-EPHOS ligand 137 as a single isomer in 69% yield (Scheme 21).
110,111
  
 
 
 
Scheme 21. Preparation of SEMI-EPHOS Ligand. 
 
An important class of unsymmetrical P,N-ligands was proposed by Buono et al. The 
corresponding chiral quinoline-phosphine ligands 140 (QUIPHOS) were prepared, 
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respectively by the exchange reaction between tris(dimethylamino)phosphine and a 
chiral auxiliary (Figure 15) in good to excellent yields.
112,113
  
 
 
 
Figure 15.  
 
Very interesting are diphosphorus ligands, which can be prepared in both ways. 
ESPHOS 145 can be synthesized in 76% yield as a single diastereoisomer (Scheme 22). 
Unfortunately, ESPHOS ligand 145 was not as effective as SEMI-ESPHOS 137 for the 
catalysis of asymmetric allylic substitution reactions.
111
  
 
 
 
Scheme 22. The Synthesis of ESPHOS. 
 
In the literature only a few examples of similar bi- or polyphosphorus ligands are 
known which are shown below (Figure 16).
94
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Figure 16. 
 
1.2.2.1.2. P(V) Diazaphospholidines 
Diazophospholidines have found huge attention these days as ligands in transition 
metal-catalyzed transformations. Some of them play also a key role as precursors to 
generate novel diazophospholidine boranes, and few classes of P(V) compounds such as 
oxides, sulfides or iminophosphines (Scheme 23). An important fact is that most of the 
reactions have been found to proceed with complete retention of configuration at the 
phosphorus atom.
94
   
 
Scheme 23. Preparation of Diazaphospholidine Derivatives.
94 
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Buono et al. proposed the preparation of a series of diazophospholidine derivatives from 
the P(III) precursors (Figure 17). They obtained the desired products in good yields 
ranging from 63% to 87%. Additionally, the corresponding diazophospholidine 
derivatives were achieved as one diastereomer, which was characterized as the 
theromodynamic anti diastereomer.
114,115
  
 
 
 
Figure 17. 
 
Besides P(V) oxides achieved from P(III) precursors also the design of sulfides and 
iminophosphines has been the subject of attention from a number of researchers (Figure 
18).
113,115,116
  
 
 
 
Figure 18. 
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More recently, chiral P-stereogenic phosphorus ligands have been developed owing to 
the application of borane as a protecting group.
117
 The diazaphospholidine-borane 
complexes were prepared in diastereomerically pure form in good to excellent yields 
(Figure 19).
117,118  
 
 
 
 
Figure 19. 
 
The phosphine oxide ligands prepared from P(V) precursors by a version of the first 
strategy obtain the diazophospholidines with low stereoselectivity which is equal to the 
prior formation of the corresponding P(III) products (Scheme 24).
94
 
 
 
 
Scheme 24. Preparation of 166. 
 
An exception is the relatively stereoselective reaction of the chloro derivative 166 at     
0 
o
C. This concept was used by Fiaud et.al.
119
 Their pioneering work was followed by 
Basavaiahand and co-workers who yielded a series of diazaphospholidine oxides from 
chloro derivative 166 with alcohols and amines (Figure 20).
119-122
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Figure 20. 
 
The synthesis of a new class of chiral o-hydroxyaryl phosphine oxides by the 
rearrangement of a P-O to a P-C bond with a bifunctional feature, a basic (P=O) and an 
acid side (OH), has been reported by Buono and co-workers.
123
 Due to the work of 
Melvin et al. lithium diisopropylamide (LDA) has been the most common base used in 
the rearrangement of arylphosphate to o-hydroxyarylphosphonate and derivatives which 
resulted in good yields and total diastereoselectivity. Only a few examples of this 
reaction with lower selectivity are mentioned with butyllithium. Buono et al. achieved 
the o-hydroxyphenyl diazaphospholidine oxide 173 in 94% yield through the treatment 
of compound 155 with LDA followed by an aqueous work-up (Scheme 25).
115
 
 
 
 
Scheme 25. Preparation of Hydroxyphenyl Diazaphospholidine Oxide 173 with 
LDA. 
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The diazaphospholidine oxide group has played an excellent role as an activator for the 
direct metallation of the ortho position in aromatic system generating the stabilised 
carboanion 174. Additionally, the driving force of anionic [1,3] rearrangement is the 
formation of the stable chelate complex in which both oxygen atoms can interact with 
the lithium atom (Scheme 26).
115
 
 
 
 
Scheme 26. Metalation of the ortho Position. 
 
Buono et al. presented in further work a new general procedure for the first ring-
expansion reaction of diazophospholidine oxides involving a stereospecific migration of 
P from N to C.
94,124
 The anti-177 compound can be synthesized in 94% yield in the 
presence of 2 eq. of LDA. However, the synthesis of the product 178 was readily 
achieved with 8 equivalents of LDA in 89% yield. This compound is a product of two 
diasereoselective 1,3-migration rearrangements (first P-O to P-Csp
2
 followed by P-N to 
P-Csp
2
).
94,124
 Additionally, treatment of anti-177 with 8 equivalents of LDA led to the 
diastereoselective generation of the corresponding anti-178.
124
 This fact shows that P-N 
to P-C only exists once the P-O to P-Csp
2
 step has been completed (Scheme 27).
94,124  
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Scheme 27. P–O to P–C and P–N to P–C Rearrangements in a Diazaphospholidine 
Oxide.
94
 
 
1.2.2.1.3. P(V) Secondary Diazaphospholidines 
One relevant class of P-stereogenic diaminophosphine oxides was discovered by 
Hamada, Nemoto and co-workers. They synthesized a new class of P-chirogenic 
phosphine oxides based on a chiral asymmetric diamine framework, called P-chirogenic 
diaminophosphine oxides: DIAPHOXs.
74
 
These chiral ligands with a stereogenic center on a phosphorus atom
125
 have been 
prepared from commercially available acid anhydride 182, which can be synthesized 
from (S)-aspartic acid 183
126
 which was easily converted to triamine 184 over four 
steps.
127
 The triamine was reacted with phosphorus trichloride to obtain 
triaminophosphine 185
127
 which was converted into DIAPHOX 186 by an SN
2
-type 
hydrolysis
128
 upon purification by silica with wet ethyl acetate in 60% yield       
(Scheme 28).
126,129
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Scheme 28. Preparation of Ph-DIAPHOX. 
 
The analogues of DIAPHOXs which are shown below were prepared via the same 
synthetic route as compound 186 (Figure 21).
125,128,130-132
  
 
 
 
 
Figure 21. DIAPHOX Ligands. 
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DIAPHOXs are a class of ligands which are air- and moisture-stable pentavalent 
phosphorus compounds. The chiral diaminophosphine oxides exist in equilibrium 
between pentavalent forms (RR’P(=O)H) and trivalent tautomeric forms (RR’POH) 
(Scheme 29).
125
 In this process, the secondary phosphine oxides are activated by a BSA-
induced tautomerization, resulting in a trivalent diamidophosphite form.
133,134
 The 
interesting phenomenon is that the P(V)-P(III) equilibrium does not affect the 
stereochemistry around the phosphorus center.
126
 This effect allows for the application 
of the DIAPHOXs analogues as ligands in many reactions such as Pt-catalyzed 
hydrolysis or Pt-catalyzed hydroformylation but the most popular are Pd and Ir 
enantioselective allylic substitution reactions. Additionally, it has to be mentioned that 
tautomeric phosphinous acid coordinates to the metal center through a phosphorus 
atom.
125
   
 
 
 
Scheme 29. Equilibrium between P(V) and P(III).   
 
1.2.3. Phosphorus-Nitrogen Atom Heterocyclic Compounds   
as Ligands for Asymmetric Reactions 
 
1.2.3.1. Asymmetric Hydrovinylation 
The concept of hydrovinylation defines itself as the addition of ethylene across a double 
bond or as a co-dimerisation of ethylene and an activated alkene (Scheme 30).
135
 The 
hydrovinylation reaction was first discovered in 1965 by Alderson and co-workers by 
using hydrated ruthenium and rhodium salts under high ethane pressure with a range of 
substrates. Iron, cobalt, nickel, and palladium have been also used, but nowadays 
studies have focused especially on nickel and palladium.
136
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Scheme 30. 
 
Followed by the early studies of Wilke et al.,
137
 Franciò, Leitner and co-workers 
investigated the reaction of 1,3-cyclooctadiene 194 with ethane 195 by using 
[Ni(allyl)Br]2 with NaBARF as an activator in combination with the chiral monodentate 
phosphines derived from monoterpenes and resulting the product 194 in 77% yield and 
63% ee (Scheme 31).
99
  
 
 
 
Scheme 31. 
 
1.2.3.2. Asymmetric Hydroformylation 
The hydroformylation reaction has been known for more than 70 years and is one of the 
most essential industrial processes for the production of aldehydes from C-C double 
bonds (Scheme 32).
138
 Hydroformylation is based on the application of a transition 
metal, which provides the formation of metal-carbonyl species. The resultting complex 
can be modified by the ligand and the structure HxMy(CO)zLn can be obtained.
139
 
Several metals like cobalt, rhodium or platinum were applied as a catalyst in 
hydroformylations but the most attention was paid to ruthenium.
94
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Scheme 32. 
 
Phosphorus compounds are one of the most widely accepted ligands which are able to 
form the complex and coordinate to hydroformylation reactions. Cole-Hamilton et al. 
reported the application of ESPHOS 145 and SEMI-ESPHOS 137 in the asymmetric 
hydroformylation of vinyl acetate 200 (Scheme 33). They showed that bidentate C2-
symmetric ESPHOS ligand 145 obtained better results than the monodentate analogue 
SEMI-ESPHOS 137.
140
 
 
 
 
Scheme 33. Asymmetric Hydroformylation of Vinyl Acetate.  
 
1.2.3.3. Allylic Substitution 
The allylic substitution is one of the most powerful methods for introducing chirality on 
an allylic carbon, catalyzed by a transition metal complex (Scheme 34).
141
 The allylic 
substitution can be used to create C-C, C-N or C=O bond formation with transition 
metals mainly including palladium, iridium and ruthenium and involving electrophilic 
π-allylmetal intermediates.142 
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Scheme 34. Allylic Substitution. 
 
Recently, a few groups proved that diazaphospholidines with two different donor atoms 
(P, N) are brilliant ligands for these allylic transformations. One of the reasons is that 
this kind of ligand is able to impart an electronic distortion upon the allyl moiety of the 
palladium complex and the nucleophilic attack is predicted to occur trans to the better 
π–acceptor.143 
One of the most investigated HASPO ligand for Pd-catalyzed asymmetric allylic 
substitution reactions with carbon nucleophiles is DIAPHOX. Nemoto, Hamada and    
co-workers obtained the desired product 205 in 94% yield and an excellent ee of 99% 
from 1,3-diphenylallyl acetate 202 with dimethyl malonate (Scheme 35). This type of 
reaction is one of the most important benchmark-system to examine the ability of novel 
chiral ligands.
144
 
 
 
 
Scheme 35.  Asymmetric Allylic Alkylation using DIAPHOX as a Ligand. 
 
1.2.3.4. Diels-Alder Reaction 
The formation of a cyclic adducts from two unsaturated molecules plays an important 
role in organic chemistry. From the cycloaddition reactions one of the most important 
and well-known reaction is the Diels-Alder reaction (4+2 cycloaddition), which can be 
catalyzed by chiral Lewis acids.
94
 Also P-ligands found applications in such reactions.  
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Buono et al. employed the QUIPHOS 140 in the Cu-catalyzed enantioselective 4+2 
cycloaddition of N-acrylamide dienophiles 205 and cyclopentadiene 51 (Scheme 36). 
They obtained two isomers with very high endo/exo ratios and excellent yields and 
enantioselectivities if the reagents were mixed at 78 oC and slowly warmed to room 
temperature.
94,145
  
 
 
 
Scheme 36.  Catalytic Diels-Alder Reaction. 
 
1.2.4. Summary 
Phosphorus compositions play an essential role in chemistry and especially in organic 
chemistry where the attention is devoted to organophosphorus compounds. This stems 
from the fact that phosphorus has the ability to form bonds with many other elements. 
Phosphorus compounds have found applications in many areas of life, such as 
agriculture, medicine or organic synthesis. 
Due to the interest in organophosphorus compounds, phosphorus derivatives have been 
investigated by many researchers. There are many examples of the phosphorus 
compositions which are subsequently examined. One of the most desired and 
investigated groups of organophosphorus compounds are phosphines. This large group 
can be synthesized by many methods. General preparations of phosphines are multi-step 
processes which involve tetra- or pentacoordinated intermediates. From phosphine 
derivatitives P-heterocycles are not less interesting compounds especially when 
phosphorus-heteroatom heterocycles are concerned. Nowadays, the most important 
direct precursors of free phosphines are phosphine oxides and phosphine boranes. For 
many years chiral phosphines are one of the most widely accepted ligands which are 
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able to generate complexes that are successfully applied in transition metal-catalyzed 
asymmetric processes.   
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2. Results and Discussion 
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2.1. Aim of the Work 
The aim of the work was the development of novel chiral ligands which are the essential 
part of asymmetric catalysis. One important class of chiral ligands are diamines, which 
have attracted substantial attention over the last years. Hence, a good amount of chiral 
diamine ligands has been discovered. One significant starting material from the chiral 
pool is camphor and several diamine ligands have been prepared from camphor and the 
number of chiral 1,3-diamines are limited.
 
However, ligands from camphoric acid are 
still rare. Therefore, the preparation of a new class of ligands from camphoric acid, a 
cheap, common chiral building block derived from camphor is desirable.  
The purpose of this work was the preparation of novel ligands and their application in 
asymmetric transformations. This includes the investigation of primary and secondary 
1,3-diamine ligands which found application in the asymmetric Henry or nitroaldol 
reaction. The later is one of the most useful methods for the formation of C-C bonds in 
organic synthesis. Later on, special attention should be paid to the HASPO (heteroatom-
substituted secondary phosphine oxide) ligands which exist in equilibrium between 
pentavalents form [RR’P(O)H] and trivalent tautomeric forms (RR’POH). They were 
synthesized from the new chiral diamines derived from camphoric acid.  
 
2.1.1. Synthesis of Camphoric 1,3-Diamine 
The rigid camphoric 1,3-diamine 208 was synthesized from (+)-camphoric acid 209, a 
cheap, common chiral building block derived from camphor
146,147
 via a Schmidt 
reaction.
148,149
 To a reaction mixture of (+)-(1R,3S)-camphoric acid 209 in concentrated 
sulfuric acid and ethanol free chloroform was added sodium azide. The reaction was 
carried out for 20 h at 50 °C. The desired product 208 was obtained as a white solid in 
71% yield (Scheme 37).  
 
Scheme 37. 
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The camphor diamine 208 was used in the next steps as a starting material for the 
preparation of a new class of diamine ligands which have been applied to the 
asymmetric nitroaldol Henry reaction and also for synthesizing HASPO (heteroatom-
substituted secondary phosphine oxide) ligands. From diamine 208 two types of ligands 
can be prepared. One class of ligands in the structure includes both nitrogen atoms with 
the same substituent while the second class contains only one aryl substituted nitrogen 
atom. These two different types of diamine ligands are designed to induce different 
chirality in asymmetric reactions. From later research can be deduced that ligands 
include nitrogen atoms with different substituted aryl groups in the structure provides 
higher enantiomeric excess while secondary diamines with the same substituent affords 
lower enantioselectivities. 
 
2.1.2. Preparation of Diamine Ligands with the Same 
Substituent on Both Nitrogen Atoms 
Enantiopure diamines with two secondary amine groups were prepared through an 
alkylation by treating the camphor diamine 208 with arylmethylene chloride or with an 
aldehyde, followed by the reduction of the corresponding imine (Scheme 38).
150
 
 
 
 
Scheme 38. 
 
Following the first strategy, the enantiopure diamine 210 was performed under dry 
conditions with diamine 208 and 2,4,6-trimethylbenzylchloride 211 in the presence of 
the triethylamine in acetonitrile under reflux. The corresponding product 210 was 
obtained as colorless oil in 57% yield (Scheme 39). 
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Scheme 39. 
 
Similarly, product 212 was prepared by the reaction of diamine 208 and                        
9-bromofluorene 213 under reflux in acetonitrile. The desired compound 212 was 
purified by flash column chromatography to afford a yellow solid in 59 % yield 
(Scheme 40). 
 
 
 
Scheme 40. 
 
In both cases the products were obtained as disubstitued compounds. Monosubstitued 
product was not observed despite the reactions were performed with the use of 1 equiv. 
of aryl halide. 
Furthemore, as shown below the diamine 214 formation was performed in two steps. 
First benzaldehyde 68 and camphor diamine 208 were refluxed in toluene in the 
presence of a catalytic amount of p-toluenesulfonic acid, followed by the reduction of 
imine 215 which is an efficient method for the preparation of diamine 214 in 75 % yield 
(Scheme 41). 
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Scheme 41. 
 
2.1.3. Selective Monoalkylation 
Enantiopure diamines with a primary amine function were prepared via a 
monoalkylation reaction by treating the diamine 208 with an aryl halide 216-224 in the 
presence of Pd2(dba)3, BINAP and NaOtBu according to a modified procedure reported 
by Dorta.
151
 After purification by acid base extraction treatment products 225-233 were 
obtained in good to excellent yields. The results are summarized in Table 1.
152-154
  
 
Tabele 1. Monoalkylation Reaction by Treating Diamine 208 with Aryl Halide via 
                  a Buchwald-Hartwig Amination. 
 
 
 
Entry Arene Product Yield [%] 
 
 
1 
 
 
 
           
 
                
 
 
 
82 
 
 
2 
 
 
 
 
 
99 
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3 
 
 
 
 
  
 
 
60 
 
 
 
 
4 
 
 
 
 
 
 
 
97 
 
5 
 
 
 
 
 
64 
 
6 
 
 
 
 
73 
 
7 
 
 
 
 
 
49 
 
8 
 
 
 
 
 
 
48 
 
9 
 
 
 
 
33 
 
The results which are summarized in Table 1 show that the reaction accepted arenes 
with various substitution patterns. For example the 2-bromoanisole 217 (Table 1, Entry 
2) gave a brilliant yield of 99%. Also the most sterically hindered 2-bromomesitylene 
219 (Table 1, Entry 4) resulted excellent yield of 97%, while 1-bromo-2-
isopropylbenzene 222 (Table 1, Entry 7) gave less than 50% yields. Bromobiphenyls 
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such as 2-bromo-1,1’-biphenyl 221 (Table 1, Entry 6) and 3-bromobiphenyl 223 (Table 
1, Entry 8) resulted in an yield of 73% and 48% respectively. On the other hand due to 
the axial chirality of 1-(2-bromophenyl)naphthalene the product 233 (Table 1, Entry 9) 
was obtained as a mixture of diastereomers in 33%.
152
 The resulted product 233 of two 
diastereomers which does not possess a stereogenic center could not be separate by 
column chromatography.
152
 
Additionally, it is remarkable that the arylation is highly selective despite the high 
reaction temperature. In all cases the other possible regioisomers were not observed. 
This fact results from sterical hindrance around tertiary carbon. Only the desired 
monoalkylated products which were identified by 
1
H-, 
13
C-NMR and 2D spectra- 
HMBC were present.
152
 As an example the HMBC spectrum for 232 proved that the 
proton at the C(1)-atom appears at 3.75 ppm and coupled with the quaternary aromatic 
carbon at 149.04 ppm. A coupling of this aromatic carbon with the protons of the 
methyl group attached to the C(3) atom was not observed, which excludes the other 
regioisomers (Figure 22).  
 
 
Figure 22. 
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2.1.4. Alkylation of Monosubtituted Diamines 
A series of enantiopure secondary diamines with two different substituted nitrogen 
atoms were synthesized via an alkylation of monosubstituted diamine by aryl halides 
such as mesitylmethylene chloride 211,
155
 9-(chloromethyl)anthracene 234 or benzyl 
bromide 235 in the presence of the triethylamine in acetonitrile under reflux. The 
corresponding results are summarized in Table 2. 
 
Tabele 2. Alkylation Reaction of Monosubstituted Diamines. 
 
 
 
Entry Arene Alkyl halide Product Yield [%] 
 
 
1 
 
 
 
 
 
 
 
 
 
 
64 
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2 
 
 
 
 
 
 
71 
 
3 
 
 
  
 
 
 
 
 
62 
 
 
 
4 
 
 
 
 
 
 
 
61 
 
5 
 
 
 
 
 
 
 
54 
 
6 
 
 
 
 
 
 
57 
 
7 
 
 
 
 
 
 
51 
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8 
 
 
 
 
 
 
57 
 
 
9 
 
 
 
 
 
 
 
 
0 
 
 
10 
  
 
 
 
 
0 
 
The results are summarized in Table 2 and present those products with 
mesitylmethylene chloride 211 and diamines 225-231 or acetylated diamine 236 gave 
yields between 50-70 %. The TLC plate and NMR spectra of the crude products showed 
that starting material did not react completely despite the lengthening of the reaction 
time to 48 hours. An attempt was made for secondary diamines by alkylation of 
monosubstituted diamine 225 with 9-(chloromethyl)anthracene 224 (Table 2, Entry 9) 
and benzyl bromide 235 (Table 2, Entry 10), but expected products were not isolated. 
Additionally, the secondary diamine formations 248 was attempted to be performed in 
two steps. First benzaldehyde 68 and monosubstituted diamine 225 were refluxed in 
toluene in the presence of a catalytic amount of p-toluenesulfonic acid, followed by the 
reduction of product 247 in methanol (Scheme 42). No product was achieved.  
 
 
Scheme 42. 
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Furthemore, the preparation of secondary diamine 249 was also tried by Buchwald-
Hartwig amination. Enantiopure diamines with a secondary amine function was 
prepared via a monoalkylation reaction by treating the diamine 226 with an aryl halide 
216 in the presence of Pd2(dba)3, BINAP and NaOtBu (Scheme 43). No product was 
obtained.  
 
 
 
Scheme 43. 
 
2.2. Application of Primary and Secondary Diamines 
to the Henry Reaction 
 
 2.2.1. Nitroaldol Henry Reaction 
The addition reaction between a nitroalkane and a carbonyl compound in the presence 
of a chiral metal complex and addivites, was discovered by Louis Henry in 1895.
156,157
 
The asymmetric Henry or nitroaldol reaction is one of the most useful methods for the 
formation of C-C bonds in organic synthesis.
158
 The nitroaldol reaction provides an easy 
access to chiral β-nitroalcohols, which can be converted into chiral buildings blocks, 
such as 1,2-aminoalcohols, α-hydroxy acids, 1,2-diamines and other precursors of 
biologically active compounds.
157,159,160  
The Henry reaction has found huge applications in synthesis of natural products, 
polyaminoalcohols, polihydroxylated amides and especially in pharmaceutical 
industries,
161
 for example: HIV protease inhibitors, antifungal or antibacterial peptides 
and α/β-adrenergic agonists or antagonists.162 Even though the applications are very 
important, the asymmetric nitroaldol reaction was unknown to the world until 1992, 
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when Shibasaki et al. reported the first example of a highly asymmetric addition of 
nitroalkene and aldehyde catalyzed by a bimetallic complex of lanthanum(III), lithium 
and 1,1’-bi-2-naphthol (BINOL).157,163 Also Trost and co-workers discovered new chiral 
dinuclear zinc semi-aza-crown complexes, which are found to be successful catalysts 
for inducing high enantioselectivity in the addition of nitromethane to various 
aldehydes.
164
 
Since this time, many chiral metal complexes have been developed for nitroaldol 
reactions, for example copper complexes (Jørgensen et al.),
157
 which have low-toxicity 
and perfect chelating properties.
165
 Among the ligands which have been used in    
Cu(II)-catalyzed asymmetric Henry reaction are N,N-donor ligands, such as bis-
oxazolines, bis-pyridines, bis-imine, and chiral diamines.
165,166
 Also many other 
efficient metal-based catalysts like Zn triflate-chiral amino alcohol complexes
167
 or 
salen-cobalt complexes
168
 have found applications for this reaction.
164
 
In the present work the potential of various diamine ligands was explored in the copper-
catalyzed asymmetric Henry reaction. First, 10 mol% secondary ligand (210, 214, 237, 
244) with 10 mol% Cu(OAc)2∙H2O was applied as a catalyst by using benzaldehyde 68 
and 10 equiv. of nitromethane in the presence of 3 mol% DABCO 252 as a base in 
methanol at 0 °C. The results are summarized in Table 3. 
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Table 3. The Nitroaldol Reaction with Secondary Diamine Ligands. 
 
 
 
Entry Ligand Yield [%] ee [%] Config. 
 
 
1 
 
 
 
 
26 
 
 
11 
 
 
R 
 
 
2 
 
 
 
 
57 
 
 
7 
 
 
R 
 
 
3 
 
 
 
 
4 
 
 
Rac 



 
 
4 
 
 
 
 
3 
 
 
Rac 



 
From Table 3 it can be concluded that the best results were obtained with ligand 214 
(Table 3, Entry 2), which resulted 57% yield and 7% ee. Ligand 210 (Table 3, Entry 1) 
increased the enantioselectivity up to 11% but the yield decreased. In the other two 
cases the products were obtained as racemates.  
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Due to the best result which gave ligand 214, a series of experiments were prepared in 
order to further optimize the reaction conditions with various influences like impact of 
copper salts, bases, solvents and temperature. The results are summarized in Table 4. 
 
Table 4. Henry Reaction with Ligand 214 under Different Reaction Conditions. 
 
 
 
Entry Solvent Copper Salt T [°C] Yield [%] ee [%] 
1 MeOH Cu(OAc)2
.
H2O 0 57 7 
2 EtOH Cu(OAc)2
.
H2O 0 57 6 
3 i-PrOH Cu(OAc)2
.
H2O 0 45 7 
4
a
 MeOH Cu(OAc)2
.
H2O 0 55 rac  
5 MeOH Cu(OAc)2
.
H2O rt 77 3 
6 MeOH CuCl 0 74 6 
7 MeOH CuCl2 0 50 4 
8 MeOH Cu(OTf)2 0 0 
9 EtOH Cu(OTf)2 0 4 2 
10 i-PrOH Cu(OTf)2 0 0 
11 THF Cu(OTf)2  0 
a
 3 mol% Et3N 
 
From Table 4 can be concluded that changing the solvent did not increased the yield and 
enantioselectivity either. Different copper salts were also investigated. Copper(I) 
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chloride (Table 4, Entry 6) and copper(II) chloride (Table 4, Entry 7) gave yields 
around 50-70% but no improvement in ee was observed, while copper 
trifluoromethansulfonate (Table 4, Entries 8-11) decreased the yields to 0%. 
Additionally at room temperature (Table 4, Entry 5) a yield of 77% was obtained.  
Following the general procedure, different diamine ligands were applied under the same 
conditions. A complex formed with 10 mol% ligand (225-233 and 236 or 251) and 10 
mol% Cu(OAc)2∙H2O was estimated as a catalyst by using benzaldehyde 68 as a model 
substrate and 10 equiv. of nitromethane as reagent in the presence of 3 mol% DABCO 
252 as a base in methanol at 0 °C. The results are summarized in Table 5. 
 
Tabele 5. Henry Reaction with the Monosubstituted Diamine Ligands. 
 
 
 
 
Entry Ligand Yield [%] ee [%] Config. 
 
 
1 
 
 
 
 
18 
 
 
4 
 
 
S 
 
 
2 
 
                
 
 
82 
 
 
45 
 
 
S 
     
 
3 
 
 
 
60 
 
38 
 
S 
 
4 
 
 
 
78 
 
31 
 
S 
Results and Discussion 
57 
 
 
 
5 
 
 
 
 
34 
 
 
47 
 
 
S 
 
 
6 
 
 
 
 
41 
 
 
37 
 
 
S 
 
 
7 
 
 
 
 
56 
 
 
69 
 
 
S 
 
8 
 
 
 
64 
 
45 
 
S 
 
9 
 
 
 
32 
 
30 
 
S 
 
10 
 
                
 
84 
 
48 
 
S 
 
11 
 
 
 
 
 
6 
 
Rac 
 
- 
 
The highest ee of 69% gave ligand 230 (Table 5, Entry 7), while the best yield of 82% 
was obtained with ligand 225 (Table 5, Entry 2). On the other hand, diamine 251 with 
heteroaromatic substituent was also tested. The ligand 251 (Table 5, Entry 1) resulted 
18% yield and 4% ee. Acetylated diamine 236 (Table 5, Entry 11) obtained the 
nitroaldol product as a racemate with 6% yield. It is a significant fact that in general a 
sterically demanding substituent at one ortho position of the arene ring increases the 
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enantiomeric excess. On the other hand, if an arene substituent is too large, the yield 
reduces.  
Diamines with a primary amine group afford the S enantiomer with good results, while 
diamines with two secondary amine functions provided the R enantiomer, although in 
low enantioselectivities. 
A series of experiments were performed in order to further optimize the reaction 
conditions with ligand 225 with various influences of copper salts, bases, solvents, 
reaction time and temperature. The results are summarized in Table 6. 
 
Tabele 6. The Nitroaldol Reaction with Ligand 225 under Different Reaction 
Conditions. 
 
 
 
 
 
Entry Solvent Copper Salt T [°C] Yield [%] ee [%] 
1 MeOH Cu(OAc)2
.
H2O 0 82 45 
2 EtOH Cu(OAc)2
.
H2O 0 53 49 
3 iPrOH Cu(OAc)2
.
H2O 0 47 46 
4 MeOH CuCl 0 65 34 
5
a
 MeOH Cu(OAc)2
.
H2O 0 69 47 
6
b
 MeOH Cu(OAc)2
.
H2O 0 75 41 
7
c
 MeOH Cu(OAc)2
.
H2O 0 60 47 
8 MeOH - 0 68 rac 
9 MeOH Cu(OAc)2
.
H2O rt 63 38 
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10 MeOH - 0 59 rac  
11 MeOH Cu(OAc)2
.
H2O 25 39 53 
12
d
 MeOH Cu(OAc)2
.
H2O 25 42 54 
13 THF Cu(OAc)2
.
H2O 25 11 73 
14 H2O Cu(OAc)2
.
H2O rt 21 31 
15 THF CuCl 0 56 36 
16 MeOH CuCl2 0 60 16 
17 MeOH Cu[C6H11(CH2)3CO2]2 0 92 52 
18 THF Cu[C6H11(CH2)3CO2]2 0 26 72 
19 CH2Cl2 Cu[C6H11(CH2)3CO2]2 0 9 56 
20 MeOH Cu[CH3(CH2)3CH(C2H5)CO2]2 0 93 77 
21
e
 MeOH Cu(OAc)2
.
H2O 0 69 46 
 a
 3 mol% Et3N 
 
b
 15 mol% diamine 225 
 
c
 Cu(OAc)2
.
H2O 15 mol%  
 
d
 Reaction time 48 h 
 
e
 200 equiv. MeNO2 
 
From Table 6 can be concluded that methanol is the most appropriate solvent. Two 
others alcohols like ethanol (Table 6, Entry 2) and iso-propanol (Table 6, Entry 3) were 
tested, which resulted lower yields. Different copper salts were also investigated. 
Copper(I) chloride (Table 6, Entry 14) and copper(II) chloride (Table 6, Entry 16) gave 
yields around 60% but did not improve the ee. Longer reaction time and lower 
temperature did not result satisfactory yields and ee’s. Also water (Table 6, Entry 14) 
did not give better yield and ee. However, using THF (Table 6, Entry 13) increased 
significantly the ee but reduced the yield. Additionally, the influence of a variety          
of carboxylate counter-anions was examined. By comparing the results                      
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copper(II)-2-ethylhexanoate (Table 6, Entry 20) with a racemic chiral stereocenter 
resulted an excellent yield of 93% and enantiomeric excess of 77%, while copper(II) 
cyclohexanebutyrate decreased the ee (Table 6, Entry 17). Interestingly, the racemic 
stereocenter could form two diastereomeric complexes in the present case where one 
carboxylate ligand is replaced with the diamine ligand.  
Also ligand 230 was tested under different conditions (Table 7). Nevertheless, the 
obtained enantioselectivities were higher and the yields decreased compared to ligand 
225.  
 
Tabele 7. The Copper Catalyzed Henry Reaction with Ligand 230 under Different 
Reaction Conditions. 
 
 
 
 
Entry Solvent Copper Salt Yield [%] ee [%] 
1 MeOH Cu(OAc)2
.
H2O 56 69 
2 THF Cu[C6H11(CH2)3CO2]2 21 84 
3 MeOH Cu[C6H11(CH2)3CO2]2 74 72 
4 CH2Cl2 Cu[C6H11(CH2)3CO2]2 5 76 
5 MeOH Cu[CH3(CH2)3CH(C2H5)CO2]2 59 74 
 
Following the results obtained with ligand 225 the reactions of nitromethane with 
electron-rich and electron-poor benzaldehydes were investigated (Table 8). 
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Tabele 8. The Nitroaldol Reaction with Various Aldehydes. 
 
 
 
 
Entry Ar T [°C] Product Yield [%] ee [%] 
1 Ph 0 250 93 77 
2 3-Cl-C6H4 0 253 65 63 
3 2-NO2-C6H4 0 254 68 82 
4 3-NO2-C6H4 0 255 57 59 
5 2-MeO-C6H4 0 256 65 83 
 
It can be seen from the table that aldehydes in the ortho position are obtaining the best 
enantiomeric excess in up to 83% (Table 8, Entry 5) but unfortunately the yield is 
reduced.  
Ultimately, the electronic effect on benzaldehyde with nitroethane was then explored. 
The results are summarized in Table 9.  
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Tabele 9. The Henry Reaction with Nitroethane and Various Aldehydes. 
 
 
 
Entry Ar T [°C] Product Yield [%] ee [%] 
syn/anti 
dr 
syn/anti 
1 Ph 0 257 41 58/27 28/72 
2 2-NO2-C6H4 0 258 73 57/53 62/38 
3 2-MeO-C6H4 0 259 30 63/39 47/53 
 
The resulting syn/anti selectivities of diastereoisomers were determined by 
1
H-NMR. 
Benzaldehyde obtained the product 257 with nitroethanol in 41% yield and 58% ee of 
syn diastereomer and 27% ee of anti diastereomer (Table 9, Entry 1). By comparing the 
results between ortho-nitrobenzaldehyde (Table 9, Entry 2) and ortho-
methoxybenzaldehyde (Table 9, Entry 3), the first one provided significantly higher 
yield 73% with 57% ee of syn diastereomer and 53% ee of anti diastereomer than the 
second aldehyde.  
 
2.3. Cyclization of Diamines with Phosphorus 
Trichloride 
Heteroatom-substituted phosphine oxides are simply accessible from diamines.
169
 A 
new class of chiral HASPO (heteroatom-substituted secondary phosphine oxide) 
ligands
155,170
 for transition-metal-catalyzed reactions was prepared in two steps from the 
new diamines, by treating the secondary diamine with PCl3 and Et3N at 60 
o
C. The 
temperature was slowly raised to room temperature in toluene. After filtration through 
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MgSO4, the heterocyclic chloride derivative was obtained. In the second step, H2O and 
Et3N were added to the chloride derivative at 60 
o
C. The temperature was slowly 
raised to room temperature in toluene. After filtration through MgSO4 the desire product 
was obtained.
96,77 
The presence of Et3N as a base was required because of the formation 
of HCl.
102
 The desired products were characterized by mass spectrometry and 
multinuclear NMR spectroscopy. 
31
P-NMR chemical shifts were respectively in the 
same range as those reported for analogous ligands.
96,97
 The results with selected       
31
P-NMR data are shown in Table 10. 
 
Table 10. Heteroatom-Substituted Phosphines. 
 
 
 
 
 
 
Entry Diamine Product Yield [%] 
31
P, δ [ppm] 
 
 
 
1 
 
 
 
 
 
 
 
 
94 
 
 
 
10.1 
 
 
2* 
 
 
 
 
 
85 
 
 
10.1 
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3 
  
 
 
 
73 
 
 
9.6 
 
 
4 
 
 
 
  
 
 
 
89 
 
 
 
 
3.9 
 
 
 
 
 
5 
 
 
 
 
 
 
 
 
97 
 
 
 
 
3.9 
 
 
6 
 
 
 
  
 
 
 
89 
 
 
 
 
3.9 
 
 
 
7 
  
 
 
 
 
37 
 
 
 
 
 
 
1.9 
 
 
8 
  
 
 
 
15 
 
 
4.2 
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9 
 
 
 
 
 
 
 
85 
 
 
 
4.9 
 
 
10 
 
 
 
 
 
 
  
 
 
 
97 
 
 
5.4 
 
 
11 
  
 
 
 
86 
 
 
5.4 
 
From Table 10 it is possible to conclude that excellent yields can be obtained. The 
products were obtained as one diastereoisomer. It is remarkable that the reactions 
carried out on a larger scale gave cleaner desired products which did not need any 
purification. Only one product obtained from diamine 240 was achieved as two 
diatereoisomers 265a (Table 10, Entry 7) and 265b (Table 10, Entry 8) which were 
separated by column chromatography (Figure 23). The reason of the formation of two 
diastereoisomers can be due to the structure of the corresponding ligand, which is steric 
hinderance. Followed by the Ackerman suggestion,
169
 the HASPO ligand 260 was also 
prepared in CH2Cl2 but the yield was lower than in toluene. 
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Figure 23. 
 
The absolute configuration of the HASPO ligands was established by NOESY-NMR 
spectra. It can be assume that the HASPO ligands containing the same substituent on the 
nitrogen atoms have S configuration on the phosphorus atom while ligands with two 
different substituents on the nitrogen atoms show R configuration on the phosphorus 
atom.
171
 
Furthermore, 
31
P-NMR resonances for the HAPSO ligands were in the range of                  
δ = 1.9-10 ppm whereas, the ligand (S)-265 appeared at δ = 4.2 ppm (Figure 24). 
Additionally, the 
1
H-NMR spectra of the HASPO ligands present some interesting 
characteristics. The proton attached to the phosphorus appeared as a characteristic 
doublet with a coupling between JP-H = 617.0-649.9 Hz. Additionally, NOESY-NMR 
studies revealed that the P-H bond in the ligands is on the same side as the Me2C bridge 
(Figure 25). The exception is with one of the two diastereoisomers 265. In this case the 
P-H bond of ligand 265b is on the other side as the Me2C bridge (Figure 26). 
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Figure 24. 
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Figure 25. 
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Figure 26. 
 
The preparation of trivalent phosphorus compounds was also tested. Unfortunately,
 
subsequent treatment of chlorodiaminophosphites with sodium methanolate, sodium 
phenoxide or commercially available alcohols such as methanol and phenol did not 
result the corresponding products (Table 11). Probably the products were not stable 
because of their sensitivity to oxygen and moisture.
172
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Table 11. The Preparation of Trivalent Phosphorus Compounds. 
 
 
 
Entry Diamine ROX Product Yield 
[%] 
 
 
1 
 
 
2 
 
 
 
 
 
MeOH 
 
 
NaOMe 
 
 
 
 
0 
 
 
0 
 
 
3 
 
 
4 
 
  
 
MeOH 
 
 
NaOMe 
 
 
0 
 
 
0 
 
 
 
5 
 
 
6 
 
 
 
PhOH 
 
 
NaOPh 
 
 
0 
 
 
0 
 
7 
 
 
8 
 
 
PhOH 
 
 
NaOPh 
 
 
 
0 
 
 
0 
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Moreover, it was attempted to prepare trivalent phosphorus derivatives from 
hexamethylphosphorus triamide and chiral diamines.
109,173,174
 Although the reactions 
were carried out under reflux for 5 days, no product was achieved (Table 12).
170 
 
Table 12. The Preparation of Trivalent Phosphorus Compounds from 
Hexamethylphosphorus Triamide. 
 
 
 
Entry Diamine Product Yield [%] 
 
 
 
1 
 
 
 
 
 
 
 
 
0 
 
 
 
 
2 
 
 
 
  
 
 
 
0 
 
 
 
On the other hand, another group of organophosphorus compounds was synthesized.  
The product 275 was obtained as a pair of diastereomers from secondary diamine 214 
with o-phenyl phosphorodichloridate in the presence of Et3N in CH2Cl2 (Scheme 44). 
The two diastereomers were separated by column chromatography resulted compound     
275a in 27% yield and compound 275b in 43% yield. The absolute configuration of the 
P*-stereocentre in the structure of 275 diastereomers were compared with the 
literature.
175-177
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Scheme 44. 
 
Also N,N-dimethylphosphoramic dichloride was tested with diamine 214 in the 
presence of Et3N in CH2Cl2 (Scheme 45). No product was achieved. 
 
 
 
Scheme 45. 
 
 
 
 
 
 
 
Results and Discussion 
73 
 
2.4. Metal-Catalyzed Asymmetric Transformations 
 
2.4.1. Pd-Catalyzed Asymmetric Allylic Substitution 
Reactions Using Carbon Nucleophiles 
 
2.4.1.1. Asymmetric Allylic Alkylation of 1,3-Diphenylallyl Acetate  
Recently, special attention has been devoted to studies included the investigation of the 
chiral ligands with a stereogenic center on the phosphorus atom, followed by the 
formation of an effective asymmetric environment around a central metal.
94
  
Thus, chiral HASPO ligands were applied to some important type of reactions. First the 
asymmetric allylic alkylation was investigated. The Pd-catalyzed asymmetric allylic 
alkylation of (E)-1,3-diphenylallyl acetate 202 with the stabilized carbanion derived 
from keto ester in the presence of N,O-bis(trimethylsilyl)acetamide (BSA) is one of the 
most important benchmark-systems to examine the ability of novel chiral ligands 
(Scheme 46).
144 
  
 
 
Scheme 46. 
 
First, the HASPO ligand 258 with the same substituent on both nitrogen atoms and 
dibenzyl malonate with (E)-1,3-diphenylallyl acetate 202 were tested in the presence of 
BSA and an additive (Table 13). 
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Table 13. Asymmetric Allylic Alkylation of 1,3-Diphenylallyl Acetate with 
Dibenzyl     Malonate. 
 
 
 
Entry Additive Solvent Yield [%] 
1 Zn(OAc)2 Toluene 0 
2
a
 NaOAc Toluene 0 
3
b
 NaH Toluene 0 
3 KOAc Toluene 4 
4 KOAc THF 0 
         
a
  After 24 h AgBF4 was added and the reaction  
                                    was carried out further 24h 
                                
 b
  Without BSA and KOAc 
 
From the Table 13 it can be concluded that the influence of different additives such as 
NaOAc, KOAc, Zn(OAc)2 was tested. The potassium salts are obviously better than 
sodium salts, and sodium salts are stronger bases than zinc salts. Additionally, no 
reaction occurs when a strong base such as sodium hydride (Table 13, Entry 2) was 
used. The desired product did not give satisfactory results. The product 277 was 
obtained in the presence of KOAc below 5% yield (Table 13, Entry 3). In other cases 
the product was not achieved. Moreover, using THF did not give the product (Table 13, 
Entry 4).  
The same reaction was investigated with HASPO ligands 262 or 264 containing in the 
structure two different substituted nitrogen atoms. Following the best result from the 
table above KOAc was applied as an additive. During the reaction different conditions 
were optimized which are presented in Table 14. No yield was obtained. 
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Table 14. Asymmetric Allylic Alkylation of 1,3-Diphenylallyl Acetate with 
Dibenzyl Malonate under Different Reaction Conditions. 
 
 
 
Entry Ligand Solvent  T [
o
C] t [h] Yield 
 
1 
2 
3 
 
 
 
 
Toluene 
 
rt 
40 
100 
 
48 
24 
24 
 
 
0 
  
4
a
 
5
b
 
6
c
 
7 
 
 
 
Toluene 
Toluene 
Toluene 
CH3CN 
 
rt 
rt 
rt 
rt 
 
120 
120 
48 
48 
 
0 
0 
0 
0 
           
a
 After 96 h 0.1 equiv. of pyridine was added 
           
b
 After 96 h 0.1 equiv. of Et3N was added 
           
c
 0.1 equiv. of Pd cat. was used 
 
Subsequently, the novel HASPO ligands 260 or 264 were also applied to the original 
reaction between (E)-1,3-diphenylallyl acetate 202 and dimethyl malonate as the C-
nucleophile.
171
 As seen from Table 15, similar to the reaction of 1,3-Diphenylallyl 
acetate with dibenzyl malonate no product was observed.  
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Table 15. Asymmetric Allylic Alkylation of 1,3-Diphenylallyl Acetate with 
Dimethyl Malonate. 
 
 
 
Entry Ligand Solvent T [
o
C] t [h] Yield [%] 
 
1 
 
 
2 
 
 
 
Toluene 
 
 
THF 
 
rt 
 
 
 
rt 
 
48 
 
 
 
48 
 
0 
 
 
0 
 
3 
 
 
 4
a
  
 
Toluene 
 
 
CH2Cl2 
 
rt → 40 
 
 
rt 
 
40 → 24 
 
 
48 
 
0 
 
 
0 
a
  Instead of Pdcat., Ircat. was used and NaPF6 was added 
 
Consequently, analogous reactions were performed with diethyl malonate as the C-
nucleophile. No product was achieved (Table 16). 
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Table 16. Asymmetric Allylic Alkylation of 1,3-Diphenylallyl Acetate with    
Diethyl Malonate. 
 
 
 
Entry Ligand Solvent Yield 
1 
 
 
2 
 
Toluene 
 
 
THF 
0 
 
 
0 
 
 
3 
 
 
 
Toluene 
 
 
0 
 
Similarly as in the substitution reaction, using the substrate with a phenyl group also 
HASPO ligands were investigated in the Pd-catalyzed construction of quaternary 
stereocenters (Scheme 47).
94 
 
 
 
Scheme 47. 
 
The HASPO ligands 260, 264 or 268 and methyl 2-oxocyclopentanecarboxylate with 
cinnamyl acetate 280 were applied in the presence of BSA and an additive. The desired 
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product was not achieved although the reactions were carried out under different 
conditions with various influences like impact of palladium catalysts, bases as additives, 
solvents, temperatures and reaction times. The results are presented in Table 17.  
 
Table 17. Asymmetric Allylic Alkylation of Cinnamyl Acetate with Methyl 2-
Oxocyclopentanecarboxylate. 
 
 
 
Entry Ligand Additive Pdcat. Solvent T 
 [
o
C] 
t  
[h] 
Yield 
[%] 
1 
 
2 
 
3 
 
4
a
 
 
5 
 
6 
7 
8 
 
 
 
 
 
 
Zn(OAc)2 
 
Zn(OAc)2 
 
Zn(OAc)2 
 
Zn(OAc)2 
 
NaOAc 
 
Zn(OAc)2 
NaOAc 
KOAc 
(η3-C3H5-
PdCl)2 
(η3-C3H5-
PdCl)2 
(η3-C3H5-
PdCl)2 
(η3-C3H5-
PdCl)2 
(η3-C3H5-
PdCl)2 
Pd2(dba)3 
Pd2(dba)3 
(η3-C3H5-
PdCl)2 
Toluene 
 
Toluene 
 
Toluene 
 
Toluene 
 
Toluene 
 
Toluene 
Toluene 
CH2Cl2 
rt 
 
40 
 
rt 
 
rt 
 
rt 
 
rt 
rt 
rt 
20 
 
18 
 
48 
 
72 
 
72 
 
72 
72 
72 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
0 
0 
Results and Discussion 
79 
 
 
9 
 
 
Zn(OAc)2 
 
(η3-C3H5-
PdCl)2 
 
Toluene 
 
Rt 
 
48 
 
0 
 
10 
 
 
Zn(OAc)2 
 
(η3-C3H5-
PdCl)2 
 
Toluene 
 
rt → 40 
 
24 → 18 
 
0 
a
 Without BSA, n-BuLi and TMSCl were used 
 
2.4.1.2. Other Nucleophiles 
P-stereogenic ligands can react in Ir- or Pd-catalyzed allylic substitutions with non-
carbon nucleophiles. A transition-metal-catalyzed asymmetric allylic amination is a 
powerful method for the formation C-N of bonds (Scheme 48).
94 
 
 
 
Scheme 48. 
 
The HASPO ligand 262 and (E)-1,3-diphenylallyl acetate 202 with benzylamine were 
tested in the presence of BSA. The desired product was not observed (Scheme 49).  
 
Scheme 49. 
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2.4.1.3. Preparation of Trivalent Phosphorus Ligands from 
Pentavalent Phosphorus Species 
During the preliminary studies on a new series of HASPO ligands, the pentavalent 
phosphorus species were activated in situ by N,O-bis(trimethylsilyl)acetamide (BSA)  to 
induced P(V) - P(III) tautomerization (a commonly used abbreviations for valency) to 
afford trivalent phosphorus compounds, which play a role as the actual ligand (Scheme 
50).
131,144
 The generation of a trivalent phosphorus compounds were monitored by 
31
P-
NMR spectroscopy. The principal investigation was performed with symmetric 
secondary P-ligand 260 and BSA in a ratio of 1:4 in toluene-D8. The experiment was 
controlled at different times, however the best result was obtained after 24 h. 
31
P-NMR 
showed that pentavalent ligand 260 (chemical shift: 8.1 ppm, toluene-D8) reacted with 
BSA to provide the formation of a trivalent phosphorus species (chemical shift: 117.4 
ppm, toluene-D8) (Figure 27). 
 
 
 
Scheme 50. Reaction Mechanism of BSA-Induced P(V)-P(III) Transformation of 
HASPO Ligand 260. 
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Figure 27. 
31
P-NMR of BSA and Ligand 260 after 24 h. 
 
Further investigation revealed that when asymmetric HASPO ligand 264, with a 
chemical shift of 2.40 ppm was reacted with BSA in toluene-D8, the generation of the 
trivalent phosphorus species, with a chemical shifted 104.9 ppm, was observed similar 
to the case of symmetric HASPO ligand 260 (Figure 28). 
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Figure 28. 
31
P-NMR of BSA and Ligand 264 after 24 h. 
 
2.4.1.4. Preparation of Allylic Palladium(II) Complexes with Trivalent 
Phosphorus Ligands 
Following the Nemoto, Hamada and co-workers investigations, the neutral palladium 
complexes were prepared with the new corresponding ligand with the well known 
bridged chloride complex
178
 (η3-C3H5)2Pd2Cl2 in dry toluene in a ratio: ligand : BSA : 
Pdcat. = 1:4:1. To obtain information about the formation of the Pd complex (Scheme 
51), an experiment was also examined by 
31
P-NMR. 
 
 
 
Scheme 51. Preparation of Pd-Ligand Complex. 
 
First the Pd-complex was achieved with trivalent phosphorus compound which contains 
in the structure two nitrogen atoms with the same substituents. 
31
P-NMR suggests that 
complex Pd-260 was formed, but the reagents did not react completely. The resulting 
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31
P-NMR spectra showed two sharp signals, with approximately the same ratio 1:1, 
from the two rotamers.
178
 For the complex Pd-260 spin system at 102.9 and 102.5 ppm 
appeared with δ= 79.3 Hz (Figure 29). 
 
 
 
  
 
Figure 29. 
31
P-NMR of Pd-260 Complex. 
 
Further examination was carried out under the same conditions with asymmetric 
trivalent ligand 264. 
31
P-NMR spectra showed that change of the substituent from the 
ligand containing the same substituent on both nitrogen atoms to the compound which 
has in the structure nitrogen atoms with different substituted aryl groups has a huge 
influence on the formation of rotamers. In this case the asymmetric chiral trivalent 
ligand led to some discrimination between the two rotamers. The ratio of the desired 
rotamers obtained from the 
31
P-NMR spectra was 1:2. For this complex spin system at 
92.4 and 91.8 ppm appeared with δ= 116.7 Hz (Figure 30). Additionally, the 
experiment was prepared with other catalysts such as Pd2(dba)3, Pd(OAc)2 and CuCl. 
No stable complex was achieved. 
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Figure 30. 
31
P-NMR of Pd-264 Complex. 
 
Detailed investigations into the reaction mechanism of complex Pd-264 did not give the 
satisfactory answer for the question why the final product could not be obtained.  There 
are two possibilities to explain this fact. One option could be the high stability of the 
complex and the second option is that the corresponding complex can not be recycled 
after the reaction. The whole general reaction mechanism procedure (Scheme 52)
179
 was 
repeated in a NMR tube in dry conditions and every step of the reaction was controlled 
by 
31
P-NMR. The cycle begins by generation of trivalent ligand 264 by BSA and in the 
next step formation of the complex Pd(0)-264 (Scheme 51). Oxidative addition of Pd(0) 
to form the π-allyl species with 1,3-diphenylallyl acetate 202 then occurs with 
ionization of a leaving group center, providing the key η3-π-allyl-Pd2+ complex. This 
intermediate has been observed spectroscopically and the 
31
P-NMR study permitted to 
prove that the signals did not change which means that the complex is very stable 
(Figure 31). Nucleophilic addition to the reaction mixture showed on 
31
P-NMR that the 
signals did not change prior to the addidion of diphenylallyl acetate (Figure 32). 
Additionally, the use of potassium acetate as an added catalyst has advantages in the 
reactions which involve a wide range of carbon nucleophiles because if BSA does not 
convert the dibenzyl malonate into its related silyl ketene acetal then it can be suggested 
that the catalytic activity of the potassium acetate serves to initiate the formation of a 
dibenzyl malonate nucleophile.
180
 Following the 
31
P-NMR spectrum after addition of 
KOAc as an additive it is possible to conclud that the complex is very stable and it does 
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not react with other reagents resulting the desired product, or the product is generated in 
small quantities what can be concluded from new signals at 96.2 and 95.3 Hz (Figure 
33). Summarizing, the whole experiment proved that the complex Pd-264 was not an 
active catalyst for the Pd-catalyzed asymmetric allylic alkylation of 1,3-diphenylallyl 
acetate 202 with dibenzyl malonate. 
 
 
 
Scheme 52. Mechanism of Asymmetric Allylic Substitution. 
 
 
Figure 31. 
31
P-NMR of BSA + Pd-264 Complex + 1,3-Diphenylallyl Acetate. 
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Figure 32. 
31
P-NMR of BSA+Pd-264 Complex + 1,3-Diphenylallyl Acetate + 
Dibenzyl Malonate. 
 
 
 
Figure 33. 
31
P-NMR of BSA + Pd-264 Complex + 1,3-Diphenylallyl Acetate + 
Dibenzyl Malonate +KOAc. 
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2.4.2. Copper-Catalyzed Conjugated Borylation Reactions 
In organic synthesis one of the most significant chiral building blocks are 
enantioenriched chiral organoboron compounds.
181
 Several transition metals catalyze 
the β-boration, but the most convenient and efficient metal to mediate the 
chemoselective formation of β-borated esters, ketones, nitriles, and amides is copper.182 
The first application of a copper(I) salt modified with chiral diphosphines to α,β-
unsaturated carbonyl compounds was investigated by Yun and co-workers.
182
 
 
2.4.2.1. Borylation of a C-C Double Bond Catalyzed by Chiral 
HASPO-Copper(I) Complex 
The mechanism for the conjugate boration of enones shows that the protonated product 
and a copper alkoxide are achieved via an intermediate copper enolate that undergoes 
protolytic cleavage by an alcohol. Additionally, the copper alkoxide reacts with diboron 
to regenerate the active copper boryl complex (Scheme 53).
183
 
 
 
 
Scheme 53. Mechanism of Borylation of a C-C Double Bond 
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Following the previous studies, the HASPO ligands 262 or 266 were applied to the 
enantioselective β-boration of enolate. A pentavalent ligand (0.11 equiv.) was 
transformed by BSA (0.09 equiv.) to the trivalent phosphorus compound in toluene. A 
complex of trivalent ligand with CuCl (0.1 equiv.) was estimated as a catalyst by using 
methyl cinnamate 280 (1 equiv.) as a model substrate and adding bis(pinacolato)diboron 
(1.1 equiv.) in the presence of NaOtBu (0.3 equiv.) as a base and MeOH (2 equiv.) as a 
proton source in toluene at 55 oC. The results are summarized in Table 18. 
 
Table 18. Borylation of a C-C Double Bond in the Presence of BSA. 
 
 
 
Entry Ligand Yield [%] ee [%] 
 
 
1 
 
 
 
51 
 
 
Rac 
 
 
2 
 
 
 
37 
 
 
Rac 
 
From the Table 18 it can be concluded that HASPO ligand 262 (Table 18, Entry 1) gave 
higher yield than HASPO ligand 266 (Table 18, Entry 2). Unfortunatelly both of them 
obtained the desired product as racemate. 
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Also ligands 262 and 266 were tested under different conditions, specifically without 
BSA (Table 19). Nevertheless resulted yields decreased compare to results from Table 
18 and similarly as in the above case the desire product was obtained as a racemates.  
 
Table 19. Borylation of a C-C Double Bond without Tautomerisation of HASPO 
Ligands. 
 
 
 
Entry Ligand Yield [%] ee [%] 
 
 
1 
 
 
 
18 
 
 
Rac 
 
 
2 
 
 
 
11 
 
 
Rac 
 
A series of experiments were performed in order to further optimize the reaction 
conditions with HASPO ligands and the impact of copper salt and BSA. No product was 
obtained. The results are summarized in Table 20. 
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Table 20. Borylation of a C-C Double Bond with the impact of BSA and CuCl. 
Entry Ligand CuCl [mol%] BSA [mol%] Yield [%] ee [%] 
 
 
1 
 
 
0 

0 
 
9 

0 
 
0 
 
0 
 

 

 
 
2 
 
 
0 
 
0 
 
9 
 
0 
 
0 
 
0 
 


 
 
 
2.4.2.2. Asymmetric Synthesis of α-Amino Boronate Esters 
The HASPO ligands were applied to the asymmetric synthesis of α-amino boronate 
esters via organocatalytic pinacolboryl addition to tosyldimines.
184
 A pentavalent ligand 
262 (0.04 equiv.) was transformed by BSA (0.09 equiv.) to trivalent ligand in THF. A 
complex of trivalent ligand with CuCl (0.04 equiv.) was estimated as a catalyst by using 
tosylaldimines 284-287 (1 equiv.) as a model substrate and bis(pinacolato)diboron (1.2 
equiv.) in the presence of Cs2CO3 (0.15 equiv.) and MeOH (2.5 equiv.) as a proton 
source in THF at 70 
o
C. A series of experiments were performed in order to further 
optimize reaction conditions with HASPO ligand 262 with various influences of copper 
salt and BSA. No products were obtained. The results are summarized in Table 21.
170 
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Table 21. Asymmetric Synthesis of α-Amino Boronate Esters in Various Reaction 
Conditions. 
 
 
 
Entry Tosylaldimines CuCl 
[mol%] 
BSA 
[mol%] 
Product Yield 
[%] 
 
1 
 
4 
0 
4 
0 
9 
9 
0 
0  
0 
0 
0 
0 
 
2 
 
4 
0 
4 
0 
9 
9 
0 
0  
0 
0 
0 
0 
 
3 
 
4 
0 
4 
0 
9 
9 
0 
0  
0 
0 
0 
0 
 
4 
 
4 
0 
4 
0 
9 
9 
0 
0  
0 
0 
0 
0 
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2.4.3. Michael Addition 
The Michael addition also called conjugated addition reaction is an addition of a 
nucleophile to a α,β-unsaturated carbonyl compound in the presence of a transition 
metal to avoid direct attack on the carbonyl group of the Michael acceptor.
185 
 
2.4.3.1. Michael Addition of Thiophenol 
The HASPO ligand 267 (0.05 equiv.) and the catalyst (0.08 equiv.) were applied to the 
Michael addition with thiophenol 292 (1 equiv.) and chalcone 293 (1 equiv.) in toluene. 
A series of experiments were performed in order to further optimize reaction conditions 
with HASPO ligands with various influences of impact of catalysts. The results are 
summarized in Table 22.
170
 
 
Table 22. Michael Addition Reaction with Different Reaction Conditions. 
 
 
 
Entry Mcat. Yield [%] ee [%] 
1 Sc(SO3CF3)3 91 rac 
2 Y(SO3CF3)3 32 6 
3 HoCl3 49 9 
4  61 rac 
 
From the Table 22 it can be concluded that scandium(III) trifluoromethanesulfonate 
gave the corresponding product 294 as a racemate in excellent 91% yield (Table 22, 
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Entry 1). Holium(III) chloride resulted the product 294 in 9% enantioselectivity while 
the yield decreased to 49% (Table 22, Entry 3). 
 
2.4.3.2. Michael Addition of Carbonyl Compound 
The HASPO ligand 267 (0.18 equiv.) and K2CO3 (3 equiv.) were applied to the Michael 
addition with diethyl malonate (1.5 equiv.) and chalcone 290 (1 equiv.) in toluene 
(Scheme 54). No corresponding product was obtained.
170
 
 
 
 
Scheme 54. 
 
2.5. Chiral HASPO Ligands as Chiral Shift Reagents 
Nowadays it is very important to find efficient methods for the easy and fast 
measurement of the enantiomeric excess of chiral compounds.
186
 The application of 
chiral shift reagent, also called chiral solvating reagent for NMR spectroscopy is one of 
the most useful method to achieve determination of the enantiomeric excesses of chiral 
organic molecules. The advantage of this convenient method is an easy performance 
without using any chiral derivatization of the analyte.
187
 Many different kinds of shift 
reagents, such as lanthanide complexes, crown ethers, cyclodextrins, porphyrins, 
macrocycles, and others have been investigated by many researchers.
188
 
The novel chiral HASPO ligands were evaluated as chiral resolving agents in dry 
toluene. The chiral shift experiments were carried out by measuring the 
1
H-NMR and 
19
F-NMR spectra of a mixture of HASPO ligand 262 with two different substituted 
nitrogen atoms or HASPO ligand 258 with the same substituted nitrogen atoms with α-
(trifluoromethyl)benzyl alcohol in a ratio 1:1 in toluene at room temperature. Table 23 
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shows the splitting with HASPO ligands 262 and 260 did not change for the CF3 group. 
In both cases, the signals shifted properly.  
 
Table 23. Resolution of α-(Trifluoromethyl)benzyl Alcohol in the Presence of  
HASPO Ligands (
19
F-NMR). 
  Entry Ligand δ (ppm) 19F δ (Hz) 
1 - 78.16/78.13 0 
 
 
2 
 
 
 
77.89/77.86 
 
 
7 
  
 
3 
 
 
 
77.73/77.70 
 
 
0 
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Figure 34. 
 
The 
1
H-NMR spectra were also recorded for the mixture of compounds which are 
mentioned above. The results are presented in Table 24. The HASPO ligand 260 
interacted with the methine proton of α-trifluoromethyl benzyl alcohol and showed a 
splitting of 7 Hz, while no stereodiscrimination for the CF3 group was observed from 
the more symmetrical ligand 260. 
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Table 24. Resolution of Alcohol in the Presence of HASPO Ligands (
1
H-NMR). 
  Entry Ligand δ (ppm) 1H δ (Hz) 
1 - 4.45/4.42 0 
 
 
2 
 
 
 
4.63/4.61 
 
 
 
7 
 
 
  
 
3 
 
 
 
4.91/4.88 
 
 
0 
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Figure 35. 
 
The mandelic acid interacted with HASPO ligands 260 and 262, and the signals shifted 
from singlet to doublet. Additionaly, the proton attached to the chiral center of mandelic 
acid interacted with ligand 262 showed a baseline separation of 6 Hz (Table 25).  
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Table 25. Resolution of Carboxylic Acid in the Presence of HASPO Ligands             
(
1
H-NMR). 
  Entry Ligand δ (ppm) 1H δ (Hz) 
1 -  0 
 
 
2 
 
 
 
 
 
 
6 
  
 
3 
 
 
 
 
 
 
1 
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Figure 36. 
 
Both ligands were tested also with BINOL which interacted with both compounds. 
Ligand 260 and the aromatic –CH showed a baseline separation of 18 Hz, while ligand 
262 showed 9 Hz. However, in both cases impurities are visible on NMR spectra  
(Table 26). 
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Table 26. Resolution of BINOL in the Presence of HASPO Ligands (
1
H-NMR). 
  Entry Ligand δ (ppm) 1H δ (Hz) 
1 - 7.63/7.61 0 
 
 
2 
 
 
 
7.66/7.64 
 
 
9 
 
  
 
3 
 
 
 
 
7.69/7.66 
 
 
18 
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Figure 37. 
 
2.6. Summary and Future Work 
The presented investigation began with the preparation of novel chiral diamines ligands 
followed by heteroatom-substituted secondary phosphine oxides based on camphoric 
acid. Two different types of diamines were prepared starting with a Schmidt reaction 
from camphoric acid. One of them with the same substituted nitrogen atoms were 
synthesized through alkylation by treating the diamine with arylmethylene chloride or 
with an aldehyde, followed by the reduction of the corresponding imine. The enantiopure 
diamines with a primary amine function were prepared via a Buchwald-Hartwig 
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amination, followed by the alkylation of the monosubstituted diamines with 
arylmethylene chloride in the second step. 
 
 
Scheme 54. 
 
The new diamine ligands were successfully applied in the copper catalyzed asymmetric 
Henry reaction. The chiral nitroaldol products were obtained in good yields and 
enantioselectivities.
152 
 
 
Scheme 55. 
 
Also a new class of chiral HASPO (heteroatom-substituted secondary phosphine oxide) 
ligands for transition-metal-catalyzed transformations was prepared from cheap camphor, 
by treating the secondary diamine with PCl3 and Et3N, followed by H2O which provided 
the desired HASPO ligands. Preliminary experiments using HASPO ligands based on 
camphoric acid indicated that trivalent phosphorus compounds are formed in the presence 
of BSA, which can be converted to HASPO complexes with palladium. The experiments 
were supported by 
31
P-NMR in toluene-D8.  
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Scheme 56. 
 
In the last section of this chapter, the HASPO ligands were presented as chiral shift 
reagents. The phosphorus compounds proved to be a versatile chiral discriminating 
agent for different types of racemic compounds such as alcohols, an acid or naphthol. 
 
Several parts of the thesis have been published.
189,190
 
 
In the future the synthesized of novel HASPO ligands can be explored in several other 
reactions such as the alkylative ring-opening with a palladium-catalyzed C-C bond 
formation, the Heck reaction, the enantioselective hydrovinylation of alkenes or the 
hydroformylation processes for the production of aldehydes from C-C double bonds. On 
the other hand, the allylpalladium chloride dimer is one of the most important catalyst 
used in organic synthesis, but the allylic substitution can be investigated with other allyl 
palladium complexes with larger ligands such as (2-methylallyl)palladium(II) chloride 
dimer or (2-butenyl)chloropalladium dimer. 
Another excellent application of the HASPO compounds would be the addition HASPO 
ligands to aromatic methyl ketones and asymmetric ketones. The hydrophosphorylation 
gives in the presence of potassium carbonate P,C-stereogenic tertiary α-hydroxyl 
phosphinates (Scheme 57).
191
 
 
Scheme 57. 
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3. Experimental 
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3.1. General Experimental 
All reactions were conducted in vacuum flame-dried glassware under an atmosphere of 
dry argon. Catalytic reactions were carried out using Schlenk line techniques.  
 
Organic Compounds 
All reagents which are not described below were purchased from commercial sources 
such as ACROS ORGANICS, SIGMA ALDRICH, MERCK AG, FLUKA AG, 
LANCASTER, and ALFA AESAR. In addition, compounds which are shown in Table 
27 were prepared by Sobia Tabassum,
153
 Amélie Blanrue
192
 and Andreas Winkel
193
 
under the supervision of Prof. Wilhelm. 
 
Table 27. 
Entry Compound 
 
1
a
 
 
(1R,3S)-1,2,2-Trimethyl-N
3
-(pyridin-2-yl)cyclopentane-1,3-diamine 251 
 
2
a
 
 
N-((1R,3S)-3-Amino-2,2,3-trimethylcyclopentyl)acetamide 236 
 
3
b
 
 
2,2,2-Trifluoro-1-phenylethanol  
 
4
c
 
 
(E)-N-(4-Chlorobenzylidene)benzenesulfonamide 284 
 
5
c
 
 
(E)-N-(2-chlorobenzylidene)benzenesulfonamide 285 
 
6
c
 
 
(E)-N-benzylidene-2,4-dinitrobenzenesulfonamide 286 
 
7
c
 
 
(E)-N-benzylidene-4-methylbenzenesulfonamide 287 
 
a
 Compound was prepared by Dr. Sobia Tabassum.
153
 
b
 Compound was prepared by Dr. Andreas Winkel.
193
  
c
 Compound was prepared by Dr. Amélie Blanrue.
192
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Solvents 
The solvents were dried according to the general, common procedures. THF and diethyl 
ether were distilled from sodium benzophenone ketyl. Toluene was distilled from 
sodium. CH2Cl2 was distilled from calcium hydride. Anhydrous methanol, ethanol and 
acetonitrile were purchased from SIGMA ALDRICH and used without any purification. 
 
Chromatography 
Reactions were monitored by TLC with MERCK Silica gel 60 F254 plates. Flash 
column chromatography was performed on Silica gel 60 (230 – 400 mesh) from 
MERCK. 
 
HPLC Analysis 
Enantiomeric excess was determined on a Merck Hitachi HPLC system with the L-7200 
autosampler using a Daicel CHIRALPACK OD-H, a Daicel CHIRALPACK AD-H and 
Daicel CHIRALPACK AS-H column. i-Propanol and n-hexane were used as mobile 
phase. 
 
NMR 
Nuclear magnetic resonance data were recorded on a BRUKER Advance 500             
(
1
H-NMR: 500 MHz, 
13
C-NMR: 126 MHz, 
15
N-NMR: 51 MHz) and on a BRUKER 
Advance 300 (
31
P-NMR: 202 MHz, 
19
F-NMR: 125 MHz). The measurements of the 
substances were performed in deuterated chloroform (99.8%, DEUTERO) or deuterated 
toluene (99.5% DEUTERO). NMR chemical shifts δ are reported in parts per million 
(ppm) and are referenced to the residual solvent signal as the internal standard: CDCl3: 
7.26 (
1
H) and 77.0 (
13
C). The coupling constants J are given in Hertz (Hz). Following 
symbols are used to analyze the spectra: br- broad, s- singlet, d- doublet, t- triplet, q- 
quartet, m- multiplet. 
 
Melting points 
Melting points were taken on a Dr Tottoli apparatus from BÜCHI and are uncorrected. 
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Infrared spectra 
Infrared IR data were recorded on a FT-IR spectrometer Vertex from BRUKER. The 
absorption of solids was measured by KBr pellets. The absorption of liquids or oils was 
measured by using thin films between NaCl plates. Absorbance frequencies are reported 
in reciprocal centimeters (cm
1
). 
 
LR-MS 
Mass spectra were recorded with a Hewlett Packard 5989B at 70 eV. Analytical data are 
given as relative mass (m/z) and the brackets indicate the intensity in percent (%) related 
to the basic peak. 
 
HR-MS 
High resolution mass spectra were recorded on a Waters Quadrupole-ToF Synapt 2G. 
 
Elemental analysis 
Elemental analysis were carried out with a vario MICROcube analysator from 
ELEMENTAR. 
 
Optical rotations 
Optical rotations were measured using a 1 dm path length (c is given as g/100 mL) on a 
PERKIN-ELMER 241 MC polarimeter in the reported solvent. 
 
Specification of configuration 
The configuration of HASPO ligands was compared to the general rules followed by 
IUPAC recommendations and matched up to ChemDraw. 
Experimental 
108 
 
3.2. Experimental Procedures for the Preparation of 
Diamines 
 
3.2.1.  Synthesis of Camphor Diamine  
 
3.2.1.1. (1R,3S)-1,2,2-Trimethylcyclopentane-1,3-diamine (208) 
 
 
 
To a stirred solution of concentrated sulfuric acid (50 mL) and ethanol-free chloroform 
(300 mL) was added (+)-(1R,3S)-camphoric acid 209 (20.00 g, 0.12 mol, 1 equiv.) at  
50 
o
C. Sodium azide (19.50 g, 0.30 mol. 3 equiv.) was added in small amounts over a 
period of 2h. The resulting mixture was stirred at 50 
o
C for 18h. The reaction mixture 
was cooled to room temperature, poured into water (500 mL) and extracted with 
chloroform (2 x 500 mL). The aqueous layer was strongly basified with 12N sodium 
hydroxide and extracted with chloroform (2 x 500 mL). After drying over anhydrous 
sodium sulfate and removal of the solvent, the product was dissolved in diethyl ether     
(100 mL). The solution was filtered and the solvent removed in vacuo to give the 
product 208 as a white solid (10.10 g, 71.00 mmol, 71 %). The spectroscopic properties 
concur with published data.
148 
 
Mp: 131 
o
C; Lit.: 128 
o
C.
148
 
1
H-NMR (500 MHz, CDCl3): δ = 2.84 (dd, J = 8.6, 7.0 Hz, 1H, H-3),  1.89 (dddd, J = 
13.9, 9.7, 8.6, 5.4 Hz, 1H, H-4), 1.44 – 1.62 (m, 2H, H-5), 1.4 (s, 4H, H-N2, H-N1), 1.08 
– 1.29 (m, 1H, H-4), ), 0.88 (s, 3H, H-8), 0.64 (d, J =4.5 Hz, 6H, H-7, H-6) ppm. 
13
C-NMR (50 MHz, CDCl3): δ = 60.9 (C-1), 60.8 (C-3), 46.2 (C-2), 38.2 (C-5), 30.2 
(C-4), 25.8 (C-8), 22.3 (C-6), 16.2 (C-7) ppm.  
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15
N-NMR (51 MHz, CDCl3): δ = 47.2 (bs, 1N, N
1
), 31.3 (bs, 1N, N
2
) ppm. 
IR (ATR): = 3390, 2964, 1571, 1469, 1370, 1322, 689, 590 cm1. 
MS (ESI, + 3 kV): m/z (%) = 143 (M+1, 100%). 
HRMS (ESI): Calc. for C8H19N2: 143.1548, found: 143.1545. 
[]20D = +28 (c = 0.48, EtOH); Lit.: []
25
D = +30 (c = 1, EtOH).
194
 
 
3.2.2. Alkylation of Camphor Diamine with Arylmethylene 
Halide 
 
General Procedure  
 
 
 
Arylmethylene halide (2 equiv.) was added to a stirring solution of 1,2,2-
trimethylcyclopentane-1,3-diamine  208 (1 equiv.) and triethylamine (2 equiv.) in dry 
acetonitrile at room temperature. The mixture was heated at reflux for 20 h. 
Triethylamine hydrochloride was filtered off and the solvent was removed under 
vacuum. The crude product was purified by column chromatography on silica gel with 
CH2Cl2 as an eluent and the product was eluted with CH2Cl2/EtOAc, 90:10. 
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3.2.2.1. (1R,3S)-1,2,2-Trimethyl-N1,N3-bis(2,4,6-trimethylbenzyl) 
cyclopentane-1,3-diamine (210) 
 
 
 
Prepared from 2,4,6-trimethylbenzylchloride 211 (0.71 g, 4.23 mmol), 1,2,2-
trimethylcyclopentane-1,3-diamine 208 (0.30 g, 2.09 mmol) and triethylamine        
(0.55 mL, 4.30 mmol) in dry acetonitrile (20 mL). After work up, the product was 
further purified via column chromatography (CH2Cl2/EtOAc, 90:10) and diamine 210 
was obtained as colorless oil (0.46 g, 1.14 mmol, 57%). 
 
1
H-NMR (500 MHz, CDCl3): δ = 6.89 (d, J = 12 Hz, 4H, H-3’, H-5’, H-3’’, H-5’’), 
3.86 (d, J = 11.4 Hz, 1H, H-1’’’), 3.82 – 3.79 (m, 1H, H-1’’’’), 3.71 – 3.67 (m, 1H, H-
1’’’’), 3.64 – 3.60 (m, 1H, H-1’’’), 2.97 – 2.92 (m, 1H, H-3), 2.43 (s, 6H, 6’-CH3, 6’’-
CH3), 2.40 (s, 6H, 2’-CH3, 2’’-CH3), 2.32 (s, 6H, 4’-CH3, 4’’-CH3), 2.22 – 2.11 (m, 2H, 
H-4, H-5), 1.76 (m, 1H, H-5), 1.60 – 1.50 (m, 1H, H-4), 1.28 (s, 3H, H-8), 1.02 (s, 3H, 
H-7), 0.92 (s, 3H, H-6) ppm. 
13
C-NMR (50 MHz, CDCl3): δ = 137.1 (C-1’, C-1’’), 136.2 (C-4’), 136.1 (C-4’’), 134.7 
(C-2’, C-6’), 134.5 (C-2’’, C-6’’), 128.9 (C-3’, C-5’, C-3’’, C-5’’), 68.1 (C-3), 64.4 (C-
2), 47.5 (C-1’’’), 40.9 (C-1’’’’), 34.1 (C-4), 28.9 (C-5), 23.9 (C-7), 21.0 (4’-CH3, 4’’-
CH3), 20.6 (C-8)19.5 (2’-CH3, 2’’-CH3, 6’-CH3, 6’’-CH3) 16.8 (C-6) ppm.  
IR (ATR): = 2953, 2918, 2862, 1715, 1610, 1444, 1369, 1107, 848, 798, 714 cm1. 
MS (ESI, + 3 kV): m/z (%) = 407 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C28H43N2: 407.43426, found: 407.3431. 
[]20D = +33 (c = 0.45, EtOH). 
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3.2.2.2. (1R,3S)-N1,N3-Di(9H-fluoren-9-yl)-1,2,2-trimethylcyclopentane-
1,3-diamine (212) 
 
 
 
Prepared from 9-bromofluorene 213 (1.03 g, 4.20 mmol), 1,2,2-trimethylcyclopentane-
1,3-diamine 208 (0.30 g, 2.10 mmol) and triethylamine (0.58 mL, 4.20 mmol) in dry 
acetonitrile (20 mL). After work up, the product was further purified via column 
chromatography (CH2Cl2/EtOAc, 90:10) and the diamine 212 was obtained as a yellow 
solid (0.60 g, 1.25 mmol, 59%). 
 
Mp: 162 
o
C. 
1
H-NMR (500 MHz, CDCl3): δ = 7.77 – 7.63 (m, 8H, H-1’, H-2’, H-3’, H-4’, H-5’,H-
6’, H-7’, H-8’), 7.44 – 7.24 (M, 8H, H-1’’, H-2’’, H-3’’, H-4’’, H-5’’,H-6’’, H-7’’, H-
8’’), 4.97 (s, 1H, H-9’), 4.89 (s, 1H, H-9’’), 3.08 (s, 1H, H-3), 2.30 – 1.87 (m, 4H, H-4, 
H-5), 1.31 (s, 3H, H-8), 1.01 (s, 3H, H-7), 0.98 (s, 3H, H-6) ppm. 
13
C-NMR (50 MHz, CDCl3): δ = 149.5 (C-9’a), 149.2 (C-9’’a), 147.3 (C-8’a), 146.3 
(C-8’’a), 140.6 (C-4’a), 140.5 (C-4’b), 140.2 (C-4’’a), 140.1 (C-4’’b), 127.9 (C-1’), 
127.9 (C-8’), 127.7 (C-1’’), 127.6 (C-8’’), 127.5 (C-2’), 127.4 (C-7’), 127.3 (C-2’’), 
126.9 (C-7’’), 125.5 (C-3’), 125.5 (C-6’), 125.1 (C-3’’), 125.0 (C-6’’), 119.9 (C-4’), 
119.8 (C-5’), 119.7 (C-4’’), 119.6 (C-5’’), 64.8 (C-1), 63.9 (C-3), 62.4 (C-9’), 59.7 (C-
9’’), 48.3 (C-2), 36.8 (C-5), 30.0 (C-4), 24.0 (C-8), 23.5 (C-6), 17.1 (C-7) ppm.  
IR (ATR): = 3348, 3044, 2963, 1448, 1265, 1066, 797, 727 cm1. 
MS (ESI, + 3 kV): m/z (%) = 471 (M+1, 100%). 
HRMS (ESI): Calc. for C34H34N2: 471.2800, found: 471.2806. 
[]20D = 19 (c = 0.65, EtOH). 
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3.2.3. Alkylation of Camphor Diamine with Aldehyde 
 
3.2.3.1. (1R,3S,N1E,N3E)-N1,N3-Dibenzylidene-1,2,2-trimethylcyclopentane 
-1,3-diamine (215) 
 
 
 
Benzaldehyde 68 (1.42 mL, 14.00 mmol) in toluene (5 mL) was added drop wise to a 
solution of 1,2,2-trimethylcyclopentane-1,3-diamine 208 (1.00 g, 7.00 mmol),              
p-toluenosulfonic acid (70.00 mg) and toluene (15 mL) at room temperature. The 
resuling mixture was heated at reflux overnight on a Dean Stark under a stream of 
argon. After removal of the solvent, the crude product 215 was obtained as brown oil 
which was reduced in the next step. 
 
3.2.3.2. (1R,3S)-N1,N3-Dibenzyl-1,2,2-trimethylcyclopentane-1,3-diamine 
(214) 
 
 
 
To a solution of N
1
,N
3
-dibenzylidene-1,2,2-trimethylcyclopentane-1,3-diamine 215 
(1.85 g, 5.82 mmol) in dry methanol (20 mL) was carefully added sodium borohydride 
(0.81 g, 21.43 mmol) under a stream of argon. The resulting mixture was stirred at room 
temperature for 5 h. Water (25 mL) was added and methanol was evaporated. Ethyl 
acetate (20 mL) was added and the organic phase was washed with 2N hydrochloric 
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acid (3 x 50 mL). The aqueous phase was basified with 12N sodium hydroxide and 
extracted with methylene chloride (3 x 50 mL). The combined organic layers were dried 
(Na2SO4). The solvent was evaporated to give a diamine 214 as yellow oil (1.38 g,   
4.37 mmol, 75%). Spectral data were consistent with literature values.
176 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.28 – 7.36 (m, 10H, H-1’, H-2’, H-3’, H-4’, H-5’ H-
6’, H-1’’, H-2’’, H-3’’, H-4’’, H-5’’, H-6’’), 3.66 – 3.92 (m, 4H, H-1’’’, H-1’’’’), 2.88 
(dd,   J = 8.2, 6.1 Hz, 1H, H-3), 2.04 (m, 1H, H-4), 1.90 (m, 1H, H-5), 1.64 (m, 1H, H-
4), 1.46 (m, 1H, H-5), 1.14 (s, 3H, H-8), 1.02 (s, 3H, H-6), 0.99 (s, 3H, H-7) ppm. 
13
C-NMR (50 MHz, CDCl3): δ = 142.1 (C-1’), 141.3 (C-1’’), 128.3 (C-2’, C-6’, C-2’’, 
C-6’’), 128.2 (C-2’’, C-6’’), 128.1 (C-3’, C-5’), 128.0 (C-3’’, C-5’’), 126.7 (C-4’), 
126.6 (C-4’’), 66.7 (C-1), 64.6 (C-3), 52.6 (C-1’’’), 47.6 (C-1’’’’), 47.3 (C-2), 34.2 (C-
4), 28.5 (C-5), 24.4 (C-8), 20.7 (C-6), 17.0 (C-7) ppm.  
 
3.2.4. Regioselective Arylation of Camphor Diamine  
 
General Procedure 
 
 
 
In a dried Schlenk-tube Pd2(dba)3 (2-4 mol%), (±)-BINAP (6-9 mol%) and NaOtBu     
(3 equiv.) were dissolved in toluene under a nitrogen atmosphere and stirred for 20 min. 
Camphor diamine 208 (1 equiv.) and a bromoaryl 216-224 (1 equiv.) were added and 
the solution was stirred for 48 h at 100 °C. The solution was filtered through a plug of 
silica and the plug was eluted with additional toluene. Thereafter, the plug was eluted 
with CH2Cl2/MeOH (9:1) until all the product was removed from the silica plug. The 
solvent was evaporated under reduced pressure and the crude product was dissolved in 
CH2Cl2. The organic phase was extracted with 12 M HCl. The aqueous phase was 
separated and washed 3x with CH2Cl2. Thereafter, the aqueous phase was cooled to      
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0 °C and 12 M NaOH was slowly added until the solution had a pH of 14. The basic 
solution was extracted 5x with CH2Cl2 and the combined organic phases were dried 
over Na2SO4, filtered and the solvent was removed. The crude product was dissolved in 
pentane and the solution was filtered to remove insoluble impurities.  
  
3.2.4.1. (1R,3S)-1,2,2-Trimethyl-N3-(o-tolyl)cyclopentane-1,3-diamine 
(225) 
 
 
 
Prepared from Pd2(dba)3 (0.80 g, 0.87 mmol, 4 mol%), (±)-BINAP (1.20 g, 1.93 mmol, 
9 mol%), NaOtBu (6.10 g, 63.48 mmol), diamine 208 (3.00 g, 21.09 mmol),                 
2-bromotoluene 216 (2.50 mL, 20.79 mmol) in toluene (360 mL). After work up, the 
product 225 was obtained as a yellow solid (4.00 g, 17.21 mmol, 82%).  
 
Mp: 95 °C. 
1
H-NMR (500 MHz, CDCl3) δ = 7.10 – 7.05 (m, 1H, H-4’), 7.03 (dd, J = 7.3, 0.6 Hz, 
1H, H-6’), 6.61 – 6.55 (m, 2H, H-5’, H-3’), 5.11 (s, 1H, H-N3), 3.68 (d, J = 4.5 Hz, 1H, 
H-3), 2.28 – 2.18 (m, 1H, H-4), 2.13 (s, 3H, 2’-CH3), 1.86 – 1.77 (m, 1H, H-5), 1.69 – 
1.56 (m, 2H, H-5, H-4), 1.18 (s, 3H, H-8), 1.02 (s, 3H, H-7), 0.98 (s, 3H, H-6) ppm.  
13
C-NMR (126 MHz, CDCl3)  = 146.6 (C-1’), 130.1 (C-6’), 126.9 (C-4’), 122.3 (C-
2’), 115.7 (C-3’), 109.6 (C-5’), 62.6 (C-3), 61.7 (C-1), 47.2 (C-2), 38.2 (C-5), 29.4 (C-
4),  26.5 (C-8), 25.0 (C-6), 17.9 (2’-CH3), 17.3 (C-7) ppm.  
15
N-NMR (51 MHz, CDCl3) δ = 82.4 (bs, 1N, N
2
), 52.1 (bs, 1N, N
1
) ppm. 
IR (ATR)  = 3288, 2967, 1602, 1580, 1502, 1448, 1386, 1364, 1314, 1262, 1227, 
1144, 1049, 980, 953, 909, 856, 745, 715, 654 cm
1
.  
MS (EI, 70 eV): m/z (%) = 248 (16) [M]
+
, 216 (10), 123 (100), 108 (15), 70 (10).  
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HRMS (ESI): Calcd. for C15H25N2: 233.2018 [M+H]
+
, found: 233.2017. 
Anal. Calc. for C15H24N2: C, 77.53; H, 10.41; N, 12.06; found: C, 77.43; H, 10.31; N, 
12.00. 
[]20D = +112 (c = 6, CHCl3). 
 
3.2.4.2. (1S,3R)-N1-(2-Methoxyphenyl)-2,2,3-trimethylcyclo-pentane-1,3-
diamine (226) 
 
 
 
Prepared from Pd2(dba)3 (0.80 g, 0.87 mmol, 4 mol%), (±)-BINAP (1.20 g, 1.93 mmol, 
9 mol%), NaOtBu (6.11 g, 63.48 mmol), diamine 208 (3.00 g, 21.09 mmol),                 
2-bromoanisole 217 (2.60 mL, 20.88 mmol) in toluene (360 mL). After work up, the 
product 226 was obtained as a yellow solid (5.20 g, 20.94 mmol, 99%).  
 
Mp: 65 °C.  
1
H-N.MR (500 MHz, CDCl3) δ =  6.85 (ddd, J = 7.7, 6.1, 1.4 Hz, 1H, H-5’), 6.77 (dd,  
J = 7.9, 1.3 Hz, 1H, H-3’), 6.66 – 6.59 (m, 2H, H-6’, H-4’), 4.96 (bs, 1H, H-N1), 3.85 (s, 
3H, 2’-OCH3), 3.73 – 3.66 (m, 1H, H-1), 2.24 (dddd, J = 13.6, 10.3, 8.5, 4.9 Hz, 1H,   
H-5), 1.76 (ddd, J = 13.2, 10.3, 6.1 Hz, 1H, H-4), 1.66 (ddd, J = 13.3, 11.0, 4.9 Hz, 1H, 
H-4), 1.54 (ddt, J = 13.7, 11.0, 6.0 Hz, 1H, H-5), 1.15 (s, 3H, H-8), 0.97 (s, 3H, H-6), 
0.96 (s, 3H, H-7) ppm.  
13
C-NMR (126 MHz, CDCl3)  = 146.9 (C-2’), 138.7 (C-1’), 121.3 (C-5’), 115.5 (C-
4’), 110.0 (C-6’), 109.8 (C-3’), 61.8 (C-1), 61.0 (C-3), 55.6 (2’-OCH3), 47.1 (C-2), 38.3 
(C-4), 29.3 (C-5), 26.3 (C-8), 23.7 (C-6), 17.2 (C-7) ppm.  
15
N-NMR (51 MHz, CDCl3) δ = 70.5 (bs, 1N, N
1
), 47.7 (bs, 1N, N
2
) ppm.  
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IR (KBr)  = 3435, 3062, 2961, 2869, 2284, 1601, 1515, 1454, 1428, 1368, 1341, 1311, 
1223, 1179, 1119, 1026, 879, 839, 737, 551 cm
1
.  
MS (EI, 70 eV): m/z (%) = 248 (16) [M]
+
, 216 (10), 123 (100), 108 (15), 70 (10).  
HRMS (ESI): Calcd. for C13H25N2O: 249.1967 [M+H]
+
, found: 249.1976. 
Anal. Calc. for C15H24N2O: C, 72.54; H, 9.74; N, 11.28; found: C, 72.41; H, 9.71; N, 
11.21. 
[]20D = +51 (c = 2.7, CHCl3). 
 
3.2.4.3. (1R,3S)-1,2,2-Trimethyl-N3-phenylcyclopentane-1,3-diamine (227) 
 
 
 
Prepared from Pd2(dba)3 (0.30 g, 0.33 mmol, 2.5 mol%), (±)-BINAP (0.52 g,            
0.80 mmol, 6 mol%), NaOtBu (1.70 g, 17.69 mmol), diamine 208 (2.50 g, 17.57 mmol), 
bromobenzene 218 (1.80 mL, 17.14 mmol) in toluene (180 mL). After work up, the 
product 227 was obtained as brown oil (2.30 g, 10.53 mmol, 60%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.15 (dd, J = 8.6 Hz, H-6’, H-2’), 6.62 ( m, 3H, H-3’, 
H-4’, H-5’), 5.2 – 4.7 (s (br), 1H, H-N1), 3.65 (m, 1H, H-3), 2.21 (m, 1H, H-4), 1.77 (m, 
1H, H-5), 1.59 (m, 2H, H-5, H-4), 1.38-1.20 (s (br), 2H, H-N
3
), 1.14 (s, 3H, H-8), 0.96 
(s, 3H, H-7), 0.95 (s, 3H, H-6) ppm.  
13
C-NMR (126 MHz, CDCl3)  = 148.7 (C-1’), 129.2 (C-6’, C-2’), 116.3 (C-4’), 113.1 
(C-5’, C-33), 62.6 (C-3), 61.3 (C-1), 47.2 (C-2), 38.2 (C-5), 29.1 (C-4), 26.5 (C-8), 24.5 
(C-6), 17.2 (C-7) ppm. 
15
N-NMR (51 MHz, CDCl3) δ = 83.8 (bs, 1N, N
2
), 51.0 (bs, 1N, N
1
) ppm.  
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IR (ATR)  = 3401, 3360, 3300, 3083, 3052, 3020, 2959, 2867, 1909, 1595, 1500, 
1468, 1312, 854, 742, 690, 502 cm
1
.  
MS (EI, 70 eV): m/z (%) = 218 (85) [M]
+
, 201 (27), 186 (77), 132 (40), 126 (97), 119 
(72), 109 (68), 93 (100), 77 (32), 70 (72), 57 (65), 41 (30).  
HRMS (ESI): Calcd. for C14H23N2: 219.1861 [M+H]
+
, found: 219.1854.  
Anal. Calc. for C14H22N2: C, 77.01; H, 10.16; N, 12.83; found: C, 76.86; H, 10.11; N, 
12.69 
 []20D = +112.2 (c = 1.05, CH2Cl2). 
 
3.2.4.4. (1S,3R)-N1-Mesityl-2,2,3-trimethylcyclopentane-1,3-diamine (228) 
 
 
 
Prepared from Pd2(dba)3 (0.80 g, 0.87 mmol, 4 mol%), (±)-BINAP (1.20 g, 1.93 mmol, 
9 mol%), NaOtBu (6.11 g, 63.48 mmol), diamine 208 (3.00 g, 21.09 mmol), 2-bromo-
1,3,5-trimethyl-benzol 219 (3.20 mL, 20.90 mmol) in toluene (360 mL). The product 
228 was obtained as yellow oil (5.30 g, 20.35 mmol, 97%).  
 
1
H-NMR (500 MHz, CDCl3) δ = 6.78 (s, 2H, H-5’, H-3’), 4.21 (bs, 1H, H-N
1
), 3.42 
(dd, J = 7.7, 4.9 Hz, 1H, H-1), 2.25 (s, 6H, 6’-CH3, 2’-CH3), 2.21 (s, 3H, 4’-CH3),    
1.90 – 1.81 (m, 1H, H-5), 1.75 – 1.60 (m, 2H, H-4), 1.54 – 1.45 (m, 1H, H-5), 1.12 (s, 
3H, H-8), 1.09 (s, 3H, H-7), 0.94 (s, 3H, H-6) ppm.  
13
C-NMR (126 MHz, CDCl3)  = 143.5 (C-1’), 129.7 (C-6’, C-2’), 129.6 (C-5’, C-3’), 
128.7 (C-4’), 66.4 (C-1), 61.2 (C-3), 47.0 (C-2), 38.2 (C-4), 28.6 (C-5), 26.8 (C-8), 23.9 
(C-6), 20.5 (C-4’), 19.4 (C-6’, C-2’), 17.1 (C-7) ppm. 
15
N-NMR (51 MHz, CDCl3) δ = 68.8 (bs, 1N, N
1
), 50.6 (bs, 1N, N
2
) ppm.  
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IR (ATR)  = 3319, 2961, 2866, 1584, 1481, 1386, 1370, 1300, 1237, 1156, 1137, 
1110, 1059, 1026, 927, 890, 851, 810, 763 cm
1
.  
MS (EI, 70 eV): m/z (%) = 260 (24) [M]
+
, 228 (22), 161 (8), 146 (21), 135 (100), 120 
(8), 86 (9), 70 (46), 57 (30), 41 (11).  
HRMS (EI): Calcd. for C17H28N2: 260.2247 [M]
+
, found: 260.2248.  
Anal. Calc. for C17H28N2: C, 78.41; H, 10.84; N, 10.76; found: C, 78.39; H, 10.80; N, 
10.75. 
[]20D = +79 (c = 4.3, CHCl3). 
 
3.2.4.5. (1R,3S)-1,2,2-Trimethyl-N3-(naphthalen-1-yl)cyclo-pentane-1,3-
diamine (229) 
 
 
 
Prepared from Pd2(dba)3 (0.51 g, 0.55 mmol, 4 mol%), (±)-BINAP (0.50 g, 0.80 mmol, 
6 mol%), NaOtBu (4.10 g, 42.66 mmol), diamine 208 (2.00 g, 14.06 mmol), 1-bromo-
naphthalene 220 (1.90 mL, 13.58 mmol) in toluene (180 mL). After work up, the 
product 229 was further purified via column chromatography (CH2Cl2/MeOH, 99:1) on 
neutral aluminum oxide and obtained as a white solid (2.41 g, 8.94 mmol, 64%). 
 
Mp: 126 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.92 (d, J = 8.0 Hz, 1H, H-8’), 7.81 – 7.74 (m, 1H, H-
5’), 7.46 – 7.37 (m, 2H, H-7’, H-6’), 7.34 (t, J = 7.9 Hz, 1H, H-3’), 7.15 (d, J = 8.2 Hz, 
1H, H-4’), 6.64 – 6.48 (m, 2H, H-N3, H-2’), 3.84 (d, J = 5.0 Hz, 1H, H-3), 2.37 – 2.25 
(m, 1H, H-4), 1.93 – 1.85 (m, 1H, H-5), 1.85 – 1.76 (m, 1H, H-4), 1.75 – 1.66 (m, 1H, 
H-5), 1.23 (s, 3H, H-8), 1.13 (s, 3H, H-7), 1.05 (s, 3H, H-6) ppm.  
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13
C-NMR (126 MHz, CDCl3)  = 144.1 (C-1’), 134.7 (C-4’a), 128.5 (C-5’), 126.8 (C-
3’), 125.5 (C-6’), 124.2 (C-7’), 124.0 (C-8’a), 120.9 (C-8’), 115.7 (C-4’), 103.6 (C-2’), 
63.3 (C-3), 62.2 (C-1), 47.5 (C-2), 38.2 (C-5), 29.2 (C-4), 26.4 (C-8), 25.7 (C-6), 17.4 
(C-7) ppm.  
15
N-NMR (51 MHz, CDCl3) δ = 83.6 (bs, 1N, N
2
), 54.4 (bs, 1N, N
1
) ppm. 
IR (ATR)  = 1258, 1227, 1153, 1028, 633, 574, 517 cm1.  
MS (EI, 70 eV): m/z (%) = 268 (34), 157 (36), 143 (100), 112 (49), 97 (44), 95 (24), 83 
(66), 71 (53), 70 (58), 69 (58), 57 (84), 55 (63), 44 (42), 43 (57), 41 (56).  
HRMS (ESI): Calcd. for C18H24N2Na: 291.1837 [M+H+Na]
+
, found: 291.1829.  
Anal. Calc. for C18H24N2: C, 80.55; H, 9.01; N, 10.44; found: C, 80.55; H, 9.13; N, 
10.43. 
[]20D = +137 (c = 2.1, CHCl3). 
 
3.2.4.6. (1S,3R)-N1-([1,1'-Biphenyl]-2-yl)-2,2,3-trimethylcyclo-pentane-1,3-
diamine (230) 
 
 
 
Prepared from Pd2(dba)3 (0.83 g, 0.87 mmol, 4 mol%), (±)-BINAP (1.21 g, 1.93 mmol, 
9 mol%), NaOtBu (6.20 g, 64.52 mmol), diamine 208 (3.10 g, 21.79 mmol), 2-bromo-
1,1´-biphenyl 221 (3.70 mL, 20.26 mmol) in toluene (360 mL). After work up, the 
product 230 was obtained as yellow oil (4.72 g, 15.96 mmol, 73%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.47 – 7.38 (m, 4H, H-6’’, H-5’’, H-3’’, H-2’’), 7.34 – 
7.29 (m, 1H, H-4’’), 7.19 (ddd, J = 8.2, 7.4, 1.7 Hz, 1H, H-6’), 7.08 (dd, J = 7.6, 1.7 Hz, 
1H, H-4’), 6.72 – 6.67 (m, 2H, H-5’, H-3’), 4.90 (s, 1H, H-N1), 3.64 (s, 1H, H-1), 2.19 
(tdt, J = 10.6, 8.2, 5.4 Hz, 1H, H-5), 1.72 (ddd, J = 13.4, 10.5, 6.0 Hz, 1H, H-4), 1.61 – 
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1.52 (m, 1H, H-4), 1.49 – 1.38 (H-5), 1.11 (s, 3H, H-8), 0.91 (s, 3H, H-7), 0.78 (s, 3H, 
H-6) ppm. 
13
C-NMR (126 MHz, CDCl3)  = 145.5 (C-2’), 140.0 (C-1’’), 130.3 (C-4’), 129.5 (C-
5’’, C-3’’), 128.6 (C-6’), 128.6 (C-6’’, C-2’’), 127.9 (C-1’), 126.9 (C-4’’), 116.0 (C-5’), 
110.5 (C-3’), 62.2 (C-1), 61.2 (C-3), 47.1 (C-2), 37.9 (C-4), 29.0 (C-5), 26.1 (C-8), 23.8 
(C-7), 17.2 (C-6) ppm.  
15
N-NMR (51 MHz, CDCl3) δ = 79.6 (bs, 1N, N
1
), 50.4 (bs, 1N, N
2
) ppm.  
IR (ATR)  = 3296, 3057, 2959, 2867, 1597, 1576, 1506, 1489, 1462, 1436, 1387, 
1368, 1319, 1283, 1161, 1144, 1063, 1007, 994, 927, 879, 841, 769, 734, 701, 615 cm
1
.  
MS (EI, 70 eV): m/z (%) = 294 (9) [M]
+
, 258 (34), 248 (15), 216 (12), 169 (99), 123 
(100), 110 (70), 70 (58), 57 (65).  
HRMS (ESI): Calcd. for C20H27N2: 295.2174 [M+H]
+
, found: 295.2162.  
Anal. Calc. for C20H26N2: C, 81.59; H, 8.90; N, 9.51; found: C, 80.95; H, 8.98; N, 9.43. 
[]20D = +44 (c = 7, CHCl3). 
 
3.2.4.7. (1S,3R)-N1-(2-Isopropylphenyl)-2,2,3-trimethylcyclopentane-1,3-
diamine (231) 
 
 
 
Prepared from Pd2(dba)3 (0.50 g, 0.55 mmol, 4 mol%), (±)-BINAP (0.81 g, 1.29 mmol, 
9 mol%), NaOtBu (4.10 g, 42.66 mmol), diamine 208 (2.00 g, 14.06 mmol), 1-bromo-2-
isopropylbenzene 222 (2.20 mL, 14.37 mmol) in toluene (350 mL). After work up, the 
product 231 was obtained as brown oil (1.80 g, 6.91 mmol, 49%). 
 
Experimental 
121 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.13 – 7.03 (m, 2H, H-5’, H-3’), 6.67 – 6.59 (m, 2H, 
H-6’, H-4’), 5.41 (s, 1H, H-N1), 3.66 (s, 1H, H-1), 2.92 – 2.87 (m, 1H, 2’-CH(CH3)2), 
2.25 – 2.17 (m, 1H, H-5), 1.84 – 1.78 (m, 1H, H-4), 1.64 – 1.56 (m, 2H, H-5, H-4), 1.25 
(t, J = 7.1 Hz, 6H, 2’-CH(CH)3), 1.16 (s, 3H, H-8), 1.02 (s, 3H, H-7), 0.97 (s, 3H, H-6) 
ppm.  
13
C-NMR (126 MHz, CDCl3) δ = 145.3 (C-1’), 132.5 (C-2’), 126.6 (C-4’), 124.9 (C-
6’), 115.9 (C-3’), 110.1 (C-5’), 62.8 (C-3), 61.5 (C-1), 47.3 (C-2), 38.5 (C-5), 29.3 (2’-
CH(CH3)2), 27.5 (C-4), 26.8 (2’-CHCH3), 25.1 (2’-CHCH3), 22.5 (C-8), 22.1 (C-7), 
17.3 (C-6) ppm.  
15
N-NMR (51 MHz, CDCl3) δ = 80.6 (br, 1N, N
1
), 51.1 (br, 1N, N
2
) ppm.  
IR (ATR)  = 3306, 2957, 2870, 1602, 1579, 1509, 1451, 1364, 1258, 1056, 886, 735 
cm
1
.  
MS (EI, 70 eV): m/z (%) = 261 (6) [M]
+
, 260 (26), 243 (5), 228 (16), 201 (2), 200 (6), 
186 (3), 161 (4), 146 (24), 135 (100), 120 (57), 110 (71), 93 (11), 71 (15), 70 (43), 57 
(56), 42 (22).  
HRMS (ESI): Calcd. for C17H29N2: 261.2331 [M+H]
+
, found: 261.2324.  
Anal. Calc. for C17H28N2: C, 78.41; H, 10.84; N, 10.76; found: C, 78.38; H, 10.34; N, 
10.90. 
[]20D = +172 (c = 0.55, CH2Cl2). 
 
3.2.4.8. (1S,3R)-N1-([1,1'-Biphenyl]-3-yl)-2,2,3-trimethylcyclopentane-1,3-
diamine (232) 
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Prepared from Pd2(dba)3 (0.08 g, 0.09 mmol, 4 mol%), (±)-BINAP (0.10 g, 0.16 mmol, 
9 mol%), NaOtBu (0.62 g, 6.24 mmol), diamine 208 (0.32 g, 2.11 mmol),                     
3-bromobiphenyl 223 (0.40 mL, 2.40 mmol) in toluene (60 mL). After work up, the 
product 232 was obtained as yellow oil (0.33 g, 1.02 mmol, 48%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.67 – 7.64 (m, 2H, H-6’’, H-5’’), 7.50 – 7.45 (m, 2H, 
H-2’’, H-3’’), 7.40 – 7.36 (m, 1H, H-4’’), 7.29 – 7.25 (m, 1H, H-6’), 6.93 (ddd, J = 7.5, 
1.6, 0.9 Hz, 1H, H-5’), 6.90 – 6.87 (m, 1H, H-4’), 6.66 (ddd, J = 8.1, 2.4, 0.8 Hz, 1H, 
H-2’), 5.19 (br s, 1H, H-N3), 3.76 (d, J = 4.6 Hz, 1H, H-1), 2.32 – 2.25 (m, 1H, H-5), 
1.87 – 1.80 (m, 1H, H-4), 1.71 – 1.63 (m, 2H, H-5, H-4), 1.19 (s, 3H, H-8), 1.04 (s, 3H, 
H-7), 1.02 (s, 3H, H-6)  ppm.  
13
C-NMR (126 MHz, CDCl3) δ = 149.1 (C-3’), 142.4 (C-1’’), 142.2 (C-5’), 129.6 (C-
5’’, C-3’’), 128.6 (C-6’), 127.3 (C-6’’, C-2’’), 127.1(C-1’), 115.6 (C-4’’), 112.2 (C-5’), 
112.1 (C-4’), 62.8 (C-1), 61.4 (C-3), 47.4 (C-2), 38.3 (C-4), 29.3 (C-5), 26.6 (C-8), 24.8 
(C-7), 17.3 (C-6) ppm.  
15
N-NMR (51 MHz, CDCl3) δ = 84.1 (bs, 1N, N
1
), 51.1 (bs, 1N, N
2
) ppm.  
IR (ATR)  = 3286, 3051, 2940, 2866, 1577, 1523, 1480, 1466, 1425, 1374, 1346, 
1253, 1161, 1140, 1076, 1011, 927, 899, 845, 759, 713, 616 cm
1
.  
MS (EI, 70 eV): m/z (%) = 294 (15) [M]
+
, 277 (4), 262 (9), 250 (3), 234 (8), 208 (4), 
195 (8), 194 (4), 170 (17), 169 (100), 155 (13), 152 (6), 126 (11), 93 (5), 70 (5), 41 (4).  
HRMS (ESI): Calcd. for C20H27N2: 295.2174 [M+H]
+
, found: 295.2172.  
Anal. Calc. for C20H28N2: C, 81.59; H, 8.90; N, 9.51; found: C, 80.70; H, 9.17; N, 9.52. 
[]20D = +88 (c = 0.49, CH2Cl2). 
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3.2.4.9. 1,2,2-Trimethyl-N3-(2-(naphthalen-1-yl)phenyl)cyclopentane-1,3-
diamine (233) 
 
 
 
Prepared from Pd2(dba)3 (0.03 g, 0.03 mmol, 4 mol%), (±)-BINAP (0.04 g, 0.06 mmol, 
9 mol%), NaOtBu (0.2 g, 2.08 mmol), diamine 208 (0.10 g, 0.71 mmol),                       
1-(2-bromophenyl)naphthalene 224 (0.20 mg, 0.70 mmol) in toluene (100 mL). After 
work up, the product 233 was obtained as a mixture of diastereoisomers with an axis of 
chirality (P, M) as a yellow solid (0.08 g, 0.23 mmol, 33%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.86 (dd, J = 16.7, 8.1 Hz, 4H, H-8’’D1, H-8’’D2, H-
2’’D1, H-2’’D2), 7.72 – 7.62 (m, 2H, H-5’’D1, H-5’’D2), 7.58 – 7.28 (m, 10H, H-4’’D1, H-
4’’D2, H-3’’D1, H-3’’D2, H-6’D1, H-6’D2, H-6’’D1, H-6’’D2, H-7’’’D1, H-7’’D2), 7.15 (dt, J 
= 7.5, 1.7 Hz, 2H, H-4’D1, H-4’D2), 6.79 – 6.74 (m, 4H, H-5’D1, H-5’D2, H-3’D1, H-3’D2) 
4.67 (d, J = 9.1 Hz, 1H, H-N
1
D1), 4.50 (d, J = 9.1 Hz, 1H, H-N
1
D2), 3.81 – 3.48 (m, 2H, 
H-1D1, H-1D2), 2.24 – 1.90 (m, 2H, H-5D1, H-5D2), 1.67 – 1.55 (m, 2H, H-4D1, H-4D2), 
1.42 – 1.20 (m, 4H, H-5D1, H-5D2, H-4D1, H-4D2), 0.96 (s, 3H, CH3, H-8D1), 0.94 (s, 3H, 
CH3, H-8D2), 0.82 (s, 3H, CH3, H-7D1), 0.78 (s, 3H, CH3, H-7D2), 0.53 (s, 3H, CH3, H-
6D1), 0.37 (s, 3H, CH3, H-6D2) ppm.  
13
C-NMR (126  MHz, CDCl3) δ = 146.6 (C-2’D1), 146.4 (C-2’D2), 137.7 (C-1’’D1, C-
1’’D2), 133.9 (C-4’’aD1), 133.7 (C-4’’aD2), 132.3 (C-8’’aD1), 132.1 (C-8’’aD2), 130.8 (C-
4’aD1, C-4’aD2), 128.8 (C-5’’D1, C-5’’D2), 128.1 (C-8’’D1), 128.1 (C-8’’D2), 127.8 (C-
4’’D1), 127.8 (C-4’’D2), 127.7 (C-6’’D1), 127.6 (C-6’’D2), 126.9 (C-7’’D1, C-7’’D2), 126.4 
(C-3’’D1, C-3’’D2), 126.1 (C-2’’D1, C-2’’D2), 125.9 (C-6’D1), 125.8 (C-6’D2), 125.8 (C-
5’D1, C-5’D2), 115.7 (C-1’D1), 115.6 (C-1’D2), 110.2 (C-3’D1), 110.1 (C-3’D2), 62.4 (C-
1D1), 62.2 (C-1D2), 60.7 (C-3D1), 60.6 (C-3D2), 46.9 (C-2D1, C-2D2), 38.2 (C-4D1, C-4D2), 
29.1 (C-5D1), 28.8 (C-5D2), 26.3 (C-8D1), 26.2 (C-8D2), 24.2 (C-6D1), 23.9 (C-6D2), 16.8 
(C-7D1), 16.7 (C-7D2) ppm. 
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3.2.5. Alkylation of Monosubtituted Diamines 
 
3.2.5.1. Alkylation by Arylmethylene Chloride or Benzyl 
Bromide 
 
General Procedure 
 
 
 
To the stirred mixture of monosubtituted diamine 225-231 (1 equiv.) and triethylamine 
(1.2 equiv.) in acetonitrile at room temperature was added arylmethylene chloride or 
benzyl bromide (1.1 equiv.). The resulting solution was refluxed overnight. After 
refluxing, the reaction mixture was cooled down, filtered and the filtrate was evaporated 
under reduced pressure. The crude residue was purified by flash column 
chromatography. 
 
3.2.5.1.1. (1R,3S)-1,2,2-Trimethyl-N3-(o-tolyl)-N1-(2,4,6-trimethylbenzyl) 
cyclopentane-1,3-diamine (237) 
 
 
 
Prepared from monosubstituted diamine 225 (0.30 g, 1.29 mmol), triethylamine       
(0.22 mL, 1.55 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.24 g, 1.42 mmol) in 
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acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 237 was obtained as colorless oil 
(0.30 g, 0.82 mmol, 64%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.18 – 7.14 (m, 1H, H-5’), 7.06 (dd, J = 7.2, 0.6 Hz, 
1H, H-6’ ), 6.96 (s, 2H, H-3’’, H-5’’), 6.69 (d, J = 7.9 Hz, 1H, H-3’), 6.65 (td, J = 7.3, 
1.0 Hz, 1H, H-4’), 4.97 (s, 1H, H-N1), 3.86 (d, J = 10.7 Hz, 1H, H-1’’’), 3.82 – 3.77 (m, 
1H, H-3), 3.74 (d, J = 10.7 Hz, 1H, H-1’’’), 2.46 (s, 6H, 2’’-CH3, 6’’-CH3), 2.39 (s, 3H, 
4’’-CH3), 2.28 – 2.18 (m, 2H, H-4), 1.90 (s, 3H, 2’-CH3), 1.80 – 1.71 (m, 2H, H-5), 1.36 
(s, 3H, H-8), 1.14 (s, 3H, H-6), 1.02 (s, 3H, H-7) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 146.6 (C-1’), 136.8 (C-2’’, C-6’’), 136.4 (C-4’’), 
134.1 (C-1’’), 130.2 (C-6’), 129.2 (C-3’’, C-5’’), 126.9 (C-5’), 122.2 (C-2’), 115.6 (C-
4’), 109.5 (C-3’), 65.5 (C-1), 62.1 (C-3), 48.8 (C-2), 40.2 (C-1’’’), 32.5 (C-4), 30.6 (C-
5), 25.9 (C-6), 21.0 (4’’-CH3), 19.6 (2’’-CH3, 6’’-CH3), 19.0 (C-8), 17.5 (C-2’), 17.0 
(C-7) ppm. 
15
N-NMR (51 MHz, CDCl3) δ = 83.8 (1N, N
2
), 53.5 (1N, N
1
) ppm. 
IR (ATR)  = 3360, 2958, 2914, 2865, 1601, 1576, 1507, 1477, 1448, 1384, 1370, 
1316, 1257, 1217, 1158, 1070, 1051, 850, 742, 713 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 365 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C25H37N2: 365.2956, found: 365.2957. 
Anal. Calc. for C25H36N2: C, 82.36; H, 9.95; N, 7.68; found: C, 82.13; H, 9.91; N,  
7.36. 
[]20D = 24 (c = 0.5, CH2Cl2). 
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3.2.5.1.2. (1R,3S)-N3-(2-Methoxyphenyl)-1,2,2-trimethyl-N1-(2,4,6-
trimethylbenzyl)cyclopentane-1,3-diamine (238) 
 
 
 
Prepared from monosubstituted diamine 226 (0.30 mg, 1.21 mmol), triethylamine    
(0.20 mL, 1.45 mmol, 1.2 equiv.) and 2,4,6-trimethylbenzylchloride 211 (0.22 g,            
1.33 mmol) in acetonitrile (10 mL). The crude product was purified via column 
chromatography (CH2Cl2/MeOH, 95:5) and the secondary diamine 238 was obtained as 
yellow oil (0.32 g, 0.85 mmol, 71%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 6.95 (s, 2H, H-3’’, H-5’’), 6.91 – 6.87 (m, 1H, H-5’), 
6.77 (dd, J = 7.9, 1.3 Hz, 1H, H-6’), 6.69 (dd, J = 8.0, 1.2 Hz, 1H, H-3’), 6.63 (td, J = 
7.7, 1.5 Hz, 1H, H-4’), 3.84 (d, J = 10.6 Hz, 1H, H-1’’’), 3.76 (dd, J = 8.4, 4.5 Hz, 1H, 
H-3), 3.72 (s, 3H, 2’’-OCH3), 3.70 (s, 1H, H-1’’’) 2.46 (s, 6H, 2’’-CH3, 6’’-CH3), 2.36 
(s, 3H, 4’’-CH3), 2.20 – 2.11 (m, 2H, H-4), 1.76 – 1.64 (m, 2H, H-5), 1.33 (s, 3H, H-8), 
1.09 (s, 3H, H-6), 0.97 (s, 3H, H-7) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 146.9 (C-2’), 138.8 (C-1’), 137.2 (C-2’’, C-6’’), 
136.3 (C-4’’), 134.3 (C-1’’), 129.0 (C-3’’, C-5’’), 121.2 (C-5’), 115.1 (C-4’), 109.5 (C-
6’, C-3’), 65.0 (C-1), 61.9 (C-3), 55.2 (2’-OCH3), 48.6 (C-2), 40.5 (C-1’’’), 32.8 (C-4), 
30.3 (C-5), 25.5 (C-6), 21.0 (4’’-CH3), 20.2 (C-8), 19.5 (2’’-CH3), 19.4 (6’’-CH3), 17.0 
(C-7) ppm. 
15
N-NMR (51 MHz, CDCl3) δ = 74.1 (bs, 1N, N
1
), 53.5 (bs, 1N, N
2
) ppm. 
IR (ATR)  = 3424, 2958, 2865, 1596, 1517, 1453, 1370, 1336, 1252, 1223, 1174, 
1110, 1027, 850, 732 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 381 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C25H37N2: 381.2913, found: 381.2906. 
Experimental 
127 
 
[]20D = 12 (c = 0.49, CH2Cl2). 
 
3.2.5.1.3. (1R,3S)-1,2,2-Trimethyl-N3-phenyl-N1-(2,4,6-trimethylbenzyl) 
cyclopentane-1,3-diamine (239) 
 
 
 
Prepared from monosubstituted diamine 227 (0.30 g, 1.37 mmol), triethylamine       
(0.23 mL, 1.65 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.26 g, 1.51 mmol) in 
acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 239 was obtained as yellow oil    
(0.30 g, 0.85 mmol, 62%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.27 – 7.23 (m, 2H, H-3’, H-5’), 7.03 (s, 2H, H-3’’, H-
5’’), 6.75 – 6.71 (m, 1H, H-4’), 6.64 (dd, J = 8.6, 0.9 Hz, 2H, H-2’, H-6’), 3.88 (d, J = 
10.6 Hz, 1H, H-1’’’), 3.78 – 3.74 (m, 2H, H-1’’’, H-3), 2.52 (s, 6H, 2’’-CH3, 6’’-CH3), 
2.43 (s, 3H, 4’’-CH3), 2.30 – 2.21 (m, 2H, H-4), 1.81 – 1.72 (m, 2H, H-5), 1.38 (s, 3H, 
H-8), 1.14 (s, 3H, H-6), 1.05 (s, 3H, H-7) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 148.7 (C-1’), 137.1 (2’-CH3, 6’’-CH3’), 136.6 (C-
1’’), 134.1 (C-4’’), 129.3 (C-3’’, C-5’’), 129.2 (C-3’, C-5’), 116.2 (C-4’), 113.0 (C-2’, 
C-6’), 65.5 (C-1), 62.7 (C-3), 48.7 (C-2), 40.6 (C-1’’’), 32.3 (C-4), 30.1 (C-5), 26.1 (C-
6), 21.1 (4’’-CH3), 19.6 (2’’-CH3, 6’’-CH3), 19.4 (C-8), 17.1 (C-7) ppm. 
IR (ATR)  = 3409, 2963, 2865, 1601, 1502, 1384, 1370, 1316, 1257, 1076, 850, 742, 
688 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 351 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C24H35N2: 351.2808, found: 351.2800. 
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[]20D = 71 (c = 0.5, CH2Cl2). 
 
3.2.5.1.4. (1R,3S)-N3-Mesityl-1,2,2-trimethyl-N1-(2,4,6-trimethylbenzyl) 
cyclopentane-1,3-diamine (240) 
 
 
 
Prepared from monosubstituted diamine 228 (0.30 g, 1.15 mmol), triethylamine       
(0.19 mL, 1.38 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.21 g, 1.27 mmol) in 
acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 240 was obtained as colorless oil 
(0.28 g, 0.11 mmol, 61%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 6.94 (s, 2H, H-3’’, H-5’’), 6.84 (s, 2H, H-3’, H-5’), 
3.89 (d, J = 10.9 Hz, 1H, H-1’’’), 3.75 (d, J = 10.9 Hz, 1H, H-1’’’), 3.58 (dd, J = 8.1, 
6.3 Hz, 1H, H-3), 2.48 (s, 6H, 2’’-CH3, 6’’-CH3), 2.36 (s, 3H, 4’’-CH3), 2.29 (s, 3H, 4’-
CH3), 2.28 (s, 6H, 2’-CH3, 6’-CH3), 2.18 – 2.01 (m, 2H, H-4, H-5), 1.67 (dqd, J = 12.0, 
10.1, 5.8 Hz, 2H, H-4, H-5), 1.32 (s, 3H, H-8), 1.12 (s, 3H, H-6), 1.10 (s, 3H, H-7) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 143.8 (C-1’), 136.9 (C-1’’), 136.3 (C-2’’, C-6’’), 
134.5 (C-4’’), 129.8 (C-3’, C-5’), 129.3 (C-4’), 129.1 (C-3’’, C-5’’), 127.7 (C-2’, C-6’), 
65.8 (C-3), 64.4 (C-1), 48.1 (C-2), 40.9 (C-1’’’), 34.0 (C-5), 30.0 (C-4), 23.8 (C-7), 21.0 
(4’- CH3), 20.6 (4’’- CH3), 20.5 (C-8), 19.6 (2’-CH3, 6’-CH3), 19.5 (2’’- CH3, 6’’- CH3), 
16.9 (C-6) ppm. 
15
N-NMR (51 MHz, CDCl3) δ = 67.46 (1N, N
2
), 54.62 (1N, N
1
) ppm. 
IR (ATR)  = 3379, 2962, 2864, 1610, 1583, 1477, 1368, 1297, 1226, 1156, 1121, 
1085, 1023, 1004, 846, 737, 717, 686, 564 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 393 ([M+H]
+
, 100%). 
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HRMS (ESI): Calc. for C27H41N2: 393.3268, found: 393.3270. 
[]20D = 1 (c = 0.48, CH2Cl2). 
 
3.2.5.1.5. (1R,3S)-1,2,2-Trimethyl-N3-(naphthalen-1-yl)-N1-(2,4,6-
trimethylbenzyl)cyclopentane-1,3-diamine (241) 
 
 
 
Prepared from monosubstituted diamine 229 (0.30 g, 1.12 mmol), triethylamine       
(0.19 mL, 1.34 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.21 g, 1.23 mmol) in 
acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 241 was obtained as brown oil    
(0.24 g, 0.61 mmol, 54%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.80 (d, J = 8.0 Hz, 1H, H-8’), 7.48 – 7.43 (m, 1H, H-
5’), 7.39 (dd, J = 9.9, 5.9 Hz, 1H, H-4’), 7.29 (d, J = 8.4 Hz, 1H, H-7’), 7.18 (d, J = 8.1 
Hz, 1H, H-6’), 7.11 (t, J = 7.5 Hz, 1H, H-3’), 7.01 (s, 2H, H-3’’, H-5’’), 6.64 (d, J = 7.6 
Hz, 1H, H-2’), 3.91 (d, J = 10.6 Hz, 2H, H-1’’’), 3.79 (d, J = 10.8 Hz, 1H, H-3), 2.48 (s, 
3H, 4’’-CH3), 2.41 (d, J = 6.4 Hz, 6H, 2’’-CH3, 6’’-CH3), 2.23-2.09 (m, 2H, H-4), 1.91 
– 1.75 (m, 2H, H-5), 1.40 (s, 3H, H-8), 1.18 (s, 3H, H-7), 1.09 (s, 3H, H-6) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 143.9 (C-1’), 137.6 (C-4’’), 136.8 (C-1’’), 136.5 (C-
2’’), 134.8 (C-6’’), 134.0 (C-4’a), 129.5 (C-5’), 128.8 (C-3’’, C-5’’), 128.3 (C-3’), 
126.9 (C-6’), 125.5 (C-7’), 123.9 (C-8’), 121.1 (C-8’a), 115.4 (C-4’), 103.0 (C-2’), 66.0 
(C-1), 62.9 (C-3), 49.2 (C-2), 40.0 (C-1’’), 31.9 (C-5), 30.2 (C-4), 26.5 (4’’-CH3), 21.1 
(C-11), 20.0 (2’’-CH3) , 19.7 (6’’-CH3), 18.8 (C-7), 17.0 (C-6) ppm. 
IR (ATR)  = 3326, 2958, 2867, 1579, 1524, 1482, 1405, 1385, 1371, 1230, 1074, 849, 
764, 720 cm
1
. 
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MS (ESI, + 3 kV): m/z (%) = 400 ([M+H]
+
, 10%). 
HRMS (ESI): Calc. for C28H37N2: 400.2878, found: 400.3000. 
[]20D = 12 (c = 0.47, CH2Cl2). 
 
3.2.5.1.6. (1R,3S)-N3-([1,1'-Biphenyl]-2-yl)-1,2,2-trimethyl-N1-(2,4,6-
trimethylbenzyl)cyclopentane-1,3-diamine (242) 
 
 
 
Prepared from monosubstituted diamine 230 (0.30 g, 1.02 mmol), triethylamine       
(0.17 mL, 1.22 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.19 g, 1.12 mmol) in 
acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 242 was obtained as yellow oil    
(0.25 g, 0.58 mmol, 57%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.46 – 7.43 (m, 2H, H-6’, H-4’’), 7.36 – 7.28 (m, 4H, 
H-3’’, H-5’’, H-3’, H-4’ ), 7.17 (dd, J = 7.4, 1.6 Hz, 1H, H-5’), 6.91 (s, 2H, H-3’’’,     
H-5’’’), 6.81 (ddd, J = 8.4, 6.2, 2.6 Hz, 2H, H-2’’, H-6’’), 4.49 (br s, 1H, H-N3), 3.79 
(d, J = 10.7 Hz, 2H, H-1’’’’), 3.62 (d, J = 10.7 Hz, 1H, H-3), 2.39 (s, 3H, 4’’’-CH3), 
2.35 (s, 6H, 2’’’-CH3, 6’’’-CH3), 2.18 – 2.11 (m, 1H, H-4), 2.07 – 1.99 (m, 1H, H-5), 
1.73 (ddd, J = 13.4, 9.7, 7.4 Hz, 1H, H-5), 1.56 – 1.47 (m, 1H, H-4), 1.33 (s, 3H, H-8), 
1.08 (s, 3H, H-7), 0.85 (s, 3H, H-6) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 145.5 (C-2’), 139.8 (C-1’’), 137.1 (C-4’’’), 136.2 (C-
2’’’, C-6’’’), 134.2 (C-3’’, C-5’’), 130.5 (C-4’), 129.3 (C-2’’, C-6’’), 129.1 (C-4’’), 
128.7 (C-3’’’, C-5’’’), 127.8 (C-6’), 127.0 (C-5’), 116.2 (C-1’), 110.7 (C-3’), 64.4 (C-
1), 62.0 (C-3), 48.2 (C-2), 40.7 (C-1’’’’), 33.4 (C-5), 30.1 (C-4), 24.8 (4’’’-CH3), 21.0 
(C-8), 19.9 (2’’’-CH3, 6’’’-CH3), 19.5 (C-7), 16.9 (C-6) ppm. 
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IR (ATR)  = 3424, 2958, 2860, 1600, 1578, 1508, 1435, 1317, 849, 768, 739, 702 
cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 427 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C30H39N2: 427.3116, found: 427.3113. 
[]20D = 50 (c = 0.48, CH2Cl2). 
 
3.2.5.1.7. (1R,3S)-N3-(2-Isopropylphenyl)-1,2,2-trimethyl-N1-(2,4,6-
trimethylbenzyl)cyclopentane-1,3-diamine (243) 
 
 
 
Prepared from monosubstituted diamine 231 (0.30 g, 1.15 mmol), triethylamine       
(0.19 mL, 1.40 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.21 g, 1.27 mmol) in 
acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 243 was obtained as yellow oil    
(0.23 g, 0.59 mmol, 51%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.15 – 7.09 (m, 2H, H-3’, H-5’), 6.95 (s, 2H, H-3’’, H-
5’’), 6.69 (dd, J = 7.8, 5.1 Hz, 2H, H-4’, H-6’), 5.20 (br s, 1H, N3H), 3.92 – 3.63 (m, 
4H, H-1’’’, H-3, 2’-CH), 2.44 (s, 6H, 2’’-CH3, 6’’-CH3), 2.38 (s, 3H, 4’’-CH3), 2.23 
(ddd, J = 18.2, 13.7, 10.5 Hz, 2H, H-5), 1.78 – 1.68 (m, 2H, H-4), 1.35 (s, 3H, H-8), 
1.16 (d, J = 6.7 Hz, 3H, 2’-C-CH3), 1.13 (s, J = 5.9 Hz, 3H, 2’-C-CH3), 1.01 (s, 3H, H-
7), 0.93 (s, 3H, H-6) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 146.3 (C-1’), 136.6 (C-4’’), 136.3 (C-2’’), 134.1 (C-
6’’’), 132.1 (C-2’’), 129.2 (C-3’’), 126.6 (C-5’’), 125.5 (C-3’), 124.9 (C-5’), 115.7 (C-
4’), 109.7 (C-6’), 65.5 (C-1), 62.2 (C-3), 49.0 (C-2), 40.2 (C-1’’’), 32.5 (C-5), 30.6 (2’-
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CH), 27.3 (2’-CH-CH3), 26.0 (2’-CH-CH3), 22.1 (4’’-CH3), 21.9 (C-8), 21.0 (2’’-CH3), 
19.5 (6’’-CH3), 18.8 (C-6), 17.1 (C-7) ppm. 
IR (ATR)  = 3370, 2963, 2870, 1601, 1579, 1508, 1453, 1386, 1369, 1312, 1258, 
1219, 1160, 1084, 1037, 850, 739 cm

. 
MS (ESI, + 3 kV): m/z (%) = 393 ([M+H]
+
, 100%).  
HRMS (ESI): Calc. for C27H41N2: 393.3280, found: 393.3270. 
[]20D = 16 (c = 0.48, CH2Cl2). 
 
3.2.5.1.8. N-((1S,3R)-2,2,3-Trimethyl-3-((2,4,6-trimethylbenzyl)amino) 
cyclopentyl)acetamide (244) 
 
 
 
Prepared from monosubstituted diamine 236 (0.30 g, 1.60 mmol), triethylamine       
(0.27 mL, 1.95 mmol) and 2,4,6-trimethylbenzylchloride 211 (0.30 g, 1.79 mmol) in 
acetonitrile (10 mL). The crude product was purified via column chromatography 
(CH2Cl2/MeOH, 95:5) and the secondary diamine 244 was obtained as brown oil    
(0.29 g, 0.92 mmol, 57%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 6.87 (s, 2H, H-3’, H-5’), 4.21 – 3.92 (m, 1H, H-1), 
3.66 (m, 2H, H-1’’), 2.36 (s, 6H, 2’-CH3, 6’-CH3), 2.27 (s, 3H, 4’-CH3), 2.16 – 2.01 (m, 
2H, H-4), 1.80 (s, 3H, C-O-CH3), 1.62 – 1.44 (m, 2H, H-5), 1.21 (s, 3H, H-8), 0.95 (s, 
3H, H-6), 0.80 (s, 3H, H-7) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 168.1 (C-O-CH3), 136.6 (C-4’), 133.5 (C-1’, C-2’, C-
6’), 129.2 (C-3’, C-5’), 66.0 (C-3), 58.7 (C-1), 48.2 (C-2), 40.2 (C-1’’), 31.5 (C-4), 30.4 
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(C-O-CH3), 25.2 (C-5), 23.5 (4’-CH3), 20.9 (C-8), 19.6 (2’-CH3, 6’-CH3), 18.4 (C-6), 
16.1 (C-7) ppm. 
IR (ATR)  = 3298, 2961, 1646, 1443, 1369, 1295, 1129, 907, 846, 731 cm1. 
MS (ESI, + 3 kV): m/z (%) = 317 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C20H33N2O: 317.2593, found: 317.2591. 
[]20D = 1 (c = 0.45, EtOH). 
 
3.2.5.1.9. (1R,3S)-N1-(Anthracen-9-ylmethyl)-1,2,2-trimethyl-N3-(o-tolyl) 
cyclopentane-1,3-diamine (245) 
 
 
 
Prepared from 9-(chloromethyl)anthracene 234 (0.21 g, 0.94 mmol), diamine 225   
(0.20 g, 0.86 mmol) and triethylamine (0.14 mL, 1.03 mmol) in dry acetonitrile          
(20 mL). The corresponding product was not obtained. 
 
3.2.5.1.10. (1R,3S)-N1-Benzyl-1,2,2-trimethyl-N3-(o-tolyl)cyclopentane-1,3-
diamine (246) 
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Prepared from benzyl bromide 235 (0.11 mL, 0.94 mmol), diamine 225 (0.20 g,       
0.86 mmol) and triethylamine (0.14 mL, 1.03 mmol) in dry acetonitrile (20 mL). The 
corresponding product was not obtained. 
 
3.2.5.2. Alkylation with Benzaldehyde 
 
3.2.5.2.1. (1R,3S,E)-N1-Benzylidene-1,2,2-trimethyl-N3-(o-tolyl) 
cyclopentane-1,3-diamine (247) 
 
 
 
Benzaldehyde 68 (0.20 mL, 1.94 mmol, 1.5 equiv.) in toluene (5 mL) was added 
dropwise to a solution of diamine 225 (0.30 g, 1.29 mmol, 1 equiv.), p-toluenosulfonic 
acid (5 mg) and toluene (20 mL) at room temperature. The resuling mixture was heated 
at reflux overnight on a Dean Stark under a stream of argon. After removal of the 
solvent, the crude product 247 was reduced in the next step. 
 
3.2.5.2.2. (1R,3S)-N1-Benzyl-1,2,2-trimethyl-N3-(o-tolyl)cyclopentane-1,3-
diamine (248) 
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To a solution of diamine 247 (0.41 g) in dry methanol (20 mL) was carefully added 
sodium borohydride (1.95 g) under a stream of argon. The resulting mixture was stirred 
at room temperature for 5 h. Water (25 mL) was added and the mixture was extracted 
with methylene chloride (3 x 50 mL). The combined organic layers were dried 
(Na2SO4). The solvent was evaporated. No product was obtained. 
 
3.2.5.3. Alkylation with Aryl Halide 
 
3.2.5.3.1. (1R,3S)-N3-(2-Methoxyphenyl)-1,2,2-trimethyl-N1-(o-tolyl) 
cyclopentane-1,3-diamine (249) 
 
 
 
In a dried Schlenk-tube Pd2(dba)3 (0.07 g,  0.08 mmol, 0.04 equiv.), (±)-BINAP (0.11 g, 
0.18 mmol, 0.09 equiv.) and NaOtBu (0.58 g, 6.04 mmol, 3 equiv.) were dissolved in 
toluene (200 mL) under a nitrogen atmosphere and stirred for 20 min. Diamine 226 
(0.50 g, 2.01 mmol, 1 equiv.) and 2-bromotoluene 216 (0.48 mL, 4.03 mmol, 1 equiv.) 
were added and the solution was stirred for 48 h at 100 °C. After work up, no product 
was obtained. 
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3.3. Application of Diamines as Ligands in the Henry 
Reaction 
 
General Procedure  
 
 
 
The appropriate ligand (1-1.5equiv.) and Lewis acid (0-1.5equiv.) were dissolved in a 
solvent (1 mL) and the mixture was stirred for 1 h at room temperature under an argon 
atmosphere. A solution of aldehyde (10 equiv.) and base (0.2 equiv.) in a solvent      
(0.5 mL) was added and the reaction mixture was stirred at various temperatures over 
15 min. A nitroalkane (100-200 equiv.) was added and the solution was stirred for the 
specific time at various temperatures. The resulting mixture was filtered through a silica 
gel column (10 cm
3
) with EtOAc (100 mL) to remove the catalyst. The solvent was 
removed under reduced pressure at < 30 °C and the crude product was purified by a 
silica gel flash column chromatography to give the corresponding β-nitro alcohol. The 
enantiomeric excess was determined by chiral HPLC analysis. Spectral data were 
consistent with literature values and the absolute configuration was assigned by 
comparison with literature values (For yields and enantiomeric excess see Table 3-9). 
 
3.3.1. (R)-2-Nitro-1-phenylethanol (R-250) 
 
 
Prepared from ligand 214 (20.00 mg, 0.06 mmol), Cu(OAc)2
.
H2O (12.00 mg,            
0.06 mmol), benzaldehyde 68 (0.63 mL, 0.62 mmol, 10 equiv), DABCO (14.00 mg, 
0.01 mmol) and CH3NO2 (3.35 mL, 6.24 mmol) in ethanol (15 mL). The crude product 
Experimental 
137 
 
was purified via column chromatography (n-hexane/EtOAc, 8:2) to give colorless oil 
(150.00 mg, 0.90 mmol, 57%). Spectral data were consistent with literature values.
195
 
 
1
H-NMR (500 MHz, CDCl3): δ = 7.48 – 7.31 (m, H-2’, H-3’,H-4’, H-5’, H-6’), 5.46 
(dd, J = 9.6, 3.0 Hz, 1H, H-2), 4.61 (dd, J = 13.4, 9.6 Hz, 1H, H-2), 4.51 (dd, J = 13.4, 
3.0 Hz, 1H, H-1), 2.84 (s, 1H, OH) ppm. 
13
C-NMR (125 MHz, CDCl3): δ = 138.1 (C-1’), 129.1 (C-3’, C-5’), 129.0 (C-2’, C-6’), 
125.9 (C-4’), 81.0 (C-2), 71.1 (C-1) ppm.  
HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 85/15 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tmajorr= 11.79 min, tminor= 14.11 min; 7% ee.
195
  
 
3.3.2. (S)-2-Nitro-1-phenylethanol (S-250) 
 
 
 
Prepared from ligand 225 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu     
(30.00 mg, 0.09 mmol), benzaldehyde 68 (0.09 mL, 0.90 mmol), DABCO (2.00 mg,          
0.02 mmol) and CH3NO2 (0.46 mL, 8.60 mmol) in methanol (1.5 mL). The crude 
product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give 
colorless oil (133.00 mg, 0.80 mmol, 93%). Spectral data were consistent with literature 
values.
196,197
  
 
1
H-NMR (500 MHz, CDCl3): δ = 7.57 – 7.20 (m, 5H, H-2’, H-3’, H-4’, H-5’, H-6’), 
5.41 (dt, J = 9.5, 3.3 Hz, 1H, H-2), 4.57 (ddd, J = 13.2, 9.6, 2.3 Hz, 1H, H-2), 4.49 (dd, 
J = 13.2, 3.1 Hz, 1H, H-1), 3.18 (s, 1H, OH) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 138.3 (C-1’), 129.0 (C-3’, C-5’), 128.9 (C-2’, C-6’), 
126.0 (C-4’), 81.2 (C-2), 71.0 (C-1) ppm.  
HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 85/15 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tminor= 11.76 min, tmajor= 14.05 min; 77% ee.
196
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3.3.3. (S)-1-(3-Chlorophenyl)-2-nitroethanol (253) 
 
 
 
Prepared from ligand 225 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu     
(30.00 mg, 0.09 mmol), 3-chlorobenzaldehyde (0.10 mL, 0.90 mmol), DABCO       
(2.00 mg,  0.02 mmol) and CH3NO2 (0.46 mL, 8.60 mmol) in methanol (1.5 mL). The 
crude product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give 
yellow oil (113.00 mg, 0.56 mmol, 65%). Spectral data were consistent with literature 
values.
196
 
 
1
H-NMR (500 MHz, CDCl3): δ = 7.42 – 7.39 (m, 1H, H-2’), 7.35 – 7.30 (m, 2H, H-4’, 
H-6’), 7.29 – 7.24 (m, 1H, H-5’), 5.43 (dd, J = 9.3, 3.1 Hz, 1H, H-2), 4.67 – 4.43 (m, 
2H, H-1, H-2), 3.18 (s, 1H, OH) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 140.0 (C-1’), 134.6 (C-3’), 130.3 (C-5’), 128.9 (C-
2), 126.1 (C-4’), 124.1 (C-2’, C-6’), 70.3 (C-1) ppm.  
HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 85:15 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tminor= 11.44 min, tmajor= 13.97 min; 63% ee.
196
 
 
3.3.4. (S)-2-Nitro-1-(2-nitrophenyl)ethanol (254) 
 
 
 
Prepared from ligand 225 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu 
(30.00 mg, 0.09 mmol), 2-nitrobenzaldehyde (130.00 mg, 0.90 mmol), DABCO      
(2.00 mg, 0.02 mmol) and CH3NO2 (0.46 mL, 8.6 mmol) in methanol (1.5 mL). The 
crude product was purified via column chromatography (n-hexane/EtOAc, 7:3) to give 
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an orange solid (123.00 mg, 0.58 mmol, 68%). Spectral data were consistent with 
literature values.
198
 
 
1
H-NMR (500 MHz, CDCl3): δ = 8.04 (dd, J = 8.2, 1.2 Hz, 1H, H-3’), 7.93 (dd, J = 7.9, 
1.1, 1H, H-5’), 7.74 (td, J = 7.7,1.2 Hz, 1H, H-4’), 7.54 (dd, J = 11.4, 4.2 Hz, 1H, H-6’), 
6.02 (d, J = 8.9 Hz, 1H, H-2), 4.88 – 4.78 (m, 1H, H-2), 4.60 – 4.49 (m, 1H, H-1), 3.42 
(s, 1H, OH) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 147.1 (C-6’), 134.4 (C-5’), 134.1 (C-2’), 129.7 (C-
1’), 128.7 (C-4’), 125.0 (C-2), 66.6 (C-1) ppm.  
HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 85:15 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tminor= 13.36 min, tmajor= 14.61 min; 82% ee.
198
 
 
3.3.5. (S)-2-Nitro-1-(3-nitrophenyl)ethanol (255) 
 
 
 
Prepared from ligand 215 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu 
(30.00 mg, 0.09 mmol), 3-nitrobenzaldehyde (130.00 mg, 0.90 mmol), DABCO      
(2.00 mg, 0.02 mmol) and CH3NO2 (0.46 mL, 8.6 mmol) in methanol (1.5 mL). The 
crude product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give a 
yellow solid (105.00 mg, 0.49 mmol, 57%). Spectral data were consistent with literature 
values.
198
 
 
1
H-NMR (500 MHz, CDCl3): δ = 8.32 (t, J = 1.8, 1H, H-2’), 8.22 (ddd, J = 8.2, 2.2, 0.9 
Hz, 1H, H-4’), 7.78 – 7.75 (m, 1H, H-6’), 7.61 (dd, J = 10.5, 5.4 Hz, 1H, H-5’), 5.59 
(dt, J = 15.1, 7.5 Hz, 1H, H-2), 4.66 – 4.56 (m, 2H, H-1, H-2), 3.33 (s br, 1H, OH) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 148.5 (C-3’), 140.0 (C-1’), 132.1 (C-6’), 129.8 (C-
5’), 123.8 (C-2), 121.0 (C-2’, C-4’), 69.7 (C-1) ppm.  
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HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 85:15 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tminor= 20.56 min, tmajor= 22.72 min; 59% ee.
198
 
 
3.3.6. (S)-1-(2-Methoxyphenyl)-2-nitroethanol (256) 
 
 
 
Prepared from ligand 225 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu 
(30.00 mg, 0.09 mmol), 2-methoxybenzaldehyde (117.00 mg, 0.90 mmol), DABCO 
(2.00 mg, 0.02 mmol) and CH3NO2 (0.46 mL, 8.60 mmol) in methanol (1.5 mL). The 
crude product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give 
yellow oil (110.00 mg, 0.56 mmol, 65%). Spectral data were consistent with literature 
values.
196 
 
1
H-NMR (500 MHz, CDCl3): δ = 7.42 (dd, J = 7.5, 1.4 Hz, 1H, H-6’), 7.35 – 7.30 (m, 
1H, H-4’), 7.00 (td, J = 7.5, 0.9 Hz, 1H, H-5’), 6.90 (d, J = 7.7 Hz, 1H, H-3’), 5.60 (dd, 
J = 9.2, 2.9 Hz, 1H, H-2), 4.64 (dd, J = 13.0, 3.2 Hz, 1H, H-2), 4.55 (dd, J = 13.0, 9.3 
Hz, 1H, H-1), 3.87 (s, 3H, O-CH3), 3.30 (s br, 1H, OH) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 155.9 (C-2’), 129.8 (C-2), 127.0 (C-4), 126.1 (C-1’), 
121.0 (C-6’), 110.6 (C-5’, C-3’), 67.8 (C-1), 55.2 (O-CH3) ppm.  
HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 85:15 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tminor= 10.32 min, tmajor= 11.55 min; 83% ee.
196
 
 
3.3.7. 2-Nitro-1-phenylpropan-1-ol (257) 
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Prepared from ligand 225 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu    
(30.00 mg, 0.09 mmol), benzaldehyde (0.09 mL, 0.90 mmol), DABCO (2.00 mg,     
0.02 mmol) and C2H5NO2 (0.61 mL, 8.6 mmol) in methanol (1.5 mL). The crude 
product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give a 
colorless oil (63.00 mg, 0.35 mmol, 41% as a mixture of diastereoisomers), dr (anti/syn) 
= 72:28 determined by 
1
H NMR analysis. Spectral data were consistent with literature 
values.
199
 
 
1
H-NMR (500 MHz, CDCl3): δ = 7.51 – 7.20 (m, 8.5H) (syn/anti), 5.38 (t, J = 3.6 Hz, 
0.7H) (anti), 5.02 (dd, J = 9.0, 3.9 Hz, 1H) (syn), 4.76 – 4.64 (m, 1.7H) (syn/anti), 2.72 
(d, J = 3.6 Hz, 0.7H) (anti), 2.70 (d, J = 4.0 Hz, 1H) (syn), 1.51 (d, J = 6.8 Hz, 2.3H) 
(anti), 1.32 (d, J = 6.8 Hz, 3H) (syn) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 138.6 (anti), 138.4 (syn), 129.2 (syn), 129.0 (anti), 
128.7 (anti), 128.5 (syn), 127.0 (syn), 126.0 (anti), 88.4 (syn), 87.6 (anti), 76.3 (syn), 
74.0 (anti), 16.4 (syn), 11.9 (anti) ppm. 
HPLC (combination of Chiralpak AD-H column + Chiralpak AS-H column, n-
hexane/i-PrOH, 95/5 v/v, 0.5 mL/min, 25 
o
C, UV = 250 nm): tmajor= 26.77 min, tminor= 
30.69 min for anti-isomer, tmajor= 33.33 min, tminor= 41.55 min for syn-isomer; 27% ee 
for anti-isomer, 58% ee for syn-isomer.
199
  
 
3.3.8. 2-Nitro-1-(2-nitrophenyl)propan-1-ol (258) 
 
 
 
Prepared from ligand 225 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu 
(30.00 mg, 0.09 mmol), 2-nitrobenzaldehyde (130.00 mg, 0.90 mmol), DABCO      
(2.00 mg, 0.02 mmol) and C2H5NO2 (0.61 mL, 8.6 mmol) in methanol (1.5 mL). The 
crude product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give a 
brown oil (142.00 mg, 0.63 mmol, 73% as a mixture of diastereoisomers), dr (anti/syn) 
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= 38:62 determined by 
1
H NMR analysis. Spectral data were consistent with literature 
values.
 200 
 
1
H-NMR (500 MHz, CDCl3): δ = 8.07 (dd, J = 8.2, 1.1 Hz, 1H) (anti), 7.99 (d, J = 8.2 
Hz, 0.6 H) (syn), 7.91 (d, J = 7.8, 1H) (anti), 7.76 – 7.68 (m, 2.2 H) (syn/anti),          
7.57 – 7.50 (m, 1.6H) (syn/anti), 6.08 (d, J = 2.1 Hz, 1H) (anti), 5.70 (d, J = 6.6, 0.6H) 
(syn), 5.15 – 4.90 (m, 1.6H) (syn/anti), 3.18 (d, J = 31.5 Hz, 1.5H) (syn/anti),            
1.55 – 1.51 (m, 5H) (syn/anti) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 148.1 (syn), 147.2 (anti), 134.2 (syn), 134.1 (anti), 
134.1 (anti), 134.0 (syn), 129.7 (syn), 129.5 (anti), 129.3 (anti), 128.9 (syn), 125.2 
(anti), 125.0 (syn), 87.6 (syn), 84.5 (anti), 70.6 (syn), 69.4 (anti), 16.1 (anti), 11.9 (syn) 
ppm.  
HPLC (combination of Chiralpak AD-H column + Chiralpak AS-H column, n-
hexane/i-PrOH, 95/5 v/v, 0.5 mL/min, 25 
o
C, UV = 250 nm): tmajor= 59.65 min, tminor= 
63.41 min for anti-isomer, tminor= 74.88 min, tmajor= 81.81 min for syn-isomer; 53% ee 
for anti-isomer, 57% ee for syn-isomer.
200
 
 
3.3.9. 1-(2-Methoxyphenyl)-2-nitropropan-1-ol (259) 
 
 
 
Prepared from ligand 257 (20.00 mg, 0.09 mmol), [CH3(CH2)3CH(C2H5)CO2]2Cu 
(30.00 mg, 0.09 mmol), 2-methoxybenzaldehyde (117.00 mg, 0.90 mmol), DABCO 
(2.00 mg, 0.02 mmol) and C2H5NO2 (0.61 mL, 8.6 mmol) in methanol (1.5 mL). The 
crude product was purified via column chromatography (n-hexane/EtOAc, 8:2) to give a 
white solid (55.00 mg, 0.26 mmol, 30% as a mixture of diastereoisomers), dr (anti/syn) 
= 53:47 determined by 
1
H NMR analysis. Spectral data were consistent with literature 
values.
199
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1
H-NMR (500 MHz, CDCl3): δ = 7.43 (dd, J = 7.6, 1.1 Hz, 1H) (anti), 7.36 – 7.26        
(m, 2H) (syn/anti), 7.05 – 6.97 (m, 2H) (anti), 6.95 – 6.87 (m, 1.5H) (syn), 5.54(dd, J = 
5.2, 4.1 Hz, 1H) (anti), 5.15 (t, J = 8.7 Hz, 0.5H) (syn), 5.01 (dq, J = 8.9, 6.8 Hz, 0.5H) 
(syn), 4.89 (qd, J = 6.9, 3.8 Hz, 1H) (anti), 3.95 – 3.86 (m, 5.5H) (syn/anti), 3.23 (d, J = 
8.5Hz, 0.5H) (syn), 3.03 (d, J=5.5 Hz, 1H) (anti), 1.49 (d, J = 6.9 Hz, 3H) (anti), 1.33 
(d, J = 6.8Hz, 1.5H) (syn) ppm.  
13
C-NMR (125 MHz, CDCl3): δ = 156.5 (syn), 155.9 (anti), 135.8 (syn), 130.1 (syn), 
129.5 (anti), 129.0 (syn), 128.6 (syn), 127.7 (anti), 126.3 (anti), 121.3 (syn), 121.0 (syn), 
120.7 (anti), 111.7 (syn), 111.0 (syn), 110.4 (anti), 87.6 (syn), 85.1 (anti), 74.0 (syn), 
70.6 (anti), 55.2 (anti), 16.5 (syn), 12.5 (anti) ppm.  
HPLC (combination of Chiralpak AD-H column + Chiralpak AS-H column, n-
hexane/i-PrOH, 95/5 v/v, 0.5 mL/min, 25 
o
C, UV = 250 nm): tmajor= 27.41 min, tminor= 
38.45 min for anti-isomer, tmajor= 46.67 min, tminor= 68.00 min for syn-isomer; 39% ee 
for anti-isomer, 63% ee for syn-isomer.
199
 
 
3.4. Preparation of Chiral Phosphorus Ligands 
 
3.4.1. Preparation of Pentavalent HASPO Ligands from 
Chloro-Derivatives 
 
General Procedure 
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Solution of the suitable diamine (1 equiv.) in toluene was added to the mixture of 
phosphorus trichloride (1.1 equiv.) and triethylamine (2.5 equiv.) in toluene at 60 °C 
over 30 min. The solution was warmed to room temperature. After 2 h, the mixture was 
filtered through MgSO4 and the filtrate was again cooled to 60 °C. Triethylamine     
(1.1 equiv.) and water (1 equiv.) were added and the cooling bath was removed. After   
1 h, the reaction mixture was filtered again through MgSO4 and the filtrate was 
concentrated under reduced pressure. The method of filtration for each compounds are 
given below. 
 
3.4.1.1. (1R,3S,5S)-2,4-Dibenzyl-1,8,8-trimethyl-2,4-diaza-3-
phosphabicyclo[3.2.1] octane 3-oxide (260) 
 
 
 
Prepared from diamine 214 (0.60 g, 1.86 mmol), phosphorus trichloride (0.18 mL,   
2.05 mmol) and triethylamine (0.66 mL, 4.65 mmol) in toluene (10 mL) and water 
(34.00 µL, 1.86 mmol), triethylamine (0.28 mL, 2.05 mmol) after filtration. After 
evaporation product 260 was obtained as a yellow solid (0.68 g, 1.75 mmol, 94%). 
 
Mp: 118.3 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.44 – 7.13 (m, 10H, H-2’, H-3’, H-4’, H-5’, H-6’, H-
2’’, H-3’’, H-4’’, H-5’’, H-6’’ ), 7.30 (d, J = 619.9 Hz, 1H, P-H), 4.69 (dd, J = 12.4, 4.9 
Hz, 1H, H-1’’’), 4.47 (dd, J = 15.4, 10.3 Hz, 1H, H-1’’’’), 4.23 (dd, J = 17.3, 10.5 Hz, 
1H, H-1’’’’), 4.08 (dd, J = 15.4, 7.3 Hz, 1H, H-1’’’), 2.86 (dd, J = 15.6, 6.7 Hz, 1H, H-
5), 2.22 (ddd, J = 13.9, 10.1, 5.8 Hz, 1H, H-6), 1.99 – 1.86 (m, 2H, H-6, H-7), 1.68 
(ddd, J = 13.8, 11.0, 5.5 Hz, 1H, H-7), 1.04 (s, 6H, H-11, H-9), 0.78 (s, 3H, H-10) ppm. 
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13
C-NMR (126 MHz, CDCl3) δ = 141.2 (C-1’), 138.1 (C-1’’), 128.6 (C-3’, C-5’), 128.5 
(C-3’’, C-5’’), 128.4 (C-2’, C-6’), 127.4 (C-2’’, C-6’’), 127.0 (C-4’), 126.7 (C-4’’), 71.4 
(C-1’’’), 67.7 (C-1’’’’), 50.1 (C-1), 47.3 (C-5), 45.6 (C-8), 36.6 (C-7), 29.2 (C-6), 24.4 
(C-9), 19.5 (C-11), 18.4 (C-10) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 10.1 ppm. 
IR (ATR)  = 3429, 3056, 3022, 2949, 2336, 1604, 1493, 1453, 1373, 1201, 1113, 
1092, 1066, 1027, 908, 876, 739, 698, 520, 481, 454 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 391 [M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C22H29N2ONaP: 391.1930, found: 391.1915. 
Anal. Calc. for C22H29N2OP: C, 71.72; H, 7.93; N, 7.60; found: C, 71.27; H, 8.12; N, 
7.60. 
[]20D = 19 (c = 0.60, EtOH). 
 
3.4.1.2. (1R,3S,5S)-1,8,8-Trimethyl-2,4-bis(2,4,6-trimethylbenzyl)-2,4-diaza 
-3-phosphabicyclo[3.2.1]octane 3-oxide (261) 
 
 
 
Prepared from diamine 210 (0.20 g, 0.49 mmol), phosphorus trichloride (0.05 mL,   
0.54 mmol) and triethylamine (0.17 mL, 1.23 mmol) in toluene (10 mL) and water  
(8.90 µL, 0.49 mmol), triethylamine (0.08 mL, 0.54 mmol) after filtration. After 
evaporation product 261 was obtained as a yellow solid (0.16 g, 0.35 mmol, 73%). 
 
Mp: 99.7 °C.  
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1
H-NMR (500 MHz, CDCl3) δ = 6.83 (d, J = 7.4 Hz, 4H, H-3’, H-5’, H-3’’, H-5’’), 
6.32 (d, J = 629.4 Hz, 1H, P-H), 4.28 (dd, J = 11.5, 3.0 Hz, 1H, H-1’’’), 4.11 (dt, J = 
21.3, 9.4 Hz, 2H, H-1’’’, H-1’’’’), 3.96 (dd, J = 14.2, 7.4 Hz, 1H, H-1’’’’), 2.59 – 2.50 
(m, 1H, H-5), 2.46 (s, 6H, 4’-CH3, 4’’-CH3), 2.34 (m, 1H, H-7), 2.25 (d, J = 3.1 Hz, 
12H, 2’-CH3, 6’-CH3, 2’’-CH3, 6’’-CH3), 2.00 – 1.81 (m, 3H, H-6, H-7, H-6), 1.32 (s, 
3H, H-9), 0.92 (s, 3H, H-11), 0.80 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 139.1 (C-4’), 138.2 (C-4’’), 137.5 (C-1’), 136.9 (C-
1’’), 130.1 (C-2’), 130.0 (C-2’’), 129.1 (C-3’, C-5’ C-3’’, C-5’’), 128.6 (C-6’), 128.5 
(C-6’’), 69.7 (C-1), 65.2 (C-5), 47.1 (C-8), 43.1 (C-1’’’), 42.3 (C-1’’’’), 35.4 (C-7), 28.0 
(C-6), 24.9 (C-10), 21.0 (4’-CH3), 20.9 (4’’-CH3), 20.4 (2’-CH3), 20.0 (2’’-CH3), 18.9 
(6’-CH3, 6’’-CH3), 18.0 (C-9), 17.9 (C-11) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 9.6 ppm. 
IR (ATR)  = 2949, 2379, 1610, 1468, 1370, 1305, 1257, 1194, 1164, 1115, 1017, 894, 
841, 747, 531 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 453 ([M+H]
+
, 100%); 453 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C28H42N2OP: 453.3032, found: 453.3035; C28H41N2ONaP: 
475.2853, found: 475.2854. 
[]20D = 12 (c = 0.50, EtOH). 
 
3.4.1.3. (1R,3R,5S)-1,8,8-Trimethyl-4-(o-tolyl)-2-(2,4,6-trimethylbenzyl)-
2,4-diaza-3-phosphabicyclo[3.2.1]octane 3-oxide (262) 
 
 
 
Prepared from diamine 237 (0.26 g, 0.72 mmol), phosphorus trichloride (0.07 mL,   
0.79 mmol), triethylamine (0.25 mL, 1.80 mmol) in toluene (10 mL) and water      
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(13.00 µL, 0.72 mmol) and triethylamine (0.11 mL, 0.79 mmol) after filtration. After 
evaporation product 262 was obtained as a white solid (0.26 g, 0.64 mmol, 89%). 
 
Mp: 170.5 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.15 – 7.04 (m, 3H, H-4’, H-5’, H-6’ ), 6.31 (d, J = 
637.2 Hz, P-H), 6.91 (s, 1H, H-3’), 6.79 (s, 2H, H-3’’, H-5’’), 4.33 (dd, J = 11.7, 3.3 
Hz, 1H, H-1’’’), 4.21 – 4.10 (m, 1H, H-1’’’), 3.08 (dd, J = 20.4, 5.5 Hz, 1H, H-5), 2.72 
(ddd, J = 14.2, 9.7, 4.9 Hz, 1H, H-6), 2.59 (ddd, J = 14.0, 9.7, 4.1 Hz, 1H, H-7), 2.48 (s, 
6H, 2’’-CH3, 6’’-CH3), 2.31 (s, 3H, 2’-CH3), 2.20 (s, 3H, 4’’-CH3), 2.15–1.91 (m, 2H, 
H-6, H-7), 1.42 (s, 3H, H-9), 1.37 (s, 3H, H-11), 0.97 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 141.8 (C-1’), 139.0 (C-2’), 137.4 (C-4’’), 131.1 (C-
3’), 129.1 (C-3’’, C-5’’), 128.7 (C-1’’) , 128.6 (C-2’’, C-6’’), 126.9 (C-4’, C-5’), 126.7 
(C-6’), 73.4 (C-11), 70.2 (C-5), 47.4 (C-8), 42.2 (C-1’’’), 35.4 (C-7), 30.0 (C-6), 24.9 
(4’’-CH3), 20.9 (6’’-CH3), 20.5 (4’’-CH3), 20.2 (C-11), 19.4 (2’-CH3), 18.2 (C-9), 18.1 
(C-10) ppm.
 
31
P-NMR (202 MHz, CDCl3) δ = 3.9 ppm 
IR (ATR)  = 3414, 2953, 2409, 1610, 1488, 1458, 1389, 1345, 1207, 1192, 1154, 
1110, 1080, 1018, 976, 890, 852, 759, 724, 544, 454 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 411 ([M+H]
+
, 58%); 453 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C25H42N2OP: 453.3032, found: 453.3035; C28H41N2ONaP: 
475.2853, found: 475.2854. 
[]20D = 73 (c = 0.52, EtOH). 
 
 
 
 
Experimental 
148 
 
3.4.1.4. (1R,3R,5S)-4-(2-Methoxyphenyl)-1,8,8-trimethyl-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octane             
3-oxide (263) 
 
 
 
Prepared from diamine 238 (0.15 g, 0.39 mmol), phosphorus trichloride (0.04 mL,   
0.43 mmol), triethylamine (0.14 mL, 0.98 mmol) in toluene (10 mL) and water        
(7.00 µL, 0.39 mmol) and triethylamine (0.06 mL, 0.43 mmol) after filtration. After 
evaporation product 263 was obtained as yellow oil (0.16 g, 0.38 mmol, 97%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 6.86 (s, 2H, 2’’-CH3, 6’’-CH3), 6.80 (m, 1H, H-3’), 
6.69 (d, J = 7.7 Hz, 1H, H-6’), 6.60 (dd, J = 7.9, 1.2 Hz, 1H, H-4’), 6.55 (d, J = 7.1 Hz, 
1H, H-5’), 6.36 (d, J = 645.2 Hz, 1H, PH), 3.81 – 3.58 (m, 5H, H-1’’’, 2’-O-CH3), 2.52 
– 2.44 (m, 1H, H-5), 2.38 (s, 6H, 2’’-CH3, 6’’-CH3), 2.28 (s, 3H, 4’’-CH3), 2.09 (dd, J = 
25.7, 12.1 Hz, 2H, H-7, H-6), 1.62 (dd, J = 19.9, 10.9 Hz, 2H, H-7,  H-6), 1.25 (s, 3H, 
H-9), 1.01 (s, 3H, H-11), 0.89 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 146.8 (C-2’), 138.9 (C-4’’), 137.2 (C-1’’), 136.1 (C-
2’’, C-6’’), 134.3(C-1’), 128.9 (C-3’’), 128.1 (C-5’’), 125.3 (C-5’), 121.3 (C-4’), 115 
(C-6’), 109.4 (C-2’), 64.9, (C-1), 61.8 (C-5), 55.1 (2’-OCH3), 48.6 (C-8), 40.5 (C-1’’’), 
32.8 (C-7), 30.2 (C-6), 25.4 (4’’-CH3), 20.9 (2’’-CH3, 6’’-CH3), 19.5 (C-9), 19.3 (C-10), 
16.9 (C-11) ppm.  
31
P-NMR (202 MHz, CDCl3) δ = 3.9 ppm. 
IR (ATR)  = 3424, 2958, 1599, 1515, 1455, 1371, 1224, 1113, 1029, 909, 850, 730 
cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 427 ([M+H]
+
, 62%); 449 ([M+Na]
+
, 100%). 
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HRMS (ESI): Calc. for C25H36N2O2P: 427.2514, found: 427.2525; C25H35N2O2NaP: 
449.2334, found: 449.2343. 
[]20D = 11 (c = 0.45, EtOH). 
 
3.4.1.5. (1R,3R,5S)-1,8,8-Trimethyl-4-phenyl-2-(2,4,6-trimethylbenzyl)-2,4-
diaza-3-phosphabicyclo[3.2.1]octane 3-oxide (264) 
 
 
 
Prepared from diamine 239 (0.27 g, 0.76 mmol), phosphorus trichloride (0.07 mL,   
0.84 mmol), triethylamine (0.27 mL, 1.91 mmol) in toluene (10 mL) and water      
(14.00 µL, 0.76 mmol) and triethylamine (0.12 mL, 0.84 mmol) after filtration. After 
evaporation product 264 was obtained as a white solid (0.27 g, 0.68 mmol, 89%). 
 
Mp: 154.3 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.28 – 7.18 (m, 4H, H-2’, H-6’, H-3’’, H-5’’), 6.84 (s, 
2H, H-3’, H-5’), 6.37 (d, J = 649.9, 1H, P-H), 4.34 (dd, J = 11.7, 2.9 Hz, 1H, H-1’’’), 
4.23 – 4.11 (m, 1H, H-1’’’), 3.63 (dd, J = 18.6, 6.0 Hz, 1H, H-5), 2.73 – 2.64 (m, 1H, 
H-6), 2.49 (s, 6H, 2’’-CH3, 6’’-CH3), 2.45 – 2.36 (m, 2H, H-7), 2.25 (s, 3H, 4’’-CH3), 
1.95 – 1.87 (m, 1H, H-6), 1.44 (s, 3H, H-9), 1.24 (s, 3H, H-11), 1.06 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 146.1 (C-1’), 139.1 (C-4’’), 137.5 (C-1’’), 129.3 (C-
3’), 129.1 (C-5’), 128.3 (C-3’’, C-5’’), 125.4 (C-2’’, C-6’’), 123.4 (C-4’), 122.2 (C-2’’, 
C-6’’), 71.5 (C-5), 70.7 (C-1), 46.9 (C-8), 42.4 (C-1’’’), 35.4 (C-7), 30.5 (C-6), 24.7 
(4’’-CH3), 21.0 (2’’-CH3), 20.5 (6’’-CH3), 19.4 (C-11), 18.0 (C-9, C-10) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 3.9 ppm. 
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IR (ATR)  = 3424, 2943, 2375, 1595, 1493, 1464, 1391, 1360, 1278, 1249, 1224, 
1205, 1154, 1114, 1087, 1058, 1016, 963, 889, 850, 747, 693, 524, 464 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 397 ([M+H]
+
, 50%); 419 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C24H34N2OP: 397.2409, found: 397.2408; C24H33N2ONaP: 
419.2228, found: 419.2232. 
[]20D = 39 (c = 0.46, EtOH). 
 
3.4.1.6. 4-Mesityl-1,8,8-trimethyl-2-(2,4,6-trimethylbenzyl)-2,4-diaza-3-
phosphabicyclo[3.2.1]octane 3-oxide (265a/ 265b) 
 
 
 
Prepared from diamine 240 (0.35 g, 0.89 mmol), phosphorus trichloride (0.09 mL,   
0.98 mmol), triethylamine (0.31 mL, 2.23 mmol) in toluene (10 mL) and water      
(16.00 µL, 0.89 mmol) and triethylamine (0.14 mL, 0.98 mmol) after filtration. After 
evaporation product 265 was obtained as a yellow solid of two diastereoisomers which 
were separated by column chromatography (n-hexane/EtOAc, 7:3).  
 
3.4.1.6.1. (1R,3R,5S)-4-Mesityl-1,8,8-trimethyl-2-(2,4,6-trimethylbenzyl)-
2,4-diaza-3-phosphabicyclo[3.2.1]octan-3-ol (265a) 
 
The product was obtained as a yellow solid (0.14g, 0.33 mmol, 37%).  
 
1
H-NMR (500 MHz, CDCl3) δ = 6.79 (t, J = 20.3 Hz, 4H, H-3’, H-5’, H-3’’, H-5’’), 
6.62 (d, J = 627.9 Hz, 1H, P-H), 4.49 (dd, J = 12.8, 5.9 Hz, 1H, H-1’’’), 4.29 – 4.12 (m, 
1H, H-1’’’), 3.09 (dd, J = 17.9, 5.0 Hz, 1H, H-5), 2.67 – 2.60 (m, 2H, H-6, H-7), 2.54 
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(s, 3H, 4’-CH3), 2.47 (s, 6H, 2’-CH3, 6’-CH3), 2.26 (s, 3H, 4’’-CH3), 2.20 (d, J = 9.3 
Hz, 6H, 2’’-CH3, 6’’-CH3), 2.09 – 2.01 (m, 1H, H-6), 1.91 – 1.85 (m, 1H, H-7), 1.37 (s, 
3H, H-9), 1.29 (m, 3H, H-11), 0.94 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 139.7 (C-1’), 138.3 (C-4’’), 137.6 (C-1’’), 137.1 (C-
6’’), 136.9 (C-1’’), 136.6 (C-6’), 130.8 (C-3’, C-5’), 130.5 (C-4’), 129.9 (C-3’’), 129.2 
(C-5’’), 73.4 (C-5), 70.6 (C-1), 48.5 (C-8), 42.3 (C-1’’), 35.8 (C-6), 30.6 (C-7), 25.9 
(4’-CH3), 22.1 (4’’-CH3), 21.5 (C-9), 20.9 (2’’-CH3), 20.7 (6’’-CH3), 20.7 (6’-CH3), 
20.6 (2’-CH3), 18.9 (C-11), 18.8 (C-10) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 1.9 ppm. 
IR (ATR)  = 3424, 2924, 2345, 2212, 1605, 1468, 1341, 1212, 1144, 1081, 1031, 968, 
850, 728, 565 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 439 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C27H40N2OP: 439.2878, found: 439.2874.  
[]20D = 54 (c = 0.56, EtOH). 
 
3.4.1.6.2. (1R,3S,5S)-4-Mesityl-1,8,8-trimethyl-2-(2,4,6-trimethylbenzyl)-
2,4-diaza-3-phosphabicyclo[3.2.1]octan-3-ol (265b) 
 
The product was obtained as a white solid (0.06 g, 0.14 mmol, 15%). 
1
H-NMR (500 MHz, CDCl3) δ = 6.79 (m, 4H, H-3, H-5, H-3’’, H-5’’), 6.69 (d, J = 
617.0 Hz, 1H, P-H), 4.28 (t, J = 10.7 Hz, 1H, H-1’’’), 4.14 (dd, J = 11.1, 7.1 Hz, 1H, H-
1’’’), 3.19 (ddd, J = 11.2, 3.5, 1.9 Hz, 1H, H-5), 2.58 – 2.45 (m, 1H, H-6), 2.44 (s, 6H, 
2’-CH3, 6’-CH3), 2.39 (s, 3H, 4’-CH3), 2.31 (s, 3H, 4’’-CH3), 2.19 (s, 3H, 2’’-CH3), 
2.18 (s, 3H, 6’’-CH3), 2.13 – 2.08 (m, 1H, H-7), 1.98 – 1.85 (m, 2H, H-6, H-7), 1.83 (s, 
1H, H-10), 1.45 (s, 1H, H-9), 1.01 (s, 1H, H-11) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 139.9 (C-1’), 139.1 (C-4’’), 137.9 (C-1’’), 136.9 (C-
2’’), 136.7 (C-6’’), 136.4 (C-4’), 130.3 (C-3’), 129.7 (C-5’), 129.0 (C-3’’, C-5’’), 127.8 
(C-2’), 127.7 (C-6’), 73.2 (C-5), 70.0 (C-1), 48.5 (C-8), 43.3 (C-1’’), 36.9 (C-6), 30.3 
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(C-7), 26.9 (4’-CH3), 21.0 (4’’-CH3), 20.7 (C-11), 20.4 (2’’-CH3), 20.0 (6’’-CH3), 19.9 
(6’-CH3), 19.6 (2’-CH3), 18.6 (C-9), 18.5 (C-10) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 4.2 ppm. 
IR (ATR)  = 3424, 2924, 2345, 2212, 1605, 1468, 1341, 1212, 1144, 1081, 1031, 968, 
850, 728, 565 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 439 ([M+H]
+
, 100%). 
HRMS (ESI): Calc. for C27H40N2OP: 439.2878, found: 439.2872.  
[]20D = 40 (c = 0.57, EtOH). 
 
3.4.1.7. (1R,3R,5S)-1,8,8-Trimethyl-4-(naphthalen-1-yl)-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octane             
3-oxide (266) 
 
 
 
Prepared from diamine 241 (0.17 g, 0.42 mmol), phosphorus trichloride (0.04 mL,   
0.46 mmol), triethylamine (0.15 mL, 1.05 mmol) in toluene (10 mL) and water        
(7.60 µL, 0.42 mmol) and triethylamine (0.06 mL, 0.46 mmol) after filtration. After 
evaporation product 266 was obtained as brown oil (0.16 g, 0.36 mmol, 85 %). 
 
1
H-NMR (500 MHz, CDCl3) δ = 8.29 (s, 1H, H-8’), 8.01 (s, 1H, H-5’), 7.83 (d, J = 8.1 
Hz, 1H, H-6’), 7.73 (d, J = 6.6 Hz, 1H, H-7’), 7.48 (m, 1H, H-4’), 7.31 – 7.26 (m, 1H, 
H-3’), 7.22 – 7.19 (m, 1H, H-2’), 6.81 (s, 2H, H- 3’’, H-5’’), 6.38 (d, J = 644.7 Hz, 1H, 
P-H), 4.41 (d, J = 10.4 Hz, 1H, H-1’’’), 4.29 – 4.20 (m, 1H, H-1’’’), 3.27 (d, J = 19.6 
Hz, 1H, H-5), 2.55 (s, 6H, 2’-CH3, 6’-CH3), 2.20 (s, 3H, 4’-CH3), 2.01 (m, 4H, H-6, H-
7), 1.66 (s, 3H, H-9), 1.50 (s, 3H, H-11), 1.01 (s, 3H, H-10) ppm. 
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13
C-NMR (126 MHz, CDCl3) δ = 139.1 (C-1’), 138.8 (C-4’’), 137.2 (C-1’’), 135.0 (C-
2’’, C-6’’), 131.9 (C-4’a, C-8’a), 129.1 (C-5’), 128.8 (C-3’’, C-5’’), 128.5 (C-3’), 127.2 
(C-6’), 126.1 (C-7’), 125.0 (C-8’), 125.7 (C-4’), 122.9 (C-2’), 73.9 (C-5), 70.2 (C-1), 
53.4 (C-8), 42.7 (C-1’’’), 36.0 (C-7), 29.7 (C-6), 24.9 (4’-CH3), 20.9 (C-11), 20.5 (2’-
CH3, 6’-CH3), 18.3 (C-9), 18.1 (C-10) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 4.9 ppm. 
IR (ATR)  = 3429, 2949, 2390, 2218, 1725, 1610, 1592, 1573, 1464, 1392, 1267, 
1197, 1150, 1113, 1079, 1052, 1014, 950, 885, 848, 796, 775, 726, 641, 571, 546, 519, 
461, 429 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 447 ([M+H]
+
, 81%); 469 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C28H36N2OP: 447.2565, found: 447.2574; C28H35N2ONaP: 
469.2385, found: 469.2388. 
[]20D = 48 (c = 0.45, EtOH). 
 
3.4.1.8. (1R,3R,5S)-4-([1,1'-Biphenyl]-2-yl)-1,8,8-trimethyl-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octane             
3-oxide (267) 
 
 
 
Prepared from diamine 242 (0.15 g, 0.35 mmol), phosphorus trichloride (0.03 mL,   
0.39 mmol), triethylamine (0.12 mL, 0.88 mmol) in toluene (10 mL) and water        
(6.00 µL, 0.35 mmol) and triethylamine (0.05 mL, 0.39 mmol) after filtration. After 
evaporation product 267 was obtained as a yellow solid (0.16 g, 0.34 mmol, 97%). 
 
Mp: 139.1 °C.  
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1
H-NMR (500 MHz, CDCl3) δ = 7.64 (d, J = 8.0 Hz, 1H, H-6’), 7.39 – 7.33 (m, 2H, H-
3’’, H-5’’), 7.29 – 7.24 (m, 3H, H-2’’, H-4’’, H-3’’), 7.21 – 7.16 (m, 3H, H-3’, H-4’, H-
5’), 6.81 (s, 2H, H-3’’’, H-5’’’), 6.23 (d, J = 642.7 Hz, 1H, P-H), 4.26 (dd, J = 11.7, 3.7 
Hz, 1H, H-1’’’’), 4.06 (dd, J = 20.8, 11.7 Hz, 1H, H-1’’’’), 3.03 – 2.95 (m, 1H, H-5), 
2.59 (ddd, J = 14.0, 9.7, 4.4 Hz, 1H, H-6), 2.40 (s, 6H, 2’’’-CH3, 6’’’-CH3), 2.26 (s, 3H, 
4’’’-CH3), 2.21 – 2.13 (m, 1H, H-7), 1.85 (dddd, J = 15.9, 13.5, 11.9, 4.5 Hz, 2H, H-6, 
H-7), 1.28 (s, 3H, H-9), 0.77 (s, 3H, H-11), 0.61 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 141.5 (C-2’), 141.3 (C-1’’), 140.8 (C-4’’’), 139.0 (C-
1’’’), 137.9 (C-2’’’), 137.4 (C-6’’’), 131.6 (C-3’’), 130.4 (C-5’’), 129.8 (C-4’), 129.1 
(C-2’), 129.1 (C-6’), 128.5 (C-3’’’), 128.3 (C-5’’’), 128.2 (C-4’’), 127.9 (C-6’), 127.1 
(C-5’), 126.0 (C-1’), 125.3 (C-3’), 74.0 (C-1), 70.0 (C-1’’’’), 47.3 (C-5), 42.5 (C-8), 
35.7 (C-7), 29.3 (4’’’-CH3), 24.7 (C-6), 21.5 (C-11), 21.0 (2’’’-CH3), 20.5 (6’’’-CH3), 
18.5 (C-9), 18.0 (C-10) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 5.4 ppm. 
IR (ATR)  = 3444, 2933, 2399, 1473, 1345, 1193, 1153, 1108, 1077, 1018, 976, 894, 
850, 762, 749, 703, 559, 528 cm
1
. 
MS (ESI, + 3 kV): m/z (%) = 472 ([M+H]
+
, 24%); 495 ([M+Na]
+
, 52%). 
HRMS (ESI): Calc. for C30H38N2OP: 473.2722, found: 473.2737; C30H37N2ONaP: 
495.2541, found: 495.2559. 
[]20D = 41 (c = 0.45, EtOH). 
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3.4.1.9. (1R,3R,5S)-4-(2-Isopropylphenyl)-1,8,8-trimethyl-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octane             
3-oxide (268) 
 
 
 
Prepared from diamine 243 (0.15 g, 0.37 mmol), phosphorus trichloride (0.04 mL,    
0.41 mmol), triethylamine (0.13 mL, 0.93 mmol) in toluene (10 mL) and water        
(6.70 µL, 0.37 mmol) and triethylamine (0.06 mL, 0.41 mmol) after filtration. After 
evaporation product 268 was obtained as a brown solid (0.14 g, 0.32 mmol, 86%). 
 
Mp: 157.2 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.23 – 7.04 (m, 3H, H-3’, H-4’, H-5’), 6.81 (d, J = 
33.2 Hz, 3H, H-6’, H-3’’, H-5’’), 6.23 (d, J = 638.8 Hz, 1H, PH), 4.40 – 4.06 (m, 2H, 
H-1’’’), 3.45 (s, 1H, 2’-CH), 3.07 (dd, J = 20.7, 5.3 Hz, 1H, H-5), 2.81 – 2.53 (m, 2H, 
H-7), 2.47 (s, 6H, 2’’-CH3, 6’’-CH3), 2.19 (s, 3H, 4’’-CH3), 1.96 (dd, J = 43.6, 32.4 Hz, 
2H, H-6), 1.47 – 1.32 (m, 6H, H-9, H-11), 1.31 – 1.13 (m, 6H, 2 x 2’-CH-CH3), 0.97 (s, 
3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 147.6 (C-1’), 139.9 (C-4’’), 138.9 (C-1’’), 137.5 (C-
2’’, C-6’’), 132.2 (C-3’’, C-5’’), 129.1 (C-6’), 128.5 (C-2’), 127.4 (C-4’), 126.5 (C-3’), 
126.3 (C-5’), 74.5 (C-5), 70.0 (C-1), 53.4 (2’-C), 47.8 (C-8), 42.6 (C-1’’’), 35.7 (C-6), 
29.9 (C-7), 26.6 (2’-C-CH3), 25.0 (2’-C-CH3), 24.5 (4’’-CH3), 23.9 (C-9), 20.9 (2’’-
CH3), 20.5 (6’’-CH3), 19.7 (C-10), 18.2 (C-11) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 5.4 ppm. 
IR (ATR)  = 3438, 2958, 2384, 1612, 1582, 1483, 1443, 1387, 1349, 1308, 1217, 
1151, 1112, 1079, 1055, 1016, 973, 890, 848, 754, 688, 548, 526, 506, 473, 446, 407 
cm
1
.  
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MS (ESI, + 3 kV): m/z (%) = 439 ([M+H]
+
, 63%); 461 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C27H40N2OP: 439.2878, found: 439.2880; C27H39N2ONaP: 
461.2698, found: 461.2700. 
[]20D =51 (c = 0.46, EtOH). 
 
3.4.2. Preparation of Trivalent Ligands from Chloro-
Derivatives 
 
General Procedure 
 
 
 
Solution of the suitable diamine (1 equiv.) in toluene was added to the mixture of 
phosphorus trichloride (1.1 equiv.) and triethylamine (2.5 equiv.) in toluene at 60 °C 
over 30 min. The solution was warmed to room temperature. After 2 h, the mixture was 
filtered through MgSO4 and the filtrate was again cooled to 60 °C. Triethylamine    
(1.1 equiv.) and alcohol (1 equiv.) were added and the cooling bath was removed. After 
1 h, the reaction mixture was filtered again through MgSO4 and the filtrate was 
concentrated under reduced pressure. 
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3.4.2.1. (1R,3S,5S)-2,4-Dibenzyl-3-methoxy-1,8,8-trimethyl-2,4-diaza-3-
phosphabicyclo[3.2.1]octane (269) 
 
 
 
The general procedure was followed for diamine 214 (0.60 g, 1.86 mmol), phosphorus 
trichloride (0.18 mL, 2.05 mmol) and triethylamine (0.66 mL, 4.65 mmol) in toluene 
(10 mL), methanol (75.00 µL, 1.86 mmol) and triethylamine (0.28 mL, 2.05 mmol) 
after filtration. No product was obtained. 
 
3.4.2.2. (1R,3R,5S)-3-Methoxy-1,8,8-trimethyl-4-(o-tolyl)-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octane (270) 
 
 
 
The general procedure was followed for diamine 237 (0.26 g, 0.72 mmol), phosphorus 
trichloride (0.07 mL, 0.79 mmol) and triethylamine (0.25 mL, 1.80 mmol) in toluene 
(10 mL), methanol (29.00 µL, 0.72 mmol) and triethylamine (0.11 mL, 0.79 mmol) 
after filtration. No product was obtained. 
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3.4.2.3. (1R,3S,5S)-2,4-Dibenzyl-1,8,8-trimethyl-3-phenoxy-2,4-diaza-3-
phosphabicyclo[3.2.1]octane (271) 
 
 
 
The general procedure was followed for diamine 214 (0.60 g, 1.86 mmol), phosphorus 
trichloride (0.18 mL, 2.05 mmol) and triethylamine (0.66 mL, 4.65 mmol) in toluene 
(10 mL), phenol (0.18 g, 1.86 mmol) and triethylamine (0.28 mL, 2.05 mmol) after 
filtration. No product was obtained. 
 
3.4.2.4. (1R,3R,5S)-1,8,8-Trimethyl-3-phenoxy-4-(o-tolyl)-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octane (272) 
 
 
 
The general procedure was followed for diamine 237 (0.26 g, 0.72 mmol), phosphorus 
trichloride (0.07 mL, 0.79 mmol) and triethylamine (0.25 mL, 1.80 mmol) in toluene 
(10 mL), phenol (0.08 g, 0.72 mmol) and triethylamine (0.11 mL, 0.79 mmol) after 
filtration. No product was obtained. 
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3.4.3. Preparation of Trivalent Phosphorus Derivatives from 
Hexamethylphosphorus Triamide 
 
General Procedure 
 
 
 
A solution of the suitable diamine (1 equiv.) in toluene was added to the mixture of 
hexamethylphosphorus triamide (1.3 equiv.) in toluene. The solution was refluxed over 
96 h. 
 
3.4.3.1. (1R,3S,5S)-2,4-Dibenzyl-N,N,1,8,8-pentamethyl-2,4-diaza-3-
phosphabicyclo[3.2.1]octan-3-amine (273) 
 
 
 
Prepared from diamine 214 (150.00 mg, 0.45 mmol) and hexamethylphosphorus 
triamide (0.11 mL, 0.59 mmol) in toluene (5 mL). The desired product was not 
obtained. 
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3.4.3.2. (1R,3R,5S)-N,N,1,8,8-Pentamethyl-4-(o-tolyl)-2-(2,4,6-
trimethylbenzyl)-2,4-diaza-3-phosphabicyclo[3.2.1]octan-3-amine 
(274) 
 
 
 
Prepared from diamine 237 (150.00 mg, 0.41 mmol) and hexamethylphosphorus 
triamide (0.10 mL, 0.54 mmol) in toluene (5 mL). The desired product was not 
obtained. 
 
3.4.4. Preparation of Pentavalent Phosphorus Oxide 
 
General Procedure  
 
 
 
A solution of the suitable diamine (1 equiv.) in dichloromethane was added dropwise to 
the mixture of phosphorus compound (1.2 equiv.) and triethylamine (2.4 equiv.) in 
dichloromethane at 0 
o
C. The reaction mixture was warmed to room temperature and 
stirred for 96 h. The solution was washed with distilled water and brine. The organic 
phase was separated and dried over MgSO4. The solvent was evaporated and the crude 
product was separated by column chromatography. The method of isolation for each 
compounds are given below. 
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3.4.4.1. 2,4-Dibenzyl-1,8,8-trimethyl-3-phenoxy-2,4-diaza-3-
phosphabicyclo[3.2.1]octane 3-oxide (275) 
 
 
 
Prepared from diamine 214 (0.35 g, 1.09 mmol), phenyl dichlorophosphate (0.31 mL, 
1.31 mmol) and triethylamine (0.37 mL, 2.62 mmol) in dichloromethane (10 mL). After 
evaporation product 268 was obtained as two diastereoisomers which were separated by 
column chromatography (n-hexane/EtOAc, 5:5). The spectroscopic properties concur 
with published data.
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3.4.4.1.1. (1R,3S,5S)-2,4-Dibenzyl-1,8,8-trimethyl-3-phenoxy-2,4-diaza-3-
phosphabicyclo[3.2.1]octane 3-oxide (275a) 
 
The product was obtained as a white solid (0.13 g, 0.28 mmol, 27 %). 
 
Mp: 124.3 °C.  
1
H-NMR (500 MHz, CDCl3) δ = 7.43 – 7.06 (m, 15H, H-1’, H-2’, H-3’, H-4’, H-5’, H-
1’’, H-2’’, H-3’’, H-4’’, H-5’’, H-1’’’, H-2’’’, H-3’’’, H-4’’’, H-5’’'), 4.55 (dd, J = 17.0, 
12.6 Hz, 1H, H-1’’’’), 4.36 (dd, J = 15.1, 8.7 Hz, 1H, H-1’’’’’), 4.15 (ddd, J = 15.2, 
13.0, 6.3 Hz, 2H, H-1’’’’, H-1’’’’’), 2.93 – 2.86 (m, 1H, H-5), 2.61 (ddd, J = 14.1, 9.7, 
4.7 Hz, 1H, H-6), 2.27 (ddd, J = 14.1, 9.7, 4.5 Hz, 1H, H-7), 2.03 – 1.97 (m, 1H, H-6), 
1.85 – 1.78 (m, 1H, H-7), 1.19 (s, 3H, H-11), 0.95 (s, 3H, H-9), 0.76 (s, 3H, H-10) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 153.2 (C-1’), 141.9 (C-1’’), 138.1 (C-1’’’), 129.5 (C- 
C-3’, C-5’), 128.6 (C-3’’, C-5’’), 128.3 (C-3’’’, C-5’’’), 128.2 (C-2’’, C-6’’), 127.2 (C-
C-2’’’, C-6’’’), 127.1 (C-4’’), 126.4 ( C-4’’’), 123.7 (C-4’), 120.4 (C-2’, C-6’), 72.4 (C-
1’’’’’), 67.8 (C-1’’’’), 51.2 (C-1), 47.2 (C-5), 46.7 (C-8), 27.8 (C-7), 24.0 (C-6), 19.1 
(C-11), 19.0 (C-9), 18.3 (C-10) ppm. 
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31
P-NMR (202 MHz, CDCl3) δ = 12.0 ppm. 
IR (ATR)  = 3061, 2938, 1595, 1488, 1452, 1375, 1242, 1203, 1100, 1065, 870, 767, 
723, 688, 511 cm
1
.  
MS (ESI, + 3 kV): m/z (%) = 461 ([M+H]
+
, 11%); 483 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C28H34N2O2P: 461.2358, found: 461.2359; C28H33N2O2NaP: 
483.2177, found: 483.2175. 
[]20D =3 (c = 0.49, EtOH). 
 
3.4.4.1.2. (1R,3R,5S)-2,4-Dibenzyl-1,8,8-trimethyl-3-phenoxy-2,4-diaza-3 
-phosphabicyclo[3.2.1]octane 3-oxide (275b) 
 
The product was obtained as colorless liquid (0.22 g, 0.48 mmol, 43%). 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.55 – 6.96 (m, 15H, H-1’, H-2’, H-3’, H-4’, H-5’, H-
1’’, H-2’’, H-3’’, H-4’’, H-5’’, H-1’’’, H-2’’’, H-3’’’, H-4’’’, H-5’’' ), 4.87 – 4.81 (m, 
1H, H-1’’’’), 4.57 (dd, J = 15.7, 10.0 Hz, 1H, H-1’’’’’), 4.22 – 4.14 (m, 1H, H-1’’’’’), 
3.98 (dd, J = 15.7, 4.2 Hz, 1H, H-1’’’’), 2.91 (dd, J = 27.3, 5.4 Hz, 1H, H-5), 2.43 (ddd, 
J = 13.9, 9.7, 4.4 Hz, 1H, H-6), 2.19 (ddd, J = 14.3, 9.7, 4.7 Hz, 1H, H-7), 1.98 – 1.91 
(m, 1H, H-7), 1.74 (ddd, J = 13.7, 12.0, 4.7 Hz, 1H, H-6), 1.44 (s, 3H, H-9), 1.00 (s, 3H, 
H-10), 0.80 (s, 3H, H-11) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 152.9 (C-1’), 141.7 (C-1’’’), 138.1 (C-1’’), 129.3 (C-
3’, C-5’), 128.5 (C-3’’’, C-5’’’), 128.4 (C-3’’, C-5’’), 128.3 (C-2’’’, C-6’’’), 127.4 (C-
2’’, C-6’’), 126.9 (C-4’’), 126.5 (C-4’’’), 123.9 (C-4’), 120.8(C-2’, C-6’) , 72.7 (C-
1’’’’), 67.9 (C-1’’’’’), 49.6 (C-1), 47.2 (C-5), 46.0 (C-8), 36.5 (C-7), 28.3 (C-6), 24.8 
(C-11), 19.0 (C-10), 18.9 (C-9) ppm. 
31
P-NMR (202 MHz, CDCl3) δ = 14.4 ppm. 
IR (ATR)  = 2938, 1587, 1484, 1448, 1369, 1198, 1203, 1086, 1058, 907, 870, 753, 
726, 689 cm
1
.  
Experimental 
163 
 
MS (ESI, + 3 kV): m/z (%) = 461 ([M+H]
+
, 71%); 483 ([M+Na]
+
, 100%). 
HRMS (ESI): Calc. for C28H34N2O2P: 461.2358, found: 461.2361; C28H33N2O2NaP: 
483.2177, found: 483.2177. 
[]20D =37 (c = 0.54, EtOH). 
 
3.4.4.2. (1S,3R,5S)-2,4-Dibenzyl-3-(dimethylamino)-1,8,8-trimethyl-2,4-
diaza-3-phosphabicyclo[3.2.1]octane 3-oxide (276) 
 
 
 
Diamine 214 (0.35 g, 1.09 mmol), dimethylphosphoramidic dichloride (0.21 g,         
1.31 mmol) and triethylamine (0.37 mL, 2.62 mmol) were placed in dichloromethane        
(10 mL). No product was obtained. 
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3.5. Allylic Substitution 
 
3.5.1. Pd-Catalyzed Asymmetric Allylic Alkylation with 
Carbon Nucleophiles 
 
General Procedure  
 
 
 
 
The appropriate ligand (0.1 equiv.) and BSA (4 equiv.) were dissolved in a solvent      
(1 mL) and the mixture was stirred for 24 h at room temperature under an argon 
atmosphere. Pdcat. (0.025 equiv.) was added and the mixture was stirred for 40 min. A 
solution of diphenylallyl acetate (1 equiv.), keto ester (1.5 equiv.) and base (0.1 equiv.) 
in a solvent (0.5 mL) was added and the reaction mixture was stirred at various 
temperatures for 24h. The solvent was removed under reduced pressure and the crude 
product was purified by a silica gel flash column chromatography to give the 
corresponding product. Spectral data were consistent with literature values and the 
absolute configuration was assigned by comparison to literature values (For optimal 
conditions see Table 13-17). 
 
3.5.1.1. (E)-Dibenyl 2-(1,3-diphenylallyl)malonate (277) 
 
 
 
Prepared according to the general procedure from ligand 260 (12.00 mg, 0.03 mmol), 
BSA (0.31 mL, 1.27 mmol), (η3-C3H5)2Pd2Cl2 (2.90 mg, 7.93∙10
-3
 mmol), -trans-
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1,3-diphenylallyl acetate 202 (80 mg, 0.32 mmol), dibenzyl malonate (0.12 mL,       
0.48 mmol) and KOAc (3.11 mg, 0.03 mmol) in toluene (1 mL). The crude product was 
purified via column chromatography (n-hexane/EtOAc, 90:10) and obtained as colorless 
oil (5.60 mg, 0.01 mmol, 4%). Spectral data were consistent with literature values.
201
 
 
1
H-NMR (500 MHz, CDCl3) δ = 7.43 – 7.01 (m, 20H, H-2’’, H-3’’, H-4’’, H-5’’ H-6’’, 
H-2’’’, H-3’’’, H-4’’’, H-5’’’ H-6’’’, H-2’’’’, H-3’’’’, H-4’’’’, H-5’’’’ H-6’’’’, H-2’’’’’, 
H-3’’’’’, H-4’’’’’, H-5’’’’’ H-6’’’’’), 6.41 (d, J = 15.8 Hz, 1H, H-4), 6.31 (dd, J = 15.7, 
8.4 Hz, 1H, H-5), 5.11 (m, 2H, 1’-O-CH2), 4.90 (m, 2H, 1-O-CH2), 4.29 (m, 1H, H-3), 
4.05 (d, J = 10.8 Hz, 1H, H-2) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 167.6 (C-1), 167.2 (C-1’), 140.1 (C-1’’’), 136.8 (C-
1’’), 135.2 (C-1’’’’, C-1’’’’’), 135.0 (C-3’’’’), 131.9 (C-5), 129.0 (C-5’’’’), 128.8 (C-
3’’’’’, C-5’’’’’), 128.5 (C-3’’C-5’’), 128.4 (C-3’’’, C-5’’’), 128.3 (C-2’’, C-6’’), 128.2 
(C-4’’), 128.1 (C-2’’’, C-6’’’), 127.5 (C-4’’’’, C-4’’’’’), 127.4 (C-2’’’’, C-6’’’’), 127.2 
(C-2’’’’’, C-6’’’’’), 126.5 (C-4’’’), 67.4 (1-O-CH2), 67.1 (1’-O-CH2), 57.8 (C-2), 49.0 
(C-3) ppm. 
 
3.5.1.2. (E)-Dimethyl 2-(1,3-diphenylallyl)malonate (278) 
 
 
 
The general procedure was followed for ligand 260 (12.00 mg, 0.03 mmol), BSA    
(0.31 mL, 1.27 mmol), (η3-C3H5)2Pd2Cl2 (2.90 mg, 7.93∙10
-3
 mmol), -trans-1,3-
diphenylallyl acetate 202 (80 mg, 0.32 mmol), dimethyl malonate (0.05 mL,             
0.48 mmol) and KOAc (3.11 mg, 0.03 mmol) in toluene (1 mL). The product was not 
obtained. 
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3.5.1.3. (E)-Diethyl 2-(1,3-diphenylallyl)malonate (279) 
 
 
 
The general procedure was followed for ligand 260 (12.00 mg, 0.03 mmol), BSA    
(0.31 mL, 1.27 mmol), (η3-C3H5)2Pd2Cl2 (2.90 mg, 7.93∙10
-3
 mmol), -trans-1,3-
diphenylallyl acetate 202 (80 mg, 0.32 mmol), diethyl malonate (0.07 mL, 0.48 mmol) 
and KOAc (3.11 mg, 0.03 mmol) in toluene (1 mL). The product was not obtained. 
 
3.5.1.4. Methyl 1-cinnamyl-2-oxocyclopentanecarboxylate (281) 
 
 
 
The general procedure was followed for ligand 260 (10.00 mg, 0.03 mmol), BSA    
(0.28 mL, 1.14 mmol), (η3-C3H5)2Pd2Cl2 (2.60 mg, 7.10∙10
-3
 mmol), cinnamyl acetate 
280 (0.05 mL, 0.28 mmol), methyl 2-oxocyclopentanecarboxylate (0.05 mL,             
0.43 mmol) and Zn(OAc)2 (5.21 mg, 0.03 mmol) in toluene (1 mL). The corresponding 
product was not obtained. 
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3.5.2. Pd-Catalyzed Allylic Substitution with Non-Carbon 
Nucleophile 
 
3.5.2.1. (R,E)-N-Benzyl-1,3-diphenylprop-2-en-1-amine (282) 
 
 
 
The general procedure was followed for ligand 262 (5.00 mg, 1.22∙10-4 mmol,          
0.04 equiv.), BSA (0.23 mL, 0.01 mmol, 3 equiv.), (η3-C3H5)2Pd2Cl2 (1.10 mg,   
3.05∙10-3 mmol, 0.01 equiv.), (±)-trans-1,3-diphenylallyl acetate 202 (75 mg,          0.31 
mmol, 1 equiv.) and benzylamine (0.10 mL, 0.91 mmol, 3 equiv.) in methyl chloride (1 
mL). The corresponding product was not obtained. 
 
3.6. The Construction of Chiral Organoboranes 
 
3.6.1. Copper-Catalyzed Asymmetric Hydroboration 
 
General Procedure 
 
 
 
The HASPO ligand (0.11 equiv.) and BSA (0.09 equiv.) were dissolved in toluene       
(1 mL) and the mixture was stirred for 24 h at room temperature under an argon 
atmosphere. CuCl (0.1 equiv.) was added and the mixture was stirred 10 min. A 
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solution of methyl cinnamate (1 equiv.), Bin2Pin2 (1.1 equiv.) and NaOtBu (.3 equiv.) in 
toluene (1 mL) was added and the reaction mixture was stirred at 55 °C 10 min. 
MeOH (2 equiv.) was added and the reaction mixture was stirred at 55 °C 24 h. The 
solvent was removed under reduced pressure and the crude product was purified by 
silica gel flash column chromatography. The enantiomeric excess was determined by 
chiral HPLC analysis. Spectra data were consistent with literature values (For yields and 
enantiomeric excess see Table 18-20). 
 
3.6.1.1. Methyl 3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) 
propanoate (283) 
 
 
 
Prepared from HASPO ligand 262 (10 mg, 2.44∙10-2 mmol), BSA (5µL, 0.02 mmol), 
CuCl (2.19 mg, 2.21∙10-2 mmol) methyl cinnamate 280 (36 mg, 0.22 mmol), Bin2Pin2 
(62 mg, 0.24 mmol), NaOtBu (6.38 mg, 6.64∙10-2 mmol, 0.3 equiv.) and MeOH (18 µL, 
0.44 mmol) in toluene. The crude product was purified by silica gel flash column 
chromatography (n-hexane/EtOAc, 95:5). The corresponding product 283 was obtained 
as colorless oil (0.025 g, 0.09 mmol, 51%). Spectra data were consistent with literature 
values.
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1
H-NMR (500 MHz, CDCl3) δ = 7.27 – 7.20 (m, 4H, H-6‘, H-5‘, H-3‘, H-2‘),          
7.17 – 7.13 (m, 1H, H-4‘), 3.61 (s, 3H, H-1‘‘‘), 2.89 (dd, J = 16.2, 10.0 Hz, 1H, H-2), 
2.74 (dd, J = 10.0, 6.1 Hz, 1H, H-3), 2.66 (dd, J = 16.2, 6.0 Hz, 1H, H-2), 1.22 (s, 6H, 
5‘‘-CH3, 4‘‘-CH3), 1.17 (s, 6H, 5‘‘-CH3, 4‘‘-CH3) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 173.8 (C-1), 141.4 (C-1‘), 128.5 (C-5‘, C-3‘), 128.2 
(C-6‘, C-2‘), 125.7 (C-4‘), 83.3 (C-5‘‘, C-4‘‘), 51.3 (C-1‘‘‘), 36.8 (C-2, C-3), 24.6 (5‘‘-
CH3, 4‘‘-CH3), 24.3 (5‘‘-CH3, 4‘‘-CH3) ppm. 
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HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 90/10 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tmajorr= 9.25 min, tminor= 13.79 min; 0% ee.  
 
3.6.2. Organocatalytic Pinacolboryl Addition to 
Tosylaldimines 
 
General Procedure 
 
 
 
The HASPO ligand (0.03 equiv.) and BSA (0.09 equiv.) were dissolved in THF (1 mL) 
and the mixture was stirred for 24 h at room temperature under an argon atmosphere. 
Tosylaldimines ((1 equiv.), CuCl (0.04 equiv.), Bin2Pin2 (1.2 equiv.) and Cs2CO3    
(0.15 equiv.) were added and the reaction was stirred at room temperature for 10 min. 
MeOH (2.5 equiv.) was added and the reaction mixture was stirred at reflux for 24 h. 
(For optimal conditions see Table 21). 
 
3.6.2.1. N-((4-Chlorophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) 
methyl) benzenesulfonamide (288) 
 
 
 
The general procedure was followed for ligand 262 (4.11 mg, 0.01 mmol) BSA       
(7.70 μL, 0.03 mmol), CuCl (1.39 mg, 1.40.10-2 mmol), B2Pin2 (106.65 mg,              
0.42 mmol), (E)-N-(4-chlorobenzylidene) benzenesulfonamide 284 (98.00 mg,         
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0.35 mmol), Cs2CO3 (17.10 mg, 0.05 mmol) and MeOH (0.04 mL, 0.88 mmol) in THF 
(1 mL). The corresponding product was not obtained. 
 
3.6.2.2. N-((2-Chlorophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) 
methyl) benzenesulfonamide (289) 
 
 
 
The general procedure was followed for ligand 262 (4.11 mg, 0.01 mmol) BSA       
(7.70 μL, 0.03 mmol), CuCl (1.39 mg, 1.40.10-2 mmol), B2Pin2 (106.65 mg,              
0.42 mmol), (E)-N-(2-chlorobenzylidene) benzenesulfonamide 285 (98.00 mg,         
0.35 mmol), Cs2CO3 (17.10 mg, 0.05 mmol) and MeOH (0.04 mL, 0.88 mmol) in THF 
(1 mL). The corresponding product was not obtained. 
 
3.6.2.3. 2,4-Dinitro-N-(phenyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) 
methyl) benzenesulfonamide (290) 
 
 
 
The general procedure was followed for ligand 262 (4.06 mg, 9.90∙10-3 mmol), BSA 
(7.26 μL, 0.03 mmol), CuCl (0.99 mg, 0.01 mmol), B2Pin2 (100.00 mg, 0.40 mmol), 
(E)-N-benzylidene-2,4-dinitrobenzenesulfonamide 286 (111.00 mg, 0.33 mmol), 
Cs2CO3 (16.12 mg, 0.05 mmol) and MeOH (0.03 mL, 0.83 mmol) in THF (1 mL). The 
corresponding product was not obtained. 
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3.6.2.4. 4-Methyl-N-(phenyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) 
methyl)benzenesulfonamide (291) 
 
 
 
The general procedure was followed for ligand 262 (4.11 mg, 0.01 mmol), BSA      
(9.42 μL, 0.04 mmol), CuCl (0.99 mg, 0.01 mmol), B2Pin2 (131.03 mg, 0.52 mmol), 
(E)-N-benzylidene-4-methylbenzenesulfonamide 287 (111.00 mg, 0.43 mmol), Cs2CO3 
(19.55 mg, 0.06 mmol) and MeOH (0.04 mL, 1.08 mmol) in THF (1 mL). The 
corresponding product was not obtained. 
 
3.7. Michael Addition 
 
General Procedure 
 
The appropriate ligand (0.05 equiv.) and catalyst (0.08 equiv.) were dissolved in toluene 
(2 mL). The Michael donor (1 equiv.) and chalcone (1 equiv.) were added and the 
reaction mixture was stirred at room temperature over 24 h. The solvent was removed 
under reduced pressure and the crude product was purified by silica gel flash column 
chromatography to give the corresponding product. The enantiomeric excess was 
determined by chiral HPLC analysis. Spectra data were consistent with literature values 
(For yields and enantiomeric excess see Table 22). 
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3.7.1. 1,3-Diphenyl-3-(phenylthio)propan-1-one (294) 
 
 
 
Prepared according to the general procedure from ligand 267 (10.00 mg, 0.02 mmol), 
HoCl3 (8.14 mg, 0.03 mmol), (E)-N-benzylidene-tiophenol 292 (46.00 mg, 0.42 mmol) 
and chalcone 293 (87.00 mg, 0.42 mmol) in toluene (1 mL). The crude product was 
purified via column chromatography (Petrolether/EtOAc, 10:1) to give a while solid 
(65.00 mg, 0.21 mmol, 49%). Spectral data were consistent with literature values.
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1
H-NMR (500 MHz, CDCl3) δ = 7.90 – 7.86 (m, 2H, H-2’’’, H-6’’’), 7.56 – 7.51 (m, 
1H, H-4’’’), 7.41 – 7.45 (m, 2H, H-3’’’, H-5’’’), 7.32 – 7.35 (m, 4H, H-2’, H-6’, H-2’’, 
H-6’’), 7.17 – 7.27 (m, 6H, H-3’, H-4’, H-5’, H-3’’, H-4’’, H-5’’), 4.97 (dd, J = 8.1, 6.0 
Hz, 1H, H-2), 3.63 (ddd, J = 23.1, 17.1, 7.1 Hz, 2H, H-3) ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 197.0 (C-1), 141.2 (C-1’), 136.8 (C-1’’), 134.3 (C-
1’’’), 133.2 (C-4’’’), 132.8 (C-2’’, C-6’’), 128.9 (C-3’’, C-5’’), 128.6 (C-3’, C-5’), 
128.4 (C-3’’’, C-5’’’), 128.1 (C-2’’’, C-6’’’), 127.8 (C-2’, C-6’), 127.5 (C-4’), 127.4 
(C-4’’), 48.3 (C-2), 44.5 (C-3) ppm. 
HPLC (Chiralcel OD-H, n-hexane/i-PrOH, 50:50 v/v, 1 mL/min, 25 
o
C, UV = 250 nm): 
tminor= 8.37 min, tmajor= 9.23 min; 9% ee. 
 
3.7.2. Diethyl 2-(3-oxo-1,3-diphenylpropyl)malonate (296) 
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The general procedure was followed for ligand 267 (10.00 mg, 0.02 mmol), K2CO3 
(49.00 mg, 0.35 mmol), diethyl malonate (28.00 mg, 0.17 mmol) and chalcone 295 
(24.00 mg, 0.12 mmol) in toluene (1 mL). The corresponding product was not obtained. 
 
3.8. HASPO Ligands as Chiral Shift Reagents 
 
3.8.1. NMR Experiments with HASPO Ligands and 
Racemic Compounds 
The HASPO ligand (1 equiv.) and the corresponding racemic compound (1 equiv.) were 
dissolved in deuterated toluene and the 
1
H-NMR and 
19
F-NMR spectra were recorded at 
room temperature. For results see Table 23-26. 
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4. Appendix 
 
HPLC- Chromatograms: 
 
(R)-2-Nitro-1-phenylethanol 
 
 
 
 
 
 
 
 
(S)-2-Nitro-1-phenylethanol 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 11.79 2103392 46.280 
2 14.11 2441529 53.720 
  4544921 100.000 
Appendix 
176 
 
 
 
 
 
 
 
rac-2-Nitro-1-phenylethanol  
 
 
 
 
 
 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 11.76 642200 11.314 
2 14.05 5034138 88.686 
  5676338 100.000 
No. Retention time (tR) [min] Area Concentration [%] 
1 11.41 1380064 49.921 
2 13.65 1384459 50.079 
  2764523 100.000 
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(S)-Nitro-1-(3-Chlorophenyl)-2-nitroethanol 
 
 
 
 
 
 
 
rac-Nitro-1-(3-Chlorophenyl)-2-nitroethanol 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 11.55 1651660 19.285 
2 13.97 6912896 80.715 
  8564556 100.000 
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(S)-2-Nitro-1-(2-nitrophenyl)ethanol 
 
 
 
 
 
 
 
 
 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 11.57 1308219 51.116 
2 14.08 1251098 48.884 
  2559317 100.000 
No. Retention time (tR) [min] Area Concentration [%] 
1 13.36 1056635 9.037 
2 14.61 10635950 90.963 
  11692585 100.000 
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rac-2-Nitro-1-(2-nitrophenyl)ethanol  
 
 
 
 
 
 
(S)-2-Nitro-1-(3-nitrophenyl)ethanol 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 13.12 3717980 49.935 
2 14.51 3727693 50.065 
  7445673 100.000 
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rac-2-Nitro-1-(3-nitrophenyl)ethanol  
 
 
 
 
 
 
(S)-1-(2-Methoxyphenyl)-2-nitroethanol 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 20.56 1816018 20.766 
2 22.72 6929058 79.234 
  8745076 100.000 
No. Retention time (tR) [min] Area Concentration [%] 
1 20.48 4101677 50.106 
2 22.75 4084300 49.894 
  8185977 100.000 
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rac-1-(2-Methoxyphenyl)-2-nitroethanol  
 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 10.32 989689 8.768 
2 11.55 10298249 91.232 
  11287938 100.000 
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2-Nitro-1-phenylpropan-1-ol 
 
 
 
 
 
 
 
 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 10.48 2590044 49.390 
2 11.76 2654049 50.610 
  5244093 100.000 
No. Retention time (tR) [min] Area Concentration [%] 
1 26.77 2488446 25.005 
2 30.69 1428573 14.355 
3 33.33 4754230 47.773 
4 41.55 1280500 12.867 
  9951749 100.000 
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rac-2-Nitro-1-phenylpropan-1-ol  
 
 
 
 
 
 
 
 
2-Nitro-1-(2-nitrophenyl)propan-1-ol 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 28.03 1607321 14.293 
2 32.19 1526350 13.573 
3 35.23 4181356 37.183 
4 44.13 3930324 34.951 
  11245351 100.000 
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rac-2-Nitro-1-(2-nitrophenyl)propan-1-ol  
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 59.65 10341972 50.021 
2 63.41 3203503 15.494 
3 74.88 1551729 7.505 
4 81.81 5577920 26.979 
  20675124 100.000 
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1-(2-Methoxyphenyl)-2-nitropropan-1-ol 
 
 
 
 
 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 61.39 5649298 24.282 
2 64.99 5543324 23.826 
3 76.51 5977812 25.694 
4 83.81 6095182 26.198 
  23265616 100.000 
No. Retention time (tR) [min] Area Concentration [%] 
1 27.41 5519955 50.869 
2 38.45 2422516 22.325 
3 46.67 2368883 21.830 
4 68.00 539973 4.976 
  10851327 100.000 
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rac-1-(2-Methoxyphenyl)-2-nitropropan-1-ol 
 
 
 
 
 
 
 
 
 
 
No. Retention time (tR) [min] Area Concentration [%] 
1 27.36 5298323 36.077 
2 38.69 4895988 33.337 
3 47.55 2308814 15.721 
4 69.65 2183132 14.865 
  14686257 100.000 
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